<SEC-DOCUMENT>0001493152-22-008931.txt : 20220404
<SEC-HEADER>0001493152-22-008931.hdr.sgml : 20220404
<ACCEPTANCE-DATETIME>20220404063409
ACCESSION NUMBER:		0001493152-22-008931
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220401
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220404
DATE AS OF CHANGE:		20220404

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanara MedTech Inc.
		CENTRAL INDEX KEY:			0000714256
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				592220004
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39678
		FILM NUMBER:		22800344

	BUSINESS ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102
		BUSINESS PHONE:		817-529-2300

	MAIL ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WOUND MANAGEMENT TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20080611

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MB SOFTWARE CORP
		DATE OF NAME CHANGE:	19960805

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INAV TRAVEL CORPORATION
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:SMTI="http://sanaramedtech.com/20220330">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_039_SMTI_sanaramedtech.com_20220330 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20220401_20220401 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000714256 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityCentralIndexKey">0000714256</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="smti-20220330.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-04-01to2022-04-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000714256</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>UNITED
STATES</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 12pt Times New Roman, Times, Serif"><b>Washington,
D.C. 20549</b></span></p>

<p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5in; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>FORM
<span id="xdx_90D_edei--DocumentType_c20220401__20220401_zcBjLphj24Qc"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Date
of Report (Date of earliest event reported): <span id="xdx_90A_edei--DocumentPeriodEndDate_c20220401__20220401_zm9kcRWjLkwb"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">April 1, 2022</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityRegistrantName_c20220401__20220401_zn5GfncDtOvb"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityRegistrantName">SANARA
    MEDTECH INC.</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Exact
    name of registrant as specified in its charter)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20220401__20220401_zTXG4rnIZE1b"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Texas</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_901_edei--EntityFileNumber_c20220401__20220401_z27M60sWdat"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityFileNumber">001-39678</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20220401__20220401_zAGGjrMv2ITl"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityTaxIdentificationNumber">59-2219994</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State
    or other jurisdiction<br />
of
    incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission
    <br />
File Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS
    Employer<br />
Identification
    No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_909_edei--EntityAddressAddressLine1_c20220401__20220401_z2WwGk3Cu0n1"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityAddressAddressLine1">1200
    Summit Avenue</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressAddressLine2_c20220401__20220401_zTm1COeHqcC3"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityAddressAddressLine2">Suite 414</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityAddressCityOrTown_c20220401__20220401_zOLyUypk4ERg"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityAddressCityOrTown">Fort
    Worth</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20220401__20220401_z27nSK8KiuDl"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--EntityAddressPostalZipCode_c20220401__20220401_zJQAXx7Djqef"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityAddressPostalZipCode">76102</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_901_edei--CityAreaCode_c20220401__20220401_zsrhsXPLLrmk"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:CityAreaCode">(817)</ix:nonNumeric></span> <span id="xdx_90A_edei--LocalPhoneNumber_c20220401__20220401_z94z9dc5XQ81"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:LocalPhoneNumber">529-2300</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Not
Applicable</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_edei--WrittenCommunications_c20220401__20220401_zx9oGA0Obk15"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--SolicitingMaterial_c20220401__20220401_zrXnKyCIXJJe"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--PreCommencementTenderOffer_c20220401__20220401_zegiGL28TMz2"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20220401__20220401_zOS5gQjvwaT2"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 36%"><span style="font: 10pt Times New Roman, Times, Serif">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; vertical-align: top; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 18%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
                                                                                                                                            Symbol(s)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; vertical-align: top; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 42%"><span style="font: 10pt Times New Roman, Times, Serif">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_edei--Security12bTitle_c20220401__20220401_zgobCk8PV67g"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:Security12bTitle">Common
    Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--TradingSymbol_c20220401__20220401_zeDwphknCcf9"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:TradingSymbol">SMTI</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span>The
    <span id="xdx_904_edei--SecurityExchangeName_c20220401__20220401_z8FkMunJ1zB8"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Emerging
growth company <span id="xdx_906_edei--EntityEmergingGrowthCompany_c20220401__20220401_zIT7sqcyOhvb"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i></i></b></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Agreement
and Plan of Merger</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, Sanara MedTech Inc., a Texas corporation (the &#8220;Company&#8221;), entered into an Agreement and Plan of Merger (the
&#8220;Merger Agreement&#8221;), by and among the Company, United Wound and Skin Solutions, LLC, a Delaware limited liability company
and wholly owned subsidiary of the Company (&#8220;UWSS&#8221;), Precision Healing Inc., a Delaware corporation (&#8220;Precision Healing&#8221;),
PH Merger Sub I, Inc., a Delaware corporation (&#8220;Merger Sub I&#8221;), PH Merger Sub II, LLC, a Delaware limited liability company
(&#8220;Merger Sub II&#8221;), and Furneaux Capital Holdco, LLC (d/b/a BlueIO), solely in its capacity as the representative of the securityholders
of Precision Healing (&#8220;BlueIO&#8221; and together with the other parties to the Merger Agreement, the &#8220;Merger Parties&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Precision
Healing is developing a diagnostic imaging and smart pad for assessing a patient&#8217;s wound and skin conditions. This comprehensive
skin and wound assessment technology is designed to quantify biochemical markers to determine the trajectory of a wound&#8217;s condition
to enable better diagnosis and treatment protocol. To date, Precision Healing has not generated revenues. As previously disclosed, UWSS
purchased approximately $2.8 million worth of Series A Convertible Preferred Stock of Precision Healing from 2020 through 2021
and entered into agreements with Precision Healing, pursuant to which UWSS began integrating the Precision Healing platform into
the WounDerm electronic medical record.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement and subject to the terms and conditions set forth therein, the Merger Parties intend to effect a business combination
wherein (i) Merger Sub I will merge with and into Precision Healing, with Precision Healing being the surviving entity and becoming a
wholly owned subsidiary of UWSS and an indirect subsidiary of the Company (the &#8220;First Merger&#8221;) and (ii) as part of the same
overall transaction, the surviving entity of the First Merger will merge with and into Merger Sub II, with Merger Sub II being the surviving
entity and continuing as a wholly owned subsidiary of UWSS and an indirect subsidiary of the Company (the &#8220;Second Merger,&#8221;
and together with the First Merger, the &#8220;Merger&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions set forth in the Merger Agreement, at the time the First Merger becomes effective (the &#8220;First Merger
Effective Time&#8221;), holders of Precision Healing common stock (&#8220;Precision Healing Common Stock&#8221;) and preferred stock
(&#8220;Precision Healing Preferred Stock&#8221;) issued and outstanding immediately prior to the First Merger Effective Time, other
than UWSS, shall be entitled to receive up to approximately $5.1 million (the &#8220;Closing Consideration&#8221;), which shall
be payable to accredited investors (&#8220;Accredited Investors&#8221;), as defined in Rule 501(a) of Regulation D promulgated under
the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in shares (the &#8220;Closing Shares&#8221;) of common stock,
par value $0.001 per share (the &#8220;Common Stock&#8221;), of the Company at a price per share equal to the average closing price of
the Common Stock for the 20 trading days prior to the First Merger Effective Time (the &#8220;Closing Stock Price&#8221;), and in cash
to Precision Healing securityholders who are not Accredited Investors. Pursuant to the Merger Agreement, upon the achievement of certain
performance thresholds, the securityholders of Precision Healing, including certain persons promised options to purchase Precision Healing
Common Stock, other than UWSS, shall be entitled to receive payments of up to $10.0 million (the &#8220;Earnout Consideration&#8221;
and together with the Closing Consideration, the &#8220;Merger Consideration&#8221;), which is payable in cash or, at the Company&#8217;s
election, is payable to Accredited Investors in shares of Common Stock (the &#8220;Earnout Shares&#8221; and collectively with the Closing
Shares, the &#8220;Merger Shares&#8221;) at a price per share equal to the greater of the Closing Stock Price and the average closing
price of the Common Stock for the 20 trading days prior to the date such Earnout Consideration is due and payable. The amount and composition
of the portion of Earnout Consideration payable is subject to adjustment and offsets as set forth in the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, at the First Merger Effective Time, each Precision Healing option (&#8220;Precision Healing Option&#8221;) granted under any
plan or agreement, including, without limitation, the Precision Healing 2020 Stock Option and Grant Plan (the &#8220;Precision Plan&#8221;),
and outstanding immediately prior to the First Merger Effective Time shall constitute an option to acquire, on the same terms and conditions
as were applicable under such Precision Healing Option immediately prior to the First Merger Effective Time, including any provisions
for acceleration, the number (rounded down to the nearest whole number) of shares of Company Common Stock, determined by multiplying
(A) the number of shares of Precision Healing Common Stock subject to such Precision Healing Option immediately prior to the First Merger
Effective Time by (B) the Exchange Ratio (as defined in the Merger Agreement). The exercise price per share of Company Common Stock subject
to any such Precision Healing Option at and after the First Merger Effective Time shall be an amount (rounded up to the nearest cent)
equal to (1) the exercise price per share of Precision Healing Common Stock subject to such Precision Healing Option immediately prior
to the First Merger Effective Time divided by (2) the Exchange Ratio.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the First Merger Effective Time, each Precision Healing warrant that was outstanding and unexercised immediately prior to the First Merger
Effective Time will be converted into a warrant to purchase Company Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consummation of the Merger is subject to certain conditions, including, among others: (i) the approval of the Merger Agreement by vote
or consent of the holders of ninety-five percent (95%) or more of the issued and outstanding shares of Precision Healing Common Stock
and the holders of a majority of the issued and outstanding shares of the Precision Healing Preferred Stock; (ii) the receipt of regulatory
approvals for the Merger&#894; (iii) receipt by the Company of executed employment agreements with each of the key employees of Precision
Healing&#894; (iv) the absence of any law or order prohibiting the consummation of the transaction&#894; (v) the absence of a &#8220;material
adverse effect&#8221; on Precision Healing or the Company&#894; (vi) the representations and warranties of the Merger Parties being true
and correct, subject to the materiality standards contained in the Merger Agreement&#894; and (vii) the Merger Parties having complied
in all material respects with their respective obligations under the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement contains customary representations and warranties made by each of the Company and Precision Healing, and also contains
customary pre-closing covenants, including, among others, covenants (i) by Precision Healing to operate its respective businesses in
the ordinary course of business consistent with past practice and to refrain from taking certain actions without the Company&#8217;s
consent&#894; (ii) by Precision Healing not to solicit or enter into certain alternative strategic transactions&#894; (iii) by Precision
Healing to take all action reasonably necessary to obtain joinder agreements and written consents from the Precision Healing securityholders
for approval of the Merger; (iv) by Precision Healing to use commercially reasonable efforts to obtain all necessary consents, waivers
and approvals of any third parties; and (v) by the Merger Parties to use their best efforts to effectuate the Merger and to do all acts
and things as may be required to carry out their obligations under the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement may be terminated under certain circumstances, including (i) by mutual agreement of the Company and Precision Healing&#894;
(ii) by the Company or Precision Healing if a court or other governmental authority issues a final judgment or takes any action having
the effect of permanently restraining, preventing or enjoining or otherwise prohibiting the Merger or making the Merger illegal; (iii)
by the Company or Precision Healing if the closing of the Merger has not taken place on or before the date that is 90 days following
the date of the Merger Agreement, if the conditions to the terminating party&#8217;s obligations to closing under the Merger Agreement
have not been satisfied and the terminating party has not waived such unsatisfied conditions by such time; (iv) by the Company or Precision
Healing if there is an uncured breach by the other party of any of its covenants or representations in the Merger Agreement that would
result in the failure of a closing condition&#894; or (v) by the Company if Precision Healing does not deliver the requisite approval
by its securityholders of the Merger Agreement and the transaction within 24 hours of execution and delivery of the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Merger Agreement does not purport to be complete and is qualified in its entirety to the complete text of
the Merger Agreement, a copy of which is filed as Exhibit 2.1 to this Current Report and is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement attached as Exhibit 2.1 hereto is included to provide investors and security holders with information regarding its
terms, and it is not intended to provide any other factual information about the Company, Precision Healing or their respective subsidiaries
and affiliates. The representations, warranties and covenants contained in the Merger Agreement were made only for the purposes of the
Merger Agreement and only as of the date of the Merger Agreement or such other date as is specified in the Merger Agreement and are qualified
by information in confidential disclosure schedules provided by the Company and Precision Healing in connection with the signing of the
Merger Agreement. These confidential disclosure schedules contain information that modifies, qualifies and creates exceptions to the
representations and warranties and certain covenants set forth in the Merger Agreement. Moreover, certain representations and warranties
in the Merger Agreement were used for the purpose of allocating risk between the Company and Precision Healing rather than establishing
matters as facts. Information concerning the subject matter of the representations and warranties may change after the date of the Merger
Agreement, which subsequent information may or may not be fully reflected in the Company&#8217;s public disclosures. Accordingly, the
representations and warranties in the Merger Agreement should not be relied upon as characterizations of the actual state of facts about
the Company or Precision Healing and the Merger Agreement should be read in conjunction with the Company&#8217;s Forms 10-K, Forms 10-Q
and other documents that are filed with the Securities and Exchange Commission.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02 Unregistered Sales of Equity Securities. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth under Item 1.01 with respect to the issuance of the Merger Shares to Precision Healing securityholders pursuant
to the Merger Agreement is incorporated herein by reference. Such issuance will be undertaken in reliance upon the exemption from the
registration requirements of the Securities Act, pursuant to Section 4(a)(2) thereof and Rule 506 of Regulation D promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01 Regulation FD Disclosure.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 4, 2022, the Company issued a press release announcing the entry into the Merger Agreement. A copy of the press release is furnished
as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information included under Item 7.01 (including Exhibit 99.1) is furnished pursuant to Item 7.01 and shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), or otherwise be subject to the liabilities
of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, whether
made before or after the date hereof and regardless of any general incorporation language in such filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="width: 0.1in">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1*</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex2-1.htm">Agreement and Plan of Merger, dated April 1, 2022, by and among Sanara MedTech Inc., United Wound and Skin Solutions, LLC, Precision Healing Inc., PH Merger Sub I, Inc., PH Merger Sub II, LLC and Furneaux Capital Holdco, LLC (d/b/a BlueIO).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release of Sanara MedTech Inc., dated April 4, 2022 (furnished pursuant to Item 7.01).</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Certain schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted
exhibit or schedule will be furnished supplementally to the SEC or its staff upon request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:&#160; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    April 4, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sanara MedTech Inc</b>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Michael D. McNeil</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael D. McNeil</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6PXSriLhLhw5xyhgi3haXSXFrRlp/9ki+pXVDDIGQnPPlCBGKjDa6QYbzqszhiG3XKIdQYo2M5oLekW53CfhZ4lVbx8q4Yf2BKXkGPTOfLJS/D86HtlglEM2mcjmVEmKZzCUUexF89ZRMrSs0TqsGlKmgYOpYo1Pcjx+O6kWG2n5IOiFbTSaBeBKN8htkFEs40EM9iW8W8jwVQThUIDKme/eNuVtHLawbbH2WHdF/Bx/hbkkf -->


</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ex2-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
2.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGREEMENT
AND PLAN OF MERGER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BY
AND AMONG</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRECISION
HEALING INC.,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>United
Wound and Skin Solutions, LLC</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Sanara
Medtech Inc.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PH
MERGER SUB I, INC.</B>,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PH
MERGER SUB II, LLC,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURNEAUX
CAPITAL HOLDCO, LLC (DBA BLUEIO)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
THE SECURITYHOLDERS&rsquo; REPRESENTATIVE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DATED
AS OF APRIL 1, 2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TABLE
OF CONTENTS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
    1. DEFINITIONS.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>2</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
    Definitions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
    Other Definitions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
    2. THE MERGERs; EFFECT OF THE MERGERs ON THE COMPANY CAPITAL STOCK</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>21</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
    Merger</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
    Effective Time; Closing</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
    Effect of the Merger</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
    Organizational Documents of the Surviving Entities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
    Officers</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6
    Effect of First Merger on Securities of Company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7
    Effect of Second Merger on Securities of Constituent Companies</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8
    Dissenting Shares</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9
    Additional Per Share Consideration.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10
    Payments at Closing for Indebtedness of the Company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11
    Payments at Closing for Company Transaction Expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12
    Payment for Securities; Exchange Mechanics</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13
    Withholding Taxes</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14
    Closing Spreadsheet</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15
    Drag-Along Sale.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
    3. REPRESENTATIONS AND WARRANTIES CONCERNING THE COMPANY.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>33</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
    Organization and Corporate Power</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
    Authorization of Transactions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
    Required Vote of Company Stockholders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
    Non-Contravention</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
    Capitalization</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
    Financial Statements</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
    Absence of Undisclosed Liabilities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8
    Accounts Receivable; Accounts Payable</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9
    Customers and Suppliers</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10
    Absence of Changes</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11
    Indebtedness</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12
    Assets</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13
    Real Property</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.14
    Personal Property</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.15
    Contracts and Commitments</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16
    Intellectual Property</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.17
    Litigation; Proceedings</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18
    Governmental Licenses and Permits</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19
    Compliance with Laws</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20
    Taxes</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21
    Employees</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.22
    Employee Benefit Plans</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.23
    Insurance</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.24
    Environmental Matters</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.25
    Names and Location</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.26
    Affiliate Transactions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.27
    Brokerage</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.28
    Illegal Payments</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TABLE
OF CONTENTS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.29
    COVID-19.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.30
    HSR Act.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.31
    Healthcare Matters</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.32
    Disclosure</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.33
    No Other Representations and Warranties; Acknowledgement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
    4. REPRESENTATIONS AND WARRANTIES OF THE BUYER PARTIES.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>61</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
    Organization and Corporate Power</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
    Authorization of Transactions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
    Non-Contravention</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
    Share Capital.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
    Brokerage</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
    [Reserved].</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
    Parent SEC Documents; Financial Statements.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
    [Reserved].</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
    Litigation; Compliance with Laws.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
    Operation of Merger Subsidiaries.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
    Due Diligence Review.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
    No Other Representations and Warranties</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
    5. ADDITIONAL AGREEMENTS.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>64</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
    Maintenance of Business</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
    No Solicitation</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
    Access to Information</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
    Notification of Certain Matters</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
    Consents; Other Actions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
    Termination of Certain Agreements.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
    Approval of Company Stockholders.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
    Confidentiality</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
    Tax Matters</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
    [Reserved].</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
    Officers and Directors Indemnification</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
    Parachute Payments</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
    Further Assurances</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
    Employee and Related Matters</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
    Conduct of Business of Parent.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
    6. AGREEMENTS RELATING TO PARENT COMMON STOCK</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>73</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
    Private Placement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
    Restrictions on Transfer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
    Current Public Information</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4
    Legends</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
    7. CONDITIONS TO CLOSING.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>74</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
    Conditions to Obligations of the Buyer Parties</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
    Conditions to the Company&rsquo;s Obligations</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
    8. INDEMNIFICATION AND RELATED MATTERS.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>78</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1
    Survival</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
    Indemnification</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TABLE
OF CONTENTS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
    9. TERMINATION OF AGREEMENT</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>85</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1
    Termination by Mutual Consent</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2
    Unilateral Termination</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3
    Effect of Termination</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
    10. MISCELLANEOUS.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>87</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1
    Amendment</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2
    Securityholders&rsquo; Representative</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3
    Waiver</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4
    Specific Performance</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5
    Expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6
    Notices</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7
    Binding Agreement; Assignment</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8
    Severability</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9
    Construction</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10
    Captions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11
    Entire Agreement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12
    Counterparts</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13
    Choice of Law; Consent to Jurisdiction</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14
    WAIVER OF JURY TRIAL</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15
    Parties in Interest</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16
    Press Releases and Announcements; Confidentiality</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17
    Consent to Representation.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18
    Further Assurances</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">93</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19
    Release</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">93</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20
    Lock-Up</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INDEX
    OF EXHIBITS</U></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Written Consent</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    B</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Securityholder Joinder Agreement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    C</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of First Merger Certificate of Merger </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    D</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
    Statement </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    E</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation
    of Contingent Payment</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INDEX
    OF SCHEDULES</U></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule
    3</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Disclosure Schedule</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule
    5.1</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintenance
    of Business</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule
    5.6</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    of Certain Agreements</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule
    7.1(f)</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required
    Contract Consents</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule
    7.1(o)</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery
    of Securityholder Joinder Agreements</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGREEMENT
AND PLAN OF MERGER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
AGREEMENT AND PLAN OF MERGER (as amended, modified or supplemented from time to time pursuant to the terms hereof, this &ldquo;<U>Agreement</U>&rdquo;)
is made as of April 1, 2022, by and among Precision Healing Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), United Wound
and Skin Solutions, LLC, a Delaware limited liability company (&ldquo;<U>Buyer</U>&rdquo;), Sanara MedTech Inc., a Texas corporation
(&ldquo;<U>Parent</U>&rdquo;), PH Merger Sub I, Inc., a Delaware corporation (&ldquo;<U>Merger Sub I</U>&rdquo;), PH Merger Sub II, LLC,
a Delaware limited liability company (&ldquo;<U>Merger Sub II</U>,&rdquo; and together with Merger Sub I, the &ldquo;<U>Merger Subs</U>,&rdquo;
and together with Parent and Buyer, each a &ldquo;<U>Buyer Party</U>,&rdquo; and collectively, the &ldquo;<U>Buyer Parties</U>&rdquo;)
and Furneaux Capital Holdco, LLC (d/b/a BlueIO), solely in its capacity as the representative of the Company Securityholders (the &ldquo;<U>Securityholders&rsquo;
Representative</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RECITALS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
WHEREAS, each of the Buyer Parties and the Company intend to effect a business combination through a merger of Merger Sub I with and
into the Company, with the Company being the surviving entity and becoming a wholly-owned subsidiary of Buyer (the &ldquo;<U>First Merger</U>&rdquo;)
and as part of the same overall transaction the surviving entity of the First Merger will merge with and into Merger Sub II, an entity
disregarded as separate from Buyer for U.S. federal and applicable state and local income Tax purposes, with Merger Sub II being the
surviving entity (the &ldquo;<U>Second Merger</U>,&rdquo; and together with the First Merger, the &ldquo;<U>Mergers</U>&rdquo;), in each
case, on the terms and conditions set forth in this Agreement and in accordance with the Delaware General Corporation Law (the &ldquo;<U>DGCL</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
WHEREAS, the Board of Directors of the Company has (i) unanimously adopted a resolution approving this Agreement and the transactions
contemplated hereby, including the Mergers, and declaring their advisability and fairness to the Company Stockholders and that such transactions
are in the best interests of the Company Stockholders, and (ii) resolved to recommend that the Company Stockholders approve and adopt
this Agreement, the Mergers and the other transactions contemplated hereby (the &ldquo;<U>Contemplated Transactions</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
WHEREAS, the Parties intend, by executing this Agreement, that the Mergers be treated as integrated steps in a single transaction contemplated
by this Agreement and will together qualify as a tax-free reorganization within the meaning of Section 368(a)(1)(A) of the Code and that
this Agreement will be, and is, adopted as a plan of reorganization within the meaning of Treasury Regulations Section 1.368-2(g);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
WHEREAS, as a condition and a material inducement to the Buyer Parties to enter into this Agreement, immediately following the execution
of this Agreement (but in no event later than 24 hours thereafter), the Company shall deliver to the Buyer Parties a complete and correct
copy of (i) a written consent in the form attached hereto as <U>Exhibit A</U> (the &ldquo;<U>Written Consent</U>&rdquo;) that has been
duly executed and delivered by the Company Stockholders constituting the Stockholder Approval (as defined herein), and (ii) Securityholder
Joinder Agreements that have been executed and delivered by each such consenting holder, including the Company Stockholders constituting
the Stockholder Approval;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
WHEREAS, prior to the Effective Time, among other things, the Company shall seek to obtain a Securityholder Joinder Agreement from all
Company Securityholders and, as applicable, a Written Consent from all Company Stockholders that have not executed and delivered the
same within 24 hours after the execution of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
WHEREAS, the respective Board of Directors (or its equivalent) of each Buyer Party has approved and adopted this Agreement and the Contemplated
Transactions; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.
WHEREAS, the Company and each Buyer Party desire to make certain representations, warranties, covenants and agreements in connection
with the Mergers and also to prescribe various conditions to the Mergers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the foregoing premises and respective representations, warranties, covenants and agreements contained
herein and other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, the Parties to this Agreement,
intending to be legally bound, hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. DEFINITIONS.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<FONT STYLE="color: windowtext"><U>Definitions</U>. For purposes of this Agreement, the following terms shall have the meanings set forth
below:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>2020
Stock Plan</U>&rdquo; means the Company&rsquo;s 2020 Stock Option and Grant Plan, as amended, supplemented, or modified from time to
time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Accounting
Principles</U>&rdquo; means the accounting policies, principles, practices and methodologies of the Company used in the preparation of
the Financial Statements, consistently applied in accordance with the Company&rsquo;s past practices, which practices are not inconsistent
with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Additional
Consideration Fully Diluted Share Amount</U>&rdquo; means, as of immediately prior to the First Merger Effective Time, the sum of the
following (without double-counting): (a) the aggregate number of shares of (i) Company Common Stock and (ii) Company Preferred Stock
on an as-converted basis, in each case, that are issued and outstanding as of immediately prior to the First Merger Effective Time (excluding,
for the avoidance of doubt, the shares of Company Capital Stock held by Buyer), (b) the number of shares of Company Capital Stock issuable
upon exercise, conversion or exchange of all securities issued and outstanding as of immediately prior to the First Merger Effective
Time that are exercisable, convertible and/or exchangeable for shares of Company Capital Stock, including all Company Options and Company
Warrants (excluding, for the avoidance of doubt, the shares of Company Capital Stock held by Buyer and the Company Options reserved or
available for future grant and not subject to any outstanding options under the 2020 Stock Plan), and (c) all rights to purchase Company
Common Stock to be issued under the 2020 Stock Option Plan for a fixed price per share of Company Common Stock that were promised to
be granted to (i) Robert Brik pursuant to that certain offer letter dated May 21, 2021, (ii) Mel McCurrie pursuant to that certain offer
letter dated September 17, 2021, and (iii) Michael DeLuca pursuant to that certain offer letter dated January 31, 2022 (such promised
options, collectively, the &ldquo;<U>Promised Options</U>&rdquo;); <U>provided</U>, <U>however</U>, that, notwithstanding anything herein
to the contrary, to the extent a holder of Company Options and/or Promised Options is no longer employed by the Company at the time the
Additional Per Share Consideration is due and payable pursuant to <U>Section 2.6</U>, <U>Section 2.9(a)</U> and <U>Exhibit E</U>, the
Company Options and/or Promised Options held by such individual shall be excluded in their entirety from &ldquo;Additional Consideration
Fully Diluted Share Amount&rdquo; and such individual shall not be entitled to any payment of the applicable Additional Per Share Consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Additional
Per Share Consideration</U>&rdquo; means, (a) with respect to each share of Company Capital Stock, Option Exercise Shares, and Warrant
Exercise Shares held by a Non-Participating Holder (for clarity, excluding Buyer) immediately prior to the First Merger Effective Time,
the amount of cash equal to such Non-Participating Holder&rsquo;s portion of the Contingent Payment or Accelerated Amount, as applicable,
(in each case, net of the Offset Reserve, net of the Contingent Payment Threshold Amount, and net of any Development Expenses Excess
applicable to the relevant Measured Product as provided in <U>Exhibit E</U>), if any, on an Additional Consideration Fully Diluted Share
Amount basis, calculated pursuant to <U>Section 2.6</U>, <U>Section 2.9(a)</U> and <U>Exhibit E</U>, (b) with respect to each share of
Company Capital Stock, Option Exercise Shares, and Warrant Exercise Shares held by a Participating Holder (for clarity, excluding Buyer)
immediately prior to the First Merger Effective Time, at the option of Parent, such amount of cash or the number of shares of Parent
Common Stock (rounded down to the nearest whole share), or a combination of the foregoing, equal to such Participating Holder&rsquo;s
portion of the Contingent Payment or Accelerated Amount, as applicable (in each case, net of the Offset Reserve, net of the Contingent
Payment Threshold Amount, and net of any Development Expenses Excess applicable to the relevant Measured Product as provided in <U>Exhibit
E</U>), on an Additional Consideration Fully Diluted Share Amount basis, calculated pursuant to <U>Section 2.6</U>, <U>Section 2.9(a)
</U>and <U>Exhibit E</U> (<U>provided</U>, that Parent may only make payments in Parent Common Stock if Parent deems it reasonably advisable
in order to preserve the tax-free nature of the Mergers under Section 368(a)(1)(A), or to the extent that, at the time the payment is
made, (i) the Parent Common Stock is registered under Section 12(b) or 12(g) of the Exchange Act, and (ii) Parent has made all filings
it is required to make under the Exchange Act during the prior twelve months; <U>provided</U>, <U>further</U> that, in no event, unless
a different percentage is agreed upon by Parent and the Securityholders&rsquo; Representative to ensure that the Continuity Of Interest
requirement set forth under Treasury Regulations Section 1.368-1(e) is satisfied, will less than 39% of the Additional Per Share Consideration
payable to Participating Holders in respect of Company Capital Stock be in the form of Parent Common Stock (determined using the Parent
Share Price)); (c) with respect to each share of Company Capital Stock, Option Exercise Shares, and Warrant Exercise Shares held by a
Non-Participating Holder (for clarity, excluding Buyer) immediately prior to the First Merger Effective Time, the cash to be released
from the Offset Reserve, if any, pursuant to <U>Section 2.9(b)</U> to such Non-Participating Holder on an Additional Consideration Fully
Diluted Share Amount basis, and (d) with respect to each share of Company Capital Stock, Option Exercise Shares, and Warrant Exercise
Shares held by a Participating Holder (for clarity, excluding Buyer) immediately prior to the First Merger Effective Time, any non-transferable
contingent right to the number of shares of Parent Common Stock (rounded down to the nearest whole share) to be released from the Offset
Reserve to such Participating Holder on an Additional Consideration Fully Diluted Share Amount basis, pursuant to <U>Section 2.9(b)</U>
(<U>provided</U>, that Parent may only make payments in Parent Common Stock if Parent deems it reasonably advisable in order to preserve
the tax-free nature of the Mergers under Section 368(a)(1)(A), or to the extent that, at the time the payment is made, (i) the Parent
Common Stock is registered under Section 12(b) or 12(g) of the Exchange Act, and (ii) Parent has made all filings it is required to make
under the Exchange Act during the prior twelve months; <U>provided</U>, <U>further</U>, that, in no event, unless a different percentage
is agreed upon by Parent and the Securityholders&rsquo; Representative to ensure that the Continuity Of Interest requirement set forth
under Treasury Regulations Section 1.368-1(e) is satisfied, will less than 39% of the Additional Per Share Consideration payable to Participating
Holders in respect of Company Capital Stock be in the form of Parent Common Stock (determined using the Parent Share Price), in each
case of clauses (a) through (d), in accordance with the Spreadsheet. For purposes of the Additional Per Share Consideration only, the
value of the Parent Common Stock shall mean the greater of (i) the Parent Share Price, and (ii) the fair market value of the Parent Common
Stock based on the average historical closing per share price of Parent Common Stock for the 20-day period prior to the date such Additional
Per Share Consideration is due and payable pursuant to <U>Section 2.6</U>, <U>Section 2.9(a)</U> and <U>Exhibit E</U> (the &ldquo;<U>Additional
Consideration Parent Share Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Adjustment
Amount</U>&rdquo; means (i) Closing Indebtedness <U>plus</U> (ii) the Closing Transaction Expenses in excess of $100,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means, with respect to any Person, any other Person controlling, controlled by or under common control with such particular Person, where
&ldquo;control&rdquo; means the possession, directly or indirectly, of the power to direct or cause the direction of the management and
policies of a Person whether through the ownership of voting securities, as trustee, personal representative or executor, by contract,
credit arrangement or otherwise; <U>provided</U>, that none of the Buyer Parties shall be deemed to be an Affiliate of the Company except
as expressly provided herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Aggregate
Consideration</U>&rdquo; means an amount equal to (i) $10,879,312, <U>minus</U> (ii) the Expense Fund Amount, <U>minus</U> (iii) the
Adjustment Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Aggregate
Exercise Price</U>&rdquo; means the sum of (i) the aggregate exercise price of all shares of Capital Stock subject to Company Warrants
and (ii) the aggregate exercise price of all shares of Capital Stock subject to Company Options, in each case, as of immediately prior
to the First Merger Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Aggregate
Per Share Closing Consideration</U>&rdquo; means an amount equal to the quotient of (i) the sum of (a) the Aggregate Consideration <U>plus
</U>(b) the Aggregate Exercise Price, <U>divided by</U> (ii) the Fully Diluted Share Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Alternative
Transaction</U>&rdquo; means any transaction or series of transactions (other than the Mergers and the Contemplated Transactions) involving:
(i) any merger, consolidation, share exchange, business combination, issuance of securities, direct or indirect acquisition of securities,
recapitalization, tender offer, exchange offer or other similar transaction in which (A) the Company is a constituent corporation or
is otherwise involved, (B) a Person or &ldquo;group&rdquo; (as defined in the Exchange Act) of Persons directly or indirectly acquires
beneficial or record ownership of securities representing more than 5% of the outstanding securities of any class of voting securities
of the Company, or (C) the Company issues securities representing more than 5% of the outstanding securities of any class of voting securities
of the Company; (ii) any direct or indirect sale, lease, exchange, transfer, license, acquisition or disposition of any business or businesses
or of assets or rights that constitute or account for 10% or more of the net revenues, net income or assets of the Company; or (iii)
any liquidation or dissolution of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Ancillary
Agreements</U>&rdquo; means each of the Letters of Transmittal, the Exchange Agent Agreement, and the Securityholder Joinder Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Base
Indemnity Period</U>&rdquo; means eighteen (18) months following the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than a Saturday, a Sunday or a day on which banks in the State of Delaware are closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Buyer
Fundamental Representations</U>&rdquo; means the representations and warranties of the Buyer Parties set forth in <U>Section 4.1</U>
(Organization and Corporate Power), <U>Section 4.2</U> (Authorization of Transactions), <U>Section 4.3</U> (Non-Contravention), <U>Section
4.4</U> (Share Capital), <U>Section 4.5</U> (Brokerage), and <U>Section 4.7</U> (Parent SEC Documents) (other than <U>Section 4.7(b)
</U>and <U>Section 4.7(d)</U>) (in each case, as qualified by the Disclosure Schedule).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Buyer
Parties&rsquo; Fraud</U>&rdquo; means any fraud, willful breach or intentional misrepresentation by any Buyer Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>CARES
Act</U>&rdquo; means the Coronavirus Aid, Relief and Economic Security Act of 2020, as in effect from time to time, together with all
amendments thereto and all regulations and guidance issued by any Governmental Authority with respect thereto, any executive order or
executive memo (including the Memorandum on Deferring Payroll Tax Obligations in Light of the Ongoing COVID-19 Disaster, dated August
8, 2020 and Notice 2020-65) and subsequent Law intended to address the consequences of COVID-19, including Health and Economic Recovery
Omnibus Emergency Solution Act, and any analogous or similar provisions under applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>CERCLA</U>&rdquo;
means the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended from time to time prior to the Closing
Date, and any rules or regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Charter
Documents</U>&rdquo; means, with respect to an entity, the (a) articles of association, certificate of association, certificate of incorporation,
certificate of formation, articles of organization, or certificate of limited partnership, (b) bylaws, limited liability company agreement,
or limited partnership agreement, and (c) other equivalent or similar organizational documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Indebtedness</U>&rdquo; means the aggregate amount of all Indebtedness of the Company as of the First Merger Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Transaction Expenses</U>&rdquo; means the aggregate amount of all Company Transaction Expenses as of the First Merger Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Code</U>&rdquo;
means the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Capital Stock</U>&rdquo; means the Company Common Stock and the Company Preferred Stock, taken together.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Common Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Employee Program</U>&rdquo; means (A) an employee benefit plan within the meaning of Section 3(3) of ERISA whether or not subject to
ERISA; (B) stock option plans, stock purchase plans, equity-based plans, phantom equity, retention plans, profit sharing plans bonus
or incentive plans, severance pay plans, programs or arrangements, deferred compensation arrangements or agreements, employment agreements,
compensation plans, programs, agreements or arrangements, change in control or similar plans, programs or arrangements, supplemental
income arrangements, vacation plans, health or medical benefits, death benefits, disability benefits, supplemental unemployment benefits,
post-employment or retirement benefits (including compensation, pension, health, medical or life insurance benefits) and all other employee
benefit plans, agreements, contracts or arrangements, not otherwise described in (A) above; and (C) plans, agreements, contracts or arrangements
providing compensation to employees, independent contractors and non-employee directors, in each case which the Company sponsors, contributes
to, or provides benefits under or through, or has any obligation to contribute to or provide benefits under or through, or if such plan
provides benefits to or otherwise covers any current or former employee, officer, independent contractor or director of the Company (or
their spouses, dependents, or beneficiaries) or with respect to which the Company has or may have any Liability (contingent or otherwise,
including by reason of being an ERISA Affiliate).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Fraud</U>&rdquo; means any fraud, willful breach, intentional misrepresentation, or criminal acts by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Fundamental Representations</U>&rdquo; means the representations and warranties of the Company set forth in <U>Section 3.1</U> (Organization
and Corporate Power), <U>Section 3.2</U> (Authorization of Transactions), subclause (ii) of <U>Section 3.4</U> (Non-Contravention), <U>Section
3.5</U> (Capitalization), and <U>Section 3.27 </U>(Brokerage) of this Agreement (in each case, as qualified by the Disclosure Schedule).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Intellectual Property Assets</U>&rdquo; means all Intellectual Property Assets owned or purported to be owned by the Company or used
or held for use by the Company or that was developed by or for the Company. &ldquo;<U>Company Intellectual Property Assets</U>&rdquo;
includes, without limitation, the Company IP Products, Company Patents, Company Marks, and Company Copyrights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
IT Systems</U>&rdquo; means all computer and information technology systems, platforms and networks owned, licensed, leased or used by
the Company, including software, hardware, data, databases, data processing or management, record keeping, communication, telecommunication,
computerized, automated or other similar systems, platforms and networks, and documentation relating to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Material Adverse Effect</U>&rdquo; means any change, event, violation, inaccuracy, circumstance or effect (any such item, an &ldquo;<U>Effect</U>&rdquo;)
that, individually or in the aggregate, has had, has or would reasonably be expected to have, or give rise to, a material adverse effect
on: (i) the business, assets, condition (financial or otherwise), capitalization, liabilities, or results of operations of the Company,
taken as a whole, or (ii) the ability of the Company to consummate the Mergers or any of the other Contemplated Transactions or to perform
any of its material obligations under this Agreement or the Ancillary Agreements; <U>provided</U>, <U>however</U>, that the term &ldquo;<U>Company
Material Adverse Effect</U>&rdquo; will not include any Effect that is or results from any of the following: (A) changes in general business
or economic conditions (including interest rates and the availability of debt financing), and events or conditions generally affecting
the industries in which the Company operates (<U>provided</U>, <U>however</U>, that such Effects do not affect the Company disproportionately
as compared to the Company&rsquo;s competitors), (B) changes in applicable Laws or interpretations thereof by any Governmental Authority,
(C) changes in financial, banking, or securities markets (including any disruption thereof and any decline in the price of any security
or any market index) (<U>provided</U>, <U>however</U>, that such Effects do not affect the Company disproportionately as compared to
the Company&rsquo;s competitors), (D) changes in GAAP, (E) national or international political or social conditions (including the engagement
by the United States or any other country in hostilities or the escalation thereof, whether or not pursuant to the declaration of a national
emergency or war) (<U>provided</U>, <U>however</U>, that such Effects do not affect the Company disproportionately as compared to the
Company&rsquo;s competitors), (F) any act of terrorism or other attack on the United States or any of their citizens, personnel, territories,
possessions, diplomatic or consular offices, military installations or equipment (<U>provided</U>, <U>however</U>, that such Effects
do not affect the Company disproportionately as compared to the Company&rsquo;s competitors), (G) any national emergency (whether or
not declared), act of God, natural disaster, pandemic (including, without limitation, the COVID-19 Pandemic), epidemic, public health
emergency, quarantine, curfew, rationing, hurricane, tornado, flood, fire, severe weather conditions, uprising, protest, boycott or civil
disobedience (<U>provided</U>, <U>however</U>, that such Effects do not affect the Company disproportionately as compared to the Company&rsquo;s
competitors), (H) the failure by the Company or its Subsidiaries to meet financial or other projections (it being understood that this
clause (H) shall not prevent a determination that any Effect underlying any such change or failure, as applicable, has resulted in a
Company Material Adverse Effect, to the extent such Effect is not otherwise excluded from this definition of Company Material Adverse
Effect), (I) any acts or omissions expressly required or permitted by the terms or conditions of this Agreement or taken (or failed to
be taken, as applicable) at the express written request or with the written consent of Parent or Buyer or the failure to take any action
expressly prohibited by this Agreement or applicable Law, or (J) the negotiation, execution, announcement, pendency, or performance of
this Agreement, any Ancillary Agreement, or the Contemplated Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Options</U>&rdquo; means all options (whether or not vested or exercisable) to purchase Company Capital Stock, whether granted under
the 2020 Stock Plan or otherwise reserved, available for future grant and not subject to any outstanding options under the 2020 Stock
Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Preferred Stock</U>&rdquo; means the Series Seed Preferred Stock, the Series A Preferred Stock, the Series A-1 Preferred Stock and the
Series A-2 Preferred Stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Representative</U>&rdquo; means a Representative of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Securityholder</U>&rdquo; means any Company Stockholder, any holder of Company Warrants or any holder of Company Options, in each case,
as of immediately prior to the First Merger Effective Time or, with respect to any time before the First Merger Effective Time, any Person
that would be a Company Securityholder if the First Merger Effective Time were to occur at such time (<U>provided</U>, <U>however</U>,
that, for purposes of this Agreement, &ldquo;<U>Company Securityholder</U>&rdquo; shall include the Buyer with respect to (i) <U>Section
3.5(c)</U>, and (ii) <U>Section 3.10(e)</U>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Securityholder Claim</U>&rdquo; means an indemnification claim against a Company Securityholder for any Loss arising under <U>Section
8.2(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Stockholder</U>&rdquo; means any holder of Company Common Stock or Company Preferred Stock as of the First Merger Effective Time or,
with respect to any time before the First Merger Effective Time, any Person that would hold Company Common Stock or Company Preferred
Stock if the First Merger Effective Time were to occur at such time (<U>provided</U>, <U>however</U>, that, for purposes of this Agreement,
&ldquo;<U>Company Stockholder</U>&rdquo; shall not include the Buyer, except as provided in (i) recitals B and E of this Agreement, (ii)
<U>Section 2.6(b)</U>, (iii) <U>Section 3.3</U>, (iv) <U>Section 3.32</U>, (v) <U>Section 5.2</U>, (vi) <U>Section 5.7</U>, and (vii)
<U>Section 5.12</U>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Transaction Expenses</U>&rdquo; means the sum of (i) the collective amount payable by the Company and/or any of its Subsidiaries for
any and all out-of-pocket costs, payments, fees and expenses (in each case, whether or not accrued, accelerated, deferred, contingent
or otherwise) incurred in connection with the Contemplated Transactions (or in connection with due diligence conducted in anticipation
of a sale or in connection with any sale process or similar strategic transaction involving the Company (whether or not consummated)),
including all fees and expenses for professional services rendered by Goodwin Procter LLP or any and all other attorneys&rsquo;, accountants&rsquo;,
financial advisors&rsquo;, finders&rsquo; or other professionals&rsquo; fees and expenses, (ii) any retention, severance, &ldquo;stay,&rdquo;
sale, commission, change of control, transaction bonuses, deferred compensation or similar amounts payable to the Company&rsquo;s current
or former employees, Representatives, independent contractors or service providers that become payable by the Company (at any time) solely
as a result of the consummation of the Contemplated Transactions, (iii) the Company&rsquo;s portion of employment, payroll, and similar
Taxes associated with compensatory payments that, in each case, become payable solely as a result of the consummation of the Contemplated
Transactions, and (iv) the cost of the D&amp;O Tail Insurance payable by the Company pursuant to <U>Section 5.11</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Warrants</U>&rdquo; means all warrants to purchase or otherwise acquire Company Capital Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Confidential
Information</U>&rdquo; means the books, records, data and other documents and confidential information concerning the Company or its
business and/or the products, services, customer development information (including customer and prospect lists), sales activities and
procedures, promotional and marketing techniques, pricing, plans and strategies, financing, development and expansion plans and credit
and financial data concerning customers and suppliers and other information of, or to the extent relating to, the Company or its business.
All knowledge and information described in the immediately preceding sentence that is not in the public domain (unless such knowledge
and information is in the public domain as a result of a breach of this or any other confidentiality agreement or similar obligation)
shall be considered Confidential Information, <U>provided</U>, however, that &ldquo;<U>Confidential Information</U>&rdquo; shall not
include such information that (A) is available to the public (other than as a result of a disclosure by in violation of the terms of
this Agreement or the Confidentiality Agreement), (B) was disclosed to party by a third party not known to such party to be under any
obligation to keep such information confidential, or (C) was independently developed by a party without reference to any Confidential
Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Confidentiality
Agreement</U>&rdquo; means that certain Non-Disclosure Agreement, made as of May 1, 2020, between the Lumicell, Inc., in its capacity
as predecessor-in-interest of the Company, and The Catalyst Group, Inc., an Affiliate of Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Contract</U>&rdquo;
means any contract, subcontract, agreement, understanding, arrangement, deed, mortgage, lease, license, sublicense, indenture, note,
bond, loan, warranty, insurance policy, sales order, purchase order or other document or instrument (including any document or instrument
evidencing any Indebtedness) to which or by which the Company is, or its respective assets or properties are, bound, or other legally
binding undertakings of any nature, whether written or oral and whether express or implied, but excluding any Company Employee Program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>COVID-19
Funds</U>&rdquo; means all grants, payments, distributions, funds, credits or refunds or other relief provided under the CARES Act, the
Paycheck Protection Program Act, or any other program authorized by any Governmental Authority or Government Healthcare Program in response
to COVID-19, or any other Law or program enacted, adopted or authorized in response to COVID-19.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>COVID-19
Measures</U>&rdquo; means any quarantine, &ldquo;shelter in place,&rdquo; &ldquo;stay at home,&rdquo; workforce reduction, social distancing,
&ldquo;personal protective equipment,&rdquo; shut down, closure, sequester, &ldquo;return to work,&rdquo; &ldquo;reopening,&rdquo; safety
or similar law, regulation, policy, rule or order promulgated by any Governmental Authority, including but not limited to the Centers
for Disease Control and Prevention and the World Health Organization, in each case, in connection with or in response to the COVID-19
Pandemic, solely to the extent that such COVID-19 Measures are binding upon the Company or the Company is otherwise legally required
to comply therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>COVID-19
Pandemic</U>&rdquo; means the SARS-Cov2 or COVID-19 pandemic, including any future resurgence or evolutions or mutations thereof and/or
any related or associated disease outbreaks, epidemics and/or pandemics resulting therefrom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedule</U>,&rdquo; &ldquo;<U>Disclosure Schedules</U>&rdquo; or &ldquo;<U>Schedule</U>&rdquo; means the Disclosure Schedule attached
hereto, dated as of the date hereof, delivered by the Company to the Buyer Parties in connection with this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Environmental
Requirements</U>&rdquo; means any Laws related to protection of the environment, human health (with respect to exposure to materials
in the environment), threatened or endangered species or environmentally sensitive areas. Environmental Law includes CERCLA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>ERISA</U>&rdquo;
means the Employee Retirement Income Security Act of 1974, as amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>ERISA
Affiliate</U>&rdquo; means any entity, trade or business that is, or at any applicable time was, a member of a group described in Section
414(b), (c), (m) or (o) of the Code or Section 4001(b)(1) of ERISA that includes the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Agent</U>&rdquo; means Securities Transfer Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Agent Agreement</U>&rdquo; means that certain Exchange Agent Agreement, dated as of the date hereof, by and among the Company, Parent
and the Exchange Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Ratio</U>&rdquo; means an amount equal to (i) the Aggregate Per Share Closing Consideration, divided by (ii) the Parent Share Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Expense
Fund Amount</U>&rdquo; means One Hundred Thousand Dollars ($100,000).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Expense
Fund Payment Amount</U>&rdquo; means, with respect to each Company Securityholder, an amount equal to the quotient of (i) the Expense
Fund Proceeds <U>divided by</U> (ii) such Company Securityholder&rsquo;s applicable Pro Rata Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Fully
Diluted Share Amount</U>&rdquo; means, as of immediately prior to the First Merger Effective Time, the sum of the following (without
double-counting): (a) the aggregate number of shares of (i) Company Common Stock and (ii) Company Preferred Stock on an as-converted
basis, in each case, that are issued and outstanding as of immediately prior to the First Merger Effective Time and (b) the number of
shares of Company Capital Stock issuable upon exercise, conversion or exchange of all securities issued and outstanding as of immediately
prior to the First Merger Effective Time that are exercisable, convertible and/or exchangeable for shares of Company Capital Stock, including
all Company Options and Company Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
means United States generally accepted accounting principles, consistently applied throughout the periods involved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Government
Healthcare Program</U>&rdquo; means any federal healthcare program as defined in 42 U.S.C. &sect; 1320a-7b(f), including Medicare, state
Medicaid programs, TRICARE and any similar or successor programs or plans, or any other federal, state or local Governmental Authority
program that provides health benefits through insurance, or otherwise, which is funded in whole or in part, directly or indirectly, by
any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Governmental
Authority</U>&rdquo; means any: (i) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction
of any nature; (ii) transnational, domestic or foreign federal, state, provincial or local government; (iii) governmental, self-regulatory
or quasi-governmental authority of any nature and political subdivision thereof (including any governmental division, department, court
or other tribunal, agency, commission, governor-in-council, cabinet, minister, instrumentality, organization, unit, body, entity, or
official) or Taxing Authority under or for the account of any of the foregoing; or (iv) with respect to any specified Person, any arbitrator
who has the authority to render a binding decision on such Person that may be enforced in a court of competent jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Governmental
Order</U>&rdquo; means any ruling, award, decision, ruling, injunction, judgment, stipulation, assessment, determination, order, writ,
decree, subpoena, or similar action entered, issued or made by any Governmental Authority (whether temporary, preliminary or permanent).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Hazardous
Substances</U>&rdquo; means any pollutant, contaminant or any toxic, radioactive or otherwise hazardous substance or material, as such
terms are defined in, identified pursuant to or regulated by any Environmental Law as well as any material regulated under Environmental
Law because of its effect or potential effect on human health or the environment, including without limitation petroleum or any fraction
thereof, asbestos or that class of substances referred to as per- and polyfluoroalkylated substances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Healthcare
Laws</U>&rdquo; means all Laws regarding relating to the provision of healthcare items and services, patient care and human health and
safety, including Laws relating to any Health Care Permit, the provision of healthcare services to enrollees of Third Party Payors, reporting
and disclosure requirements to a Governmental Authority, fraud and abuse, patient inducements, patient referrals, anti-kickback, self-referral,
fee-splitting, false claims, corporate practice of medicine, food and drugs, clinical research and studies, the submission of bills,
claims or similar requests for payment, coding, coverage, reimbursement, and billing and collections, including without limitation, the
federal civil False Claims Act (31 U.S.C. &sect;&sect; 3729 et seq.); the federal Stark Law (42 U.S.C. &sect; 13955nn); the federal Anti-Kickback
Statute (42 U.S.C. &sect; 1320a-7b(b)); the federal Civil Monetary Penalties Law (42 U.S.C. &sect; 1320a-7a); the Federal Healthcare
Fraud Law (18 U.S.C. &sect; 1347); Medicare (Title XVIII of the Social Security Act); Medicaid (Title XIX of the Social Security Act);
HIPAA; the Clinical Laboratory Improvement Act (42 U.S.C. &sect; 263a, et seq.); the federal Food, Drug &amp; Cosmetic Act (21 U.S.C.
&sect;&sect; 301-399d); the 21st Century Cures Act; the CARES Act; the Families First Coronavirus Response Act; the CARES Act Provider
Relief Fund; in each case, as amended; and any regulations promulgated pursuant to any of the foregoing statutes and comparable state
Laws that address the subject matter of any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>HIPAA</U>&rdquo;
means the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economics
and Clinical Health Act, and implementing regulations relating thereto, including the Privacy Standards (45 C.F.R. Parts 160 and 164),
the Electronic Transactions Standards (45 C.F.R. Parts 160 and 162), and the Security Standards (45 C.F.R. Parts 160, 162 and 164) promulgated
under the Administrative Simplification Standards (45 C.F.R. Parts 160, 162 and 164), as amended by the HIPAA Omnibus Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
means, with respect to any Person, any and all obligations and Liabilities of such Person (i) for borrowed money, loans or advances (including
obligations issued or incurred in exchange or substitution for borrowed money), (ii) evidenced by notes, bonds, letter of credit, debentures,
mortgage or similar instruments, or secured by a Lien on any asset or capital stock (or other equity interests) of such Person, (iii)
for lease obligations or similar arrangements, which by their terms must be treated as capital leases (as determined in accordance with
the Accounting Principles), (iv) in respect of amounts drawn under letters of credit and bankers&rsquo; acceptances or other obligations
to repay deposits or other amounts advanced by and owing to third parties, (v) for the deferred purchase price or purchase price adjustment
of property or services to such Person (including any deferred purchase price, however structured, for the acquisition by such Person
of any assets, property, services, business or other Person), (vi) under interest rate, protection agreements and all with respect to
derivatives, hedging, swaps, or similar transactions (valued at the termination value thereof), (vii) to repurchase securities issued
or instruments made by the Person, (viii) any COVID-19 Funds, (ix) the Pre-Closing Tax Amount, (x) under any sale and leaseback transaction,
any synthetic lease or tax ownership operating lease transaction and all obligations arising with respect to any transaction which is
the functional equivalent of or takes the place of borrowing but which does not constitute a liability on the balance sheet (including
any conditional sale or other title retention agreement with respect to property acquired by the Company (even though the rights and
remedies of the seller or lender under such agreement in the event of default are limited to the repossession or sale of such party)),
(xi) in the nature of guarantees of, or assurances to a creditor against, any indebtedness, obligation, claim, Liability, or loss of
any other Person with respect to the obligations described in <U>clauses (i)</U> through <U>(x)</U> above of any other Person, and (xii)
for clauses <U>(i)</U> through <U>(xi)</U> above, all accrued interest thereon, if any, and any termination fees, prepayment, discharge,
or termination penalties, &ldquo;breakage&rdquo; costs or similar fees, penalties or payments associated with the repayments of any of
the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnified
Taxes</U>&rdquo; means (a) any and all Taxes of the Company for any Pre-Closing Tax Period, including any and all Taxes imposed on the
Company with respect to the portion of any Straddle Period ending on the Closing Date (determined in accordance with <U>Section 5.9(c)(ii)</U>),
(b) any and all Taxes of any member of affiliated, consolidated, combined, or unity group of which the Company is or was a member on
or prior to the Closing, including pursuant to Treasury Regulations Section 1.1502-6 or any analogous or similar state, province, local
or non-U.S. Law, (c) any liability for Taxes of another Person imposed on the Company as a transferee or successor, by contract or otherwise,
or pursuant to any Law, rule or regulation, which Taxes relate to an event, agreement or transaction occurring on or before the Closing,
(d) any Taxes of a Company Securityholder for which Buyer or the Company is liable by reason of any requirement to withhold, (e) any
Liability for Transfer Taxes borne by the Company Securityholder pursuant to <U>Section 5.9(a)</U>, and (e) any Taxes with respect to
Pre-Closing Tax Periods that the Company has elected to defer pursuant to Section 2302 of the CARES Act or IRS Notice 2020-65 (or any
similar provision of federal, state, local or non-U.S. Law); <U>provided</U>, that Indemnified Taxes (A) shall not include (x) any Taxes
taken into account as Indebtedness or Company Transaction Expenses, if any, (y) any Taxes that are attributable to any breach by a Buyer
Party or any of their respective Affiliates of any covenants under this Agreement or (z) any Taxes that are attributable to any action,
event, or transaction taken by or at the direction of a Buyer Party or any of their respective Affiliates (including, after the Closing,
the Company and its Subsidiaries) outside the Ordinary Course of Business after the Closing on the Closing Date and (B) for the avoidance
of doubt, shall be calculated by taking into account all deductions, losses and credits (including net operating loss carryforwards)
generated in Pre-Closing Tax Periods to the extent available to reduce the amount of the applicable Taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnifying
Party</U>&rdquo; means the party against whom indemnity is sought under <U>Section 8</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Contingent Payment</U>&rdquo; means the amount (if any) due and payable to the Company Securityholders pursuant to <U>Section 2.9(a)
</U>for the Measurement Period ended on December 31, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Assets</U>&rdquo; means any and all of the following, as they exist in any jurisdiction throughout the world: (A) patents, patent
applications of any kind, patent rights, inventions, discoveries and invention disclosures (whether or not patented) (collectively, &ldquo;<U>Patents</U>&rdquo;);
(B) rights in registered and unregistered trademarks, service marks, trade names, trade dress, corporate names, logos, packaging designs,
slogans and Internet domain names, rights to social media accounts, and other indicia of source, origin or quality, together with all
goodwill associated with any of the foregoing, and registrations and applications for registration of any of the foregoing (collectively,
&ldquo;<U>Marks</U>&rdquo;); (C) copyrights in both published and unpublished works (including without limitation all compilations, databases
and computer programs, manuals and other documentation and all derivatives, translations, adaptations and combinations of the above)
and registrations and applications for registration of any of the foregoing (collectively, &ldquo;<U>Copyrights</U>&rdquo;); (D) know-how,
trade secrets, confidential or proprietary information (including customer and supplier lists, customer and supplier records, pricing
and cost information, reports, software development methodologies, technical information, proprietary business information, process technology,
plans, drawings, blue prints, know-how, inventions and invention disclosures (whether or not patented or patentable and whether or not
reduced to practice), ideas, research in progress, algorithms, data, databases, data collections, designs, processes, drawings, schematics,
blueprints, flow charts, models, strategies, prototypes, techniques, source code, source code documentation, testing procedures and testing
results and business, financial, sales and marketing plans) and rights under applicable trade secret Law in the foregoing (collectively,
&ldquo;<U>Trade Secrets</U>&rdquo;); (E) rights of publicity and privacy and data protection rights; and (F) any and all other intellectual
property rights and/or proprietary rights relating to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Key
Employees</U>&rdquo; means W. David Lee, David Strasfeld, Ira Herman, Ryan Williams, Molly Carroll, Robert Brik, Mel McCurrie, and Michael
DeLuca.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>knowledge</U>,&rdquo;
&ldquo;<U>to the Company&rsquo;s knowledge</U>&rdquo; and words and phrases of similar import mean the actual knowledge of W. David Lee
and Alan Barber, in each case, after reasonable inquiry of the Company&rsquo;s directors, managers and executive officers and all other
directors, managers and executive officers having responsibility relating to the applicable matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Law</U>&rdquo;
means any federal, national, supranational, state, provincial, local or similar statute, law, ordinance, regulation, rule, code, order,
requirement or rule of law (including common law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Leased
Real Property</U>&rdquo; means the real property leased, subleased or licensed by the Company as tenant, subtenant, licensee or other
similar party, together with, to the extent leased, licensed or owned by the Company, all buildings and other structures, facilities
or leasehold improvements, currently or hereafter located thereon, all fixtures, systems, equipment and items of personal property and
other assets of every kind, nature and description of the Company located at or attached or appurtenant thereto and all easements, licenses,
rights, options, privileges and appurtenances relating to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Legal
Proceeding</U>&rdquo; means any ongoing or threatened action, suit, litigation, arbitration, mediation, investigation, inquiry, hearing,
audit, charge, proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), examination, investigation,
settlement, demand, or claim (including any counterclaim) conducted or heard by or before, or otherwise involving, any court or other
Governmental Authority or any arbitrator or arbitration panel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liability</U>&rdquo;
means any debt, loss, damage, adverse claim, fine, penalty, duty, obligation, or liability of any nature (whether direct, indirect, known,
unknown, contingent, absolute, conditional, disclosed, undisclosed, accrued, unaccrued, secured, unsecured, derivative, joint, several,
secondary, determined, determinable, liquidated, unliquidated, due or to become due, and whether in contract, tort, strict liability,
or otherwise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Licensed
Provider</U>&rdquo; means any individual who is employed or engaged by the Company required by any Law to hold a Permit in order to perform
the type of services that individual renders to or on behalf of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lien</U>&rdquo;
means any mortgage, lien, pledge, charge, security interest, defect, exception, covenant, hypothecation, encumbrance, claim, infringement,
interference, option, license, right of first refusal, preemptive right, community property interest or restriction of any nature affecting
property, real or personal, tangible or intangible, including any restriction on the voting of any security, any restriction on the transfer
of any security or other asset, any restriction on the receipt of any income derived from any asset, any restriction on the use of any
asset, any lease in the nature thereof, any restriction on the possession, exercise or transfer of any other attribute of ownership of
any asset and any filing of or agreement to give any financing statement under the Uniform Commercial Code (or equivalent statute of
any jurisdiction). Notwithstanding the foregoing, the term &ldquo;<U>Lien</U>&rdquo; will not be deemed to include any license of Intellectual
Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Losses</U>&rdquo;
(collectively) or &ldquo;<U>Loss</U>&rdquo; (individually) means any loss, Liability, demand, claim, action, cause of action, cost, damage,
deficiency, Tax, penalty, fine or expense, whether or not arising out of third-party claims (including interest, penalties, reasonable
attorneys&rsquo;, accountants&rsquo; and other professionals&rsquo; fees and expenses, court costs and all amounts paid in investigation,
defense or settlement of any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Made
Available</U>&rdquo; means that an accurate and complete copy of the information or documents (for the avoidance of doubt, including
all amendments, waivers, exhibits and schedules thereto) is available for the Buyer Parties to download in reviewable format on the Data
Room at least three (3) days prior to the date of the execution of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Multiemployer
Plan</U>&rdquo; shall have the meaning set forth in Section 3(37) of ERISA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Non-Offset
Claim</U>&rdquo; means an indemnification claim for any Loss arising under (a) <U>Section 8.2(a)(i)</U>, but only to the extent that
such claim relates to any inaccuracy or breach of the Company Fundamental Representations, the Tax Representations, or the Healthcare
Representations, or (b) clauses (ii) through (viii) of <U>Section 8.2(a</U>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Non-Participating
Holder Per Share Closing Consideration</U>&rdquo; means, in respect of each share of Company Capital Stock that is held by a Non-Participating
Holder, an amount in cash equal to the Aggregate Per Share Closing Consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Non-Participating
Holders</U>&rdquo; means all holders of Company Capital Stock or Company Warrants that are not Accredited Investors; <U>provided</U>,
<U>however</U>, that for purposes of &ldquo;<U>Additional Per Share Consideration</U>&rdquo; only, &ldquo;<U>Non-Participating Holders</U>&rdquo;
shall also include holders of Company Options that are not Accredited Investors and remain employed with the Company as of the date of
payment of such &ldquo;<U>Additional Per Share Consideration</U>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Non-Participating
Warrant Closing Consideration</U>&rdquo; means, in respect of each share of Company Capital Stock subject to a Company Warrant that is
held by a Non-Participating Holder, an amount of cash equal to (a) the Non-Participating Holder Per Share Closing Consideration <U>minus
</U>(b) the exercise price per share of such Company Warrant, as set forth in the Spreadsheet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Offset
Amount</U>&rdquo; means an amount of $1,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Offset
Claim</U>&rdquo; means an indemnification claim for any Loss arising under <U>Section 8.2(a)(i)</U>, other than any such claim for any
Loss as a result of, arising out of or in connection with any inaccuracy or breach of the Company Fundamental Representations, the Tax
Representations, or the Healthcare Representations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Open
Source Software</U>&rdquo; means any software (in source or object code form) that is subject to (A) a license or other agreement commonly
referred to as an open source, free software, copyleft or community source code license (including but not limited to any code or library
licensed under the GNU General Public License, GNU Lesser General Public License, BSD License, Apache Software License, or any other
public source code license arrangement) or (B) any other license or other agreement that requires, as a condition of the use, modification
or distribution of software subject to such license or agreement, that such software or other software linked with, called by, combined
or distributed with such software be (1) disclosed, distributed, made available, offered, licensed or delivered in source code form,
(2) licensed for the purpose of making derivative works, (3) licensed under terms that allow reverse engineering, reverse assembly, or
disassembly of any kind, or (4) redistributable at no charge, including without limitation any license defined as an open source license
by the Open Source Initiative as set forth on www.opensource.org.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Option
Diluted Amount</U>&rdquo; means, as of immediately prior to the First Merger Effective Time, the number of shares of Company Capital
Stock issuable upon exercise, conversion or exchange of all Company Options issued and outstanding as of immediately prior to the First
Merger Effective Time; <U>provided</U>, <U>however</U>, that, notwithstanding anything herein to the contrary, for purposes of the Contingent
Payment Threshold Amount only, to the extent a holder of Company Options is no longer employed by the Company at the time the Contingent
Payment Threshold Amount is due and payable pursuant to <U>Section 2.6</U> and <U>Exhibit E</U>, the Company Options held by such individual
shall be excluded in their entirety from &ldquo;<U>Option Diluted Amount</U>&rdquo; and such individual shall not be entitled to any
payment of the Contingent Payment Threshold Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Option
Exercise Shares</U>&rdquo; means shares of Company Capital Stock issuable upon the exercise of a Company Option as of immediately prior
to the First Merger Effective Time; <U>provided</U> that, solely for purposes of the definition of &ldquo;<U>Additional Per Share Consideration</U>,&rdquo;
<U>Section 2.6(c)(iv)</U> and <U>Section 8.1</U> of <U>Exhibit E</U>, &ldquo;<U>Option Exercise Shares</U>&rdquo; shall include shares
of Company Capital Stock that would be issuable upon the exercise of Promised Options if such Promised Options had been granted as of
immediately prior to the First Merger Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Ordinary
Course of Business</U>&rdquo; means the ordinary course of business consistent with past custom and practice (including with respect
to quantity and frequency).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Parent
Common Stock</U>&rdquo; means the shares of Common Stock, par value $0.001, of Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Parent
SEC Documents</U>&rdquo; means each annual and quarterly report and registration statement filed by Parent with the SEC since December
31, 2020, and prior to the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Parent
Share Price</U>&rdquo; means the per share price of Parent Common Stock, based on the average closing price for the 20 trading days prior
to the First Merger Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Participating
Holder Per Share Closing Consideration</U>&rdquo; means, in respect of each share of Company Capital Stock that is held by a Participating
Holder, a number of shares of Parent Common Stock equal to the Participating Holder Per Share Closing Stock Consideration (rounded down
to the nearest whole number), as set forth in the Spreadsheet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Participating
Holder Per Share Closing Stock Consideration</U>&rdquo; means, in respect of each share of Company Capital Stock that is held by a Participating
Holder, an amount of Parent Common Stock equal to: (i) the Aggregate Per Share Closing Consideration, <U>divided by</U> (ii) the Parent
Share Price, as set forth in the Spreadsheet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Participating
Holders</U>&rdquo; means all holders of Company Capital Stock or Company Warrants that are Accredited Investors; <U>provided</U>, <U>however</U>,
that for purposes of &ldquo;<U>Additional Per Share Consideration</U>&rdquo; only, &ldquo;<U>Participating Holders</U>&rdquo; shall also
include holders of Company Options that are Accredited Investors and remain employed with the Company as of the date of payment of such
&ldquo;<U>Additional Per Share Consideration</U>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Participating
Warrant Closing Consideration</U>&rdquo; means, in respect of each Company Warrant that is held by a Participating Holder, such Company
Warrant shall cease to represent a right to acquire shares of Company Common Stock, and shall thereafter constitute a warrant to acquire,
on the same terms and conditions as were applicable under such Company Warrant immediately prior to the First Merger Effective Time,
including any provisions for acceleration, the number (rounded down to the nearest whole number) of shares of Parent Common Stock, determined
by multiplying (A) the number of shares of Company Common Stock subject to such Company Warrant immediately prior to the First Merger
Effective Time by (B) the Exchange Ratio (collectively, the &ldquo;<U>Replacement Warrants</U>&rdquo;). The exercise price per share
of Parent Common Stock subject to any such Company Warrant at and after the First Merger Effective Time shall be an amount (rounded up
to the nearest cent) equal to (1) the exercise price per share of Company Common Stock subject to such Company Warrant immediately prior
to the First Merger Effective Time divided by (2) the Exchange Ratio, in each case, as set forth in the Spreadsheet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Parties</U>&rdquo;
(collectively) or &ldquo;<U>Party</U>&rdquo; (individually) shall refer to the Company, the Buyer Parties and the Securityholders&rsquo;
Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Permitted
Liens</U>&rdquo; means (i) any Lien for Taxes or other governmental charges, assessments or levies that are not yet due and payable or
for which adequate reserves have been established in accordance with GAAP, (ii) any statutory or common law landlord&rsquo;s, mechanic&rsquo;s,
carrier&rsquo;s, workmen&rsquo;s, repairmen&rsquo;s or other similar Lien arising or incurred in the Ordinary Course of Business, the
existence of which does not, and would not reasonably be expected to, materially impair the marketability, value or use and enjoyment
of the asset subject to such Lien, (iii) any condition, easement or reservation of rights, including rights of way, for sewers, electric
lines, telegraph and telephone lines and other similar purposes, and affecting the fee title to any Leased Real Property and being transferred
to the Buyer Parties at the Closing that are of record as of the date of this Agreement and the existence of which does not, and could
not reasonably be expected to, materially impair the marketability, value or use and enjoyment of such real property, (iv) such imperfections
of title and encumbrances, if any, which are not material in character, amount or extent, and which do not materially detract from the
value, or materially interfere with the present use, of the property subject thereto or affected thereby, and (v) with respect to Leased
Real Property only, any Lien (including Indebtedness) encumbering the fee interest title in any Leased Real Property and not attributable
to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means any individual, partnership, limited liability company, corporation, cooperative, association, joint stock company, trust, joint
venture, unincorporated organization or Governmental Authority, body or entity or any department, agency or political subdivision thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Post-Closing
Tax Period</U>&rdquo; means any taxable period beginning after the Closing Date and the portion of any Straddle Period beginning on the
Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Closing
Tax Amount</U>&rdquo; means an amount (which shall not be less than zero ($0) dollars in any jurisdiction) equal to the aggregate amount
of (a) any Taxes with respect to Pre-Closing Tax Periods that the Company and its Subsidiaries have elected to defer pursuant to Section
2302 of the CARES Act or IRS Notice 2020-65 (or any similar provision of federal, state, local or non-U.S. Law) and (b) all accrued and
unpaid Taxes of the Company and its Subsidiaries for any Pre-Closing Tax Period, determined (i) by taking into account the Transaction
Tax Deductions and treating such Transaction Tax Deductions as accrued and deductible in the Pre-Closing Tax Period that ends on the
Closing Date to the greatest extent permitted under applicable Laws, (ii) by taking into account the amount of any net operating loss
carryforwards generated in Pre-Closing Tax Periods to the extent available to reduce liability for Taxes, (iii) by excluding any liabilities
for accruals or reserves established or required to be established under GAAP methodologies for contingent Taxes or with respect to uncertain
Tax positions, (iv) by excluding any Taxes attributable to any action (or failure to take any action) transaction or event taken by a
Buyer Party or any of their respective Affiliates (including the Company and its Subsidiaries) on the Closing Date after the Closing
outside the Ordinary Course of Business, (v) in accordance with the past practices (including reporting positions, elections and accounting
methods) of the Company or its Subsidiaries, as applicable, in preparing their Tax Returns (unless otherwise required by applicable Law),
(vi) to the extent available to offset Taxes otherwise payable, reflecting estimated (or other prepaid) Tax payments and any overpayments
of Taxes with respect to any Pre-Closing Tax Period (or portion thereof) and (vii) by excluding any deferred Tax assets and any deferred
Tax liabilities. In the case of any Straddle Period, the Tax Liability Amount shall include an amount equal to the portion of the Taxes
for such period allocated to the portion of such period ending on the Closing Date, determined pursuant to this definition and using
the conventions set forth in <U>Section 5.9(c)(ii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Closing
Tax Period</U>&rdquo; means any taxable period ending on or before the Closing Date and the portion through the end of the Closing Date
for any taxable period that includes (but does not end on) the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Privacy
Law</U>&rdquo; means HIPAA and any rules or regulations promulgated thereunder, and all other Laws relating to the privacy or security
of personal information, including but not limited to foreign, federal, state or local data breach notification Laws and health or medical
information privacy or data security laws, General Data Protection Regulation (EU) 2016/679, and the California Consumer Privacy Act
of 2018; in each case, as amended; and any regulations promulgated pursuant to any of the foregoing statutes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pro
Rata Share</U>&rdquo; means, for each Company Securityholder, the percentage equal to (i) the Aggregate Consideration payable to such
Company Securityholder, <U>divided by</U> (ii) the Aggregate Consideration payable pursuant to this Agreement to the Company Securityholders;
<U>provided</U>, <U>however</U>, that for purposes of Additional Per Share Consideration only, &ldquo;<U>Pro Rata Share</U>&rdquo; shall
be the percentage equal to (i) the Additional Per Share Consideration payable to such Company Securityholder, <U>divided by</U> (ii)
the Additional Per Share Consideration Fully Diluted Amount. Notwithstanding anything herein to the contrary, the aggregate Pro Rata
Shares of all Company Securityholders shall equal 100%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Product
Support Items</U>&rdquo; means electronic versions (paper version if electronic version not available) of the following items of the
Company, whether or not applicable to the Products: (i) system firmware; (ii) system software; (iii) build software (package and build
tree); (iv) hardware design files, including logic and schematic capture, (v) release scripts, procedures and documentation; (vi) test
suites, scripts, procedures and process documentation; (vii) performance documentation, programs and results sets; (viii) product specifications;
(ix) functional specifications; (x) design specifications; and (xi) customer service and support documentation and call history (database,
if applicable).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Release</U>&rdquo;
means any release, spill, emission, leaking, pumping, pouring, injection, deposit, dumping, emptying, disposal, discharge, dispersal,
leaching or migration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Representative</U>&rdquo;
means, with respect to any Person, any Affiliate, agent, director, officer, employee, manager, consultant, or professional advisor of
such Person, including legal counsel, accountants, and financial advisors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Second
Merger Certificate of Merger</U>&rdquo; means a certificate of merger, in form and substance reasonably satisfactory to the Buyer Parties,
to be filed with the Secretary of State of the State of Delaware, in accordance with the relevant provisions of the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securityholder
Joinder Agreement</U>&rdquo; means that certain Joinder and Support Agreement in the form attached hereto as <U>Exhibit B</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securityholder
Fraud</U>&rdquo; means any fraud, willful breach, intentional misrepresentation, or criminal acts by a Company Securityholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securityholders&rsquo;
Representative Fraud</U>&rdquo; means any fraud, willful breach, intentional misrepresentation, or criminal acts by the Securityholders&rsquo;
Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
A Preferred Stock</U>&rdquo; means the shares of preferred stock, par value $0.0001 per share, of the Company, designated as Series A
Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
A-1 Preferred Stock</U>&rdquo; means the shares of preferred stock, par value $0.0001 per share, of the Company, designated as Series
A-1 Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
A-2 Preferred Stock</U>&rdquo; means the shares of preferred stock, par value $0.0001 per share, of the Company, designated as Series
A-2 Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
Seed Preferred Stock</U>&rdquo; means the shares of preferred stock, par value $0.0001 per share, of the Company, designated as Series
Seed Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>State
Takeover Laws</U>&rdquo; means any &ldquo;fair price,&rdquo; &ldquo;moratorium,&rdquo; &ldquo;control share acquisition&rdquo; or other
anti-takeover statute or regulation of any Governmental Authority that would impose any procedural, voting, approval, fairness or other
restriction on the timely consummation of the Contemplated Transactions or restrict, impair or delay the ability of Buyer to engage in
any transaction with the Company or to vote or otherwise exercise all rights as a shareholder of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means the affirmative vote or consent of (i) the holders of ninety-five percent (95%) of the issued and outstanding
shares of Company Capital Stock (voting together as a single class on an as-converted basis) and (ii) the holders of a majority of the
issued and outstanding shares of the Company Preferred Stock (voting together as a single class on an as-converted basis).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means, with respect to any party, any corporation or other organization or Person, whether incorporated or unincorporated, of which (i)
such party or any other subsidiary of such party is a general partner (excluding such partnerships where such party or any subsidiary
of such party does not have a majority of the voting interest in such partnership) or (ii) at least 50% of the securities or other interests
having by their terms ordinary voting power to elect at least 50% of the board of directors or others performing similar functions with
respect to such corporation or other organization is directly or indirectly owned or controlled by such party or by any one or more of
its subsidiaries or affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Tax</U>&rdquo;
or &ldquo;<U>Taxes</U>&rdquo; means any federal, state, local or foreign income, gross receipts, capital gains, profits, franchise, alternative
or add-on minimum, estimated, sales, use, goods and services, transfer, registration, value added, excise, natural resources, severance,
stamp, occupation, premium, windfall profit, customs, duties, real property, ad valorem, special assessment, personal property, capital
stock, social security, unemployment, employment, disability, payroll, license, employee or other withholding, contributions or other
tax, of any kind whatsoever, or any other tax or other like assessment or charge in the nature of a tax, whether disputed or not, imposed
by any Governmental Authority, including any interest, penalties or additions to tax or additional amounts in respect of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Tax
Returns</U>&rdquo; means returns, declarations, reports, elections, claims for refund, information returns or other similar documents
(including any amendments, related or supporting schedules, statements or other information) filed or required to be filed in connection
with the determination, assessment or collection of Taxes of any party or the administration of any laws, regulations or administrative
requirements relating to any Taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Taxing
Authority</U>&rdquo; means any Governmental Authority responsible for the imposition, assessment or collection of any Tax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Third
Party Payor</U>&rdquo; means, individually and collectively, all third-party claims reimbursement programs or other reimbursement sources,
including: (i) Government Healthcare Programs, and (ii) all commercial or private, non-governmental insurance or self-funded reimbursement
programs, and including private plans or insurers that have contracts with Government Healthcare Programs (e.g., Medicare Advantage,
Medicaid managed care organizations).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Tax Deductions</U>&rdquo; means the sum of all items of loss, deduction or credit, to the greatest extent deductible for Tax purposes
and without duplication, resulting from or attributable to any payment to be made by the Company or and of its Subsidiaries in connection
with the transactions contemplated by this Agreement, including (i) the Company Transaction Expenses (or amounts that would be Company
Transaction Expenses but for being paid prior to Closing) regardless of whether such items remain unpaid as of Closing, (ii) the capitalized
financing costs and expenses and any prepayment premium resulting from the satisfaction of Indebtedness on the Closing Date or in connection
with the Closing (including any amounts treated as interest for U.S. federal Income Tax purposes), (iii) all sale, &ldquo;stay-around&rdquo;,
retention, change of control or similar bonuses or payments, or vesting of compensation or property, in each case, payable to current
or former employees, directors or consultants of the Company or any of its Subsidiaries contingent upon the Closing or, in the case of
routine bonus or similar payments not contingent upon the Closing, included as an accrual in Indebtedness or Company Transaction Expenses,
as finally determined, and (iv) any payroll or similar Taxes imposed with respect to any of the foregoing. For the avoidance of doubt,
pursuant to Revenue Procedure 2011-29, 2011 18 IRB, the deduction of 70% of any success-based fees paid by or on behalf of the Company
or its Subsidiaries in connection with the transactions contemplated under this Agreement shall be treated as deductible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer</U>&rdquo;
means, with respect to any security, to gift, sell, offer, pledge, contract to sell, grant any option or contract to purchase, purchase
any option or contract to sell, grant any right or warrant to purchase, lend or otherwise transfer (including by gift or operation of
law), dispose of, hypothecate or encumber, directly or indirectly, such security, or to enter into any swap, hedging or other arrangement
that transfers to another, in whole or in part, any of the economic consequences of ownership of such security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Unpaid
Base Indemnity Period Claim</U>&rdquo; means any Offset Claim or Non-Offset Claim where (i) the matter giving rise to such Offset Claim
or Non-Offset Claim (as applicable) has been fully and finally resolved on or before the end of the Base Indemnity Period, but (ii) the
amount due and payable by the Company Securityholders pursuant to <U>Section 8.2(a)</U> in respect of such Offset Claim or Non-Offset
Claim (as applicable) has not been paid in full prior to the payment of the Initial Contingent Payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Unpaid
Non-Offset Claim</U>&rdquo; means any Non-Offset Claim where (i) the matter giving rise to such Non-Offset Claim has been fully and finally
resolved, but (ii) the amount due and payable by the Company Securityholders pursuant to <U>Section 8.2(a)</U> in respect of such Non-Offset
Claim has not been paid in full pursuant to <U>Section 2.9(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Unpaid
Securityholder Claim</U>&rdquo; means any Company Securityholder Claim where (i) the matter giving rise to such Company Securityholder
Claim has been fully and finally resolved, but (ii) the amount due and payable by the relevant Company Securityholder pursuant to <U>Section
8.2(c)</U> in respect of such Company Securityholder Claim has not been paid in full pursuant to <U>Section 2.9(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Unresolved
Base Indemnity Period Claim</U>&rdquo; means any Offset Claim or Non-Offset Claim which has not been resolved on or before the end of
the Base Indemnity Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Unresolved
Non-Offset Claim</U>&rdquo; means any Non-Offset Claim which has not been fully resolved as of a specified time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Unresolved
Securityholder Claim</U>&rdquo; means any Company Securityholder Claim which has not been fully resolved as of a specified time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Voting
Agreement</U>&rdquo; means the Voting Agreement, dated as of November 9, 2020, by and among the Company and certain holders of Company
Capital Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>WARN
Act</U>&rdquo; means the Worker Adjustment and Retraining Notification Act of 1988, as amended, and any other applicable same or similar
Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Exercise Shares</U>&rdquo; means shares of Company Capital Stock issuable upon the exercise of a Company Warrant as of immediately prior
to the First Merger Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Other
Definitions</U>. Each of the following defined terms has the meaning given such term in the Section set forth opposite such defined term:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">280G
    Approval</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Act</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accredited
    Investor </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6(a)(i)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anti-Money
    Laundering Laws</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19(c)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable
    Limitation Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable
    Matter</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer
    Indemnified Party </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer
    Party</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification
    Form </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6(a)(i)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chosen
    Courts</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing
    Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Contracts</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.15(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Copyrights</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Indemnified Party</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    IP Products</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Licenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Marks</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Patents</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Securityholder Retention Amount</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9(d)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contemplated
    Transactions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent
    Payment</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    E</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent
    Workers</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuing
    Employee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuing
    Employee Agreement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    Representation</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    Data</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16(b)(xviii)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D&amp;O
    Indemnified Persons</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D&amp;O
    Tail Insurance</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductible
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2(d)(v)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designated
    Person</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DGCL</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dissenting
    Shares </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    Time</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense
    Fund</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2(g)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense
    Fund Proceeds</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2(g)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FDA</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19(e)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    Statement Letters</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    Merger</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    Merger Certificate of Merger</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    Merger Effective Time</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    Merger Surviving Entity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
    Care Permit</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.31(f)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare
    Representations </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HSR
    Act </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnified
    Parties</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnifying
    Securityholders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
    Statement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insiders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.26</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intended
    Tax Treatment</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Letters
    of Transmittal </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12(c)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses
    In</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses
    Out</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-Up
    Period</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-Up
    Restrictions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Materiality
    Qualifiers</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2(d)(ii)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical
    Product Laws</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19(e)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger
    Sub I</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger
    Sub II</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger
    Subs</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mergers</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Hire Documents</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1(g)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Offset
    Claim Retention Amount</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9(c)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offset
    Reserve</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OIG</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.31(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent
    Material Adverse Effect</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7(d)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payoff
    Letters</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permits</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Personal
    Data </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16(b)(xii)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20(e)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PNO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Privacy
    Policy</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16(b)(xii)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Privacy
    Requirements</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16(b)(xii)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Privileged
    Deal Communications</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Products</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19(e)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
    Property Leases</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
    Balance Sheet</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Released
    Buyer Parties</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Released
    Holder Claims</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representative
    Expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2(d)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required
    Contract Consents</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1(f)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reserve
    Deficiency</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    Party</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19(d)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second
    Merger</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second
    Merger Effective Time</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second
    Merger Surviving Entity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securityholders&rsquo;
    Representative</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spreadsheet</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder
    Letter of Transmittal</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12(c)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straddle
    Period</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9(c)(ii)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suppliers</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    Claim</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9(d)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    Representations</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
    Party Claim</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2(j)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
    Party IP Assets</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16(b)(v)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    Taxes</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Union</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21(c)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waived
    280G Benefits</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrantholder
    Letter of Transmittal</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    Consent</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2. THE MERGERs; EFFECT OF THE MERGERs ON THE COMPANY CAPITAL STOCK</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<FONT STYLE="color: windowtext"><U>Mergers</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>First Merger</U>. Upon the terms of and subject to the conditions set forth in this Agreement, and in accordance with the DGCL, at
the Effective Time, Merger Sub I shall be merged with and into the Company, whereupon the separate corporate existence of Merger Sub
I shall cease, and the Company shall continue as the surviving corporation and a wholly owned subsidiary of Buyer. The Company, as the
surviving corporation after the First Merger, is sometimes referred to as the &ldquo;<U>First Merger Surviving Entity</U>.&rdquo; The
First Merger shall become effective as the latest time of the filing and acceptance by the Secretary of State of the State of Delaware
of the First Merger Certificate of Merger or such other later time as may be agreed by the Buyer Parties and the Company and specified
in the First Merger Certificate of Merger (such time, the &ldquo;<U>First Merger Effective Time</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Second Merger</U>. <FONT STYLE="color: windowtext">Upon
the terms of and subject to the conditions set forth in this Agreement, and in accordance with the DGCL</FONT>, within three (3) Business
Days following the Closing Date, the First Merger Surviving Entity shall be merged with and into Merger Sub II, whereupon the separate
corporate existence of the First Merger Surviving Entity shall cease, and Merger Sub II shall continue as the surviving entity and a
wholly owned subsidiary of Buyer. Merger Sub II, as the surviving entity after the Second Merger, is sometimes referred to herein as
the &ldquo;<U>Second Merger Surviving Entity</U>.&rdquo; The Second Merger shall become effective at the latest time of the filing and
acceptance by the Secretary of State of the State of Delaware of the Second Merger Certificate of Merger or such other later time as
may be specified in the Second Merger Certificate of Merger (such time the &ldquo;<U>Second Merger Effective Time</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<FONT STYLE="color: windowtext"><U>Effective Time; Closing</U>. The closing of the transactions contemplated by this Agreement and the
First Merger (the &ldquo;<U>Closing</U>&rdquo;) </FONT>will take place by electronic communications and transmission of PDF documents
on a date to be mutually agreed by Parent and the Company which shall not be more than two (2) Business Days after the date on which
the last to be satisfied of all of the conditions set forth in <U>Section 7</U> has been satisfied or, to the extent permissible, waived
in writing by the parties or party entitled to the benefit thereof (except for conditions which in accordance with their terms are to
be satisfied at the Closing, but subject to the satisfaction or, to the extent permissible, written waiver by the parties or parties
entitled to the benefit of such conditions) or at such other date, time or location as the Company and Parent may mutually agree, in
each case, with original documents being exchanged contemporaneously with or promptly after the Closing, where applicable and necessary<FONT STYLE="color: windowtext">.
The date upon which the Closing actually occurs shall be referred to herein as the &ldquo;<U>Closing Date</U>.&rdquo; On the Closing
Date, the parties hereto shall cause the First Merger to be consummated by (i) filing a certificate of merger substantially in the form
attached hereto as <U>Exhibit C</U> (the &ldquo;<U>First Merger Certificate of Merger</U>&rdquo;) with the Secretary of State of the
State of Delaware, in accordance with the relevant provisions of the DGCL and (ii) making all other filings and recordings required under
the DGCL. The term &ldquo;<U>Effective Time</U>&rdquo; shall mean the time of the filing of the First Merger Certificate of Merger, or,
if different, the time of effectiveness thereof that is specified therein. </FONT>For all purposes, all of the document deliveries and
other actions to occur at the Closing will be conclusively presumed to have occurred at the same time, immediately before the First Merger
Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<FONT STYLE="color: windowtext"><U>Effect of the Mergers</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>First Merger</U>. At and after the First Merger Effective Time, the First Merger shall have the effects as set forth in the applicable
provisions of the DGCL. Without limiting the generality of the foregoing, and subject thereto, at the First Merger Effective Time, all
the property, rights, privileges, powers and franchises of each of the Company and Merger Sub I shall vest in the First Merger Surviving
Entity, and all debts, liabilities and duties of each of the Company and Merger Sub I shall attach to, and become the debts, liabilities
and duties of, the First Merger Surviving Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Second Merger</U>. At and after the Second Merger Effective Time, the Second Merger shall have the effects as set forth in the applicable
provisions of the DGCL. Without limiting the generality of the foregoing, and subject thereto, at the Second Merger Effective Time, all
the property, rights, privileges, powers and franchises of each of the First Merger Surviving Entity and Merger Sub II shall vest in
the Second Merger Surviving Entity, and all debts, liabilities and duties of each of the First Merger Surviving Entity and Merger Sub
II shall attach to, and become the debts, liabilities and duties of, the Second Merger Surviving Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the sake of clarity, it is intended that the First Merger and the Second Merger are integrated and to be considered as being performed
and occurring as an integrated transaction and a &ldquo;reorganization&rdquo; within the meaning of Section 368(a) of the Code for U.S.
federal and applicable state and local income Tax purposes (the &ldquo;<U>Intended Tax Treatment</U>&rdquo;). This Agreement is intended
to constitute a &ldquo;plan of reorganization&rdquo; within the meaning of Treasury Regulations Sections 1.368-2(g) and 1.368-3. Each
Party shall cause all Tax Returns filed by such Party to be filed in a manner consistent with the Intended Tax Treatment unless otherwise
required pursuant to a final determination within the meaning of Section 1313(a) of the Code (or any similar or corresponding provision
of state or local law); <U>provided</U>, that such Party shall have first defended the foregoing intended reporting position in good
faith in applicable Tax proceedings. The Parties shall (and shall cause their respective Subsidiaries to) (i) use their respective reasonable
best efforts to cause the Mergers, taken together, to qualify as a reorganization within the meaning of Section 368(a) of the Code and
(ii) not take any action nor fail to take any action if such action or such failure is intended or is reasonably likely to prevent or
impede the Mergers, taken together, from qualifying as a &ldquo;reorganization&rdquo; within the meaning of Section 368(a) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
<FONT STYLE="color: windowtext"><U>Organizational Documents of the Surviving Entities</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>First Merger Surviving Entity</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise determined by Parent prior to the First
Merger Effective Time, the certificate of incorporation of the First Merger Surviving Entity shall be amended and restated as of the
First Merger Effective Time to be identical to the certificate of incorporation of Merger Sub I as in effect immediately prior to the
First Merger Effective Time, until thereafter amended in accordance with the DGCL and as provided in such certificate of incorporation;
<U>provided</U>, <U>however</U>, that at the First Merger Effective Time, the certificate of incorporation of the First Merger Surviving
Entity shall be amended to change the name of the First Merger Surviving Entity to &ldquo;Precision Healing Inc.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise determined by Parent prior to the First
Merger Effective Time, the bylaws of Merger Sub I as in effect immediately prior to the First Merger Effective Time shall be the bylaws
of the First Merger Surviving Entity as of the First Merger Effective Time until thereafter amended in accordance with the DGCL and as
provided in the certificate of incorporation of the First Merger Surviving Entity and such bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Second Merger Surviving Entity</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The certificate of formation of Merger Sub II, as in
effect immediately prior to the Second Merger Effective Time, shall be the certificate of formation of the Second Merger Surviving Entity
at the Second Merger Effective Time, until thereafter amended in accordance with the Limited Liability Company Act of the State of Delaware
and as provided in such certificate of formation; <U>provided</U>, <U>however</U>, that at the Second Merger Effective Time, the certificate
of formation of the Second Merger Surviving Entity shall be amended to change the name of the Second Merger Surviving Entity to &ldquo;Precision
Healing LLC&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The limited liability company agreement of Merger Sub
II, as in effect immediately prior to the Second Merger Effective Time, shall be the limited liability company agreement of the Second
Merger Surviving Entity at the Second Merger Effective Time, until thereafter amended in accordance with the Limited Liability Company
Act of the State of Delaware and as provided in such limited liability company agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
<FONT STYLE="color: windowtext"><U>Officers of the Surviving Entities.</U></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>First Merger Surviving Entity</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise determined by Parent prior to the First
Merger Effective Time, the directors of Merger Sub I immediately prior to the First Merger Effective Time shall be the directors of the
First Merger Surviving Entity immediately after the First Merger Effective Time, each to hold the office of a director of the First Merger
Surviving Entity in accordance with the provisions of the DGCL and the certificate of incorporation and bylaws of the First Merger Surviving
Entity until his or her successor is duly elected and qualified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise determined by Parent prior to the First
Merger Effective Time, the officers of Merger Sub I immediately prior to the First Merger Effective Time shall be the officers of the
First Merger Surviving Entity immediately after the First Merger Effective Time, each to hold office in accordance with the provisions
of the bylaws of the First Merger Surviving Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Second Merger Surviving Entity</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise determined by Parent prior to the Second
Merger Effective Time, Buyer shall be the sole member (as defined in the limited liability company agreement of the Second Merger Surviving
Entity) of the Second Merger Surviving Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise determined by Parent prior to the Second
Merger Effective Time, the officers of Merger Sub II immediately prior to the Second Merger Effective Time shall be the officers of the
Second Merger Surviving Entity immediately after the Second Merger Effective Time, each to hold office in accordance with the provisions
of the limited liability company agreement of the Second Merger Surviving Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6
<FONT STYLE="color: windowtext"><U>Effect of First Merger on Securities of Company</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Certification Procedures</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Not less than five (5) Business Days prior to the Closing Date, the Company shall have delivered to the Parent, on behalf of each holder
of Company Capital Stock, each holder of Company Options and each holder of Company Warrants that is an &ldquo;accredited Investor&rdquo;
within the meaning of Rule 501 (each, an &ldquo;<U>Accredited Investor</U>&rdquo;) of the Securities Act, a certification form as specified
by Parent and reasonably acceptable to the Company (the &ldquo;<U>Certification Form</U>&rdquo;) establishing whether each such holder
of Company Capital Stock is an Accredited Investor. Such Certification Form shall require each holder to specify and prove to the Parent,
in its reasonable belief, that such holder is an Accredited Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Any holder of Company Capital Stock that Parent reasonably determines is not an Accredited Investor based on the Certification Form (with
the understanding that Parent, in its sole discretion, may decide to deem any holder who has not submitted a completed Certification
Form at least two (2) Business Days prior to the Closing Date to be a non-Accredited Investor) will receive cash for such holder&rsquo;s
portion of the Aggregate Consideration in respect of such Company Capital Stock instead of any Parent Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Effect on Company Capital Stock</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
At the First Merger Effective Time, by virtue of the First Merger and without any action on the part of any Buyer Party, the Company
or the Company Stockholders, each share of Company Capital Stock that is issued and outstanding immediately prior to the First Merger
Effective Time (excluding any shares of Company Capital Stock to be canceled pursuant to <U>Section 2.6(b)(ii)</U> and <U>(iii)</U> and
any Dissenting Shares) shall be canceled and extinguished and shall be converted into the right to receive, upon surrender of the certificates
representing such shares of Company Capital Stock in the manner provided in <U>Section 2.12</U> (it being understood that Company Stockholders
that have executed and delivered Securityholder Joinder Agreements shall be deemed to have agreed to the applicable obligations set forth
herein pursuant to such Securityholder Joinder Agreements):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
in the case of an Accredited Investor, the Participating Holder Per Share Closing Consideration <U>plus</U> any Additional Per Share
Consideration, subject to the obligation of the Company Stockholder that owns such share of Company Capital Stock immediately prior to
the First Merger Effective Time to return to the Buyer Parties or the applicable Buyer Indemnified Parties the amount so received as
a result of such conversion to the extent such Company Stockholder has, at any time and from time to time, any unsatisfied payment obligations
to such Buyer Indemnified Parties pursuant to, and subject to the terms and conditions of, <U>Section 8</U>; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
in the case of a Company Stockholder that is not an Accredited Investor, cash in the amount of the Non-Participating Holder Per Share
Closing Consideration <U>plus</U> any Additional Per Share Consideration, subject to the obligation of the Company Stockholder that owns
such share of Company Common Stock or Company Preferred Stock immediately prior to the First Merger Effective Time to return to the Buyer
Parties or the applicable Buyer Indemnified Parties the amount so received as a result of such conversion to the extent such Company
Stockholder has, at any time and from time to time, any unsatisfied payment obligations to such Indemnified Parties pursuant to, and
subject to the terms and conditions of, <U>Section 8</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Each share of Company Capital Stock held in the treasury of the Company immediately prior to the First Merger Effective Time shall be
canceled and extinguished without any conversion thereof and no payment or distribution shall be made with respect thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each share of Company Capital Stock owned by Buyer immediately
prior to the First Merger Effective Time will be cancelled and retired and will cease to exist without payment of any consideration with
respect thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Treatment of Company Options</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
Subject to the terms and conditions of this Agreement, at the First Merger Effective Time,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
Company Option granted under any <FONT STYLE="color: windowtext">Company Employee Program</FONT>, including, without limitation, the
2020 Stock Plan, and outstanding immediately prior to the First Merger Effective Time shall cease to represent a right to acquire shares
of Company Common Stock, and shall thereafter constitute an option to acquire, on the same terms and conditions as were applicable under
such Company Option immediately prior to the First Merger Effective Time, including any provisions for acceleration, the number (rounded
down to the nearest whole number) of shares of Parent Common Stock, determined by multiplying (A) the number of shares of Company Common
Stock subject to such Company Option immediately prior to the First Merger Effective Time by (B) the Exchange Ratio, in accordance with
Sections 409A and 424 of the Code and the corresponding Treasury Regulations (collectively, the &ldquo;<U>Replacement Options</U>&rdquo;).
The exercise price per share of Parent Common Stock subject to any such Company Option at and after the First Merger Effective Time shall
be an amount (rounded up to the nearest cent) equal to (1) the exercise price per share of Company Common Stock subject to such Company
Option immediately prior to the First Merger Effective Time divided by (2) the Exchange Ratio, in accordance with Sections 409A and 424
of the Code and the corresponding Treasury Regulations<FONT STYLE="color: windowtext">;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Parent shall assume sponsorship of the 2020 Stock Plan, to be effective as of the First Merger Effective Time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent shall file with the Securities and Exchange Commission
as soon as reasonably practicable following the First Merger Effective Time, a registration statement on Form S-8 relating to the shares
of Parent Common Stock issuable with respect to Company Options assumed by Parent pursuant to this <U>Section 2.6(c)</U> and Buyer shall
undertake all actions reasonably necessary to maintain the effectiveness of such registration statement thereafter for so long as any
Company Options assumed by Parent pursuant to this <U>Section 2.6(c)</U> remain outstanding; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iv)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to the terms and conditions of this Agreement,
in the case of a holder of Company Options or Option Exercise Shares that remains employed by the Company as of the date payment of any
Additional Per Share Consideration or Contingent Payment Threshold Amount, as applicable, is due and payable pursuant to <U>Section 2.9(a)
</U>and <U>Exhibit E</U>, such holder shall have the right to receive the applicable portion of the Additional Per Share Consideration
and/or any Contingent Payment Threshold Amount, in each case, calculated as contemplated by <U>Section 2.9(a)</U> and <U>Exhibit E</U>,
subject to the obligation of the holder of such Company Options and/or Option Exercise Shares to return to the Buyer Parties or the applicable
Buyer Indemnified Parties the amount so received to the extent such holder has, at any time and from time to time, any unsatisfied payment
obligations to such Buyer Indemnified Parties pursuant to, and subject to the terms and conditions of, <U>Section 8</U>; <U>provided
</U>that, for the avoidance of doubt, in no event will any portion of the Contingent Payment Threshold Amount be payable in respect of
the Promised Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Treatment of Company Warrants</U>. Subject to the terms and conditions of this Agreement, at the First Merger Effective Time, by virtue
of the First Merger and without any action on the part of the holder thereof, the Company Warrants shall be cancelled and extinguished
and automatically converted into the right to receive, for each share of Company Capital Stock for which such Company Warrant was exercisable
(it being understood that Company Securityholders that have executed and delivered Securityholder Joinder Agreements shall be deemed
to have agreed to the applicable obligations set forth herein pursuant to such Securityholder Joinder Agreements):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the case of a holder of Company Warrants that is
an Accredited Investor, the Participating Warrant Closing Consideration for each share of Company Capital Stock subject to such Company
Warrant <U>plus</U> any Additional Per Share Consideration, in each case, subject to the obligation of the holder of such Company Warrant
to return to the Buyer Parties or the applicable Buyer Indemnified Parties the amount so received as a result of such cancellation to
the extent such holder has, at any time and from time to time, any unsatisfied payment obligations to such Buyer Indemnified Parties
pursuant to, and subject to the terms and conditions of, <U>Section 8</U>; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
in the case of a holder of Company Warrants that is not an Accredited Investor, cash in the amount of the Non-Participating Warrant Closing
Consideration for each share of Company Capital Stock subject to such Warrant </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>plus
</U>any Additional Per Share Consideration<FONT STYLE="color: windowtext">, in each case, subject to the obligation of the holder of
such Warrant to return to the Buyer Parties or the applicable Buyer Indemnified Parties the amount so received as a result of such cancellation
to the extent such holder has, at any time and from time to time, any unsatisfied payment obligations to such Buyer Indemnified Parties
pursuant to, and subject to the terms and conditions of, <U>Section 8</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Effect on Capital Stock of Merger Sub I</U>. Each share of common stock of Merger Sub I issued and outstanding immediately prior to
the First Merger Effective Time shall be converted into and exchanged for one validly issued, fully paid and non-assessable share of
common stock of the First Merger Surviving Entity with the same rights, powers and privileges as the shares so converted. Each stock
certificate of Merger Sub I evidencing ownership of any shares of common stock shall continue to evidence ownership of such share of
common stock of the First Merger Surviving Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7
<FONT STYLE="color: windowtext"><U>Effect of Second Merger on Securities of Constituent Companies</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>First Merger Surviving Entity</U>. Effective as of
the Second Merger Effective Time, by virtue of the Second Merger and without any action on the part of any Buyer Party, the First Merger
Surviving Entity or the respective stockholders thereof, each share of capital stock of the First Merger Surviving Entity that is issued
and outstanding immediately prior to the Second Merger Effective Time shall be cancelled without any consideration paid therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Merger Sub II Membership Interests</U>. Effective
as of the Second Merger Effective Time, by virtue of the Second Merger and without any action on the part of any Buyer Party, the First
Merger Surviving Entity or the respective stockholders or members thereof, each membership interest of Merger Sub II that is issued and
outstanding immediately prior to the Second Merger Effective Time shall remain issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8
<FONT STYLE="color: windowtext"><U>Dissenting Shares</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
Notwithstanding any provision of this Agreement to the contrary, shares of Company Capital Stock that are outstanding immediately prior
to the First Merger Effective Time and which are held by Company Stockholders who did not vote in favor of the First Merger or consent
thereto in writing and who are entitled to demand and have properly exercised and perfected appraisal rights for such shares of Company
Capital Stock pursuant to, and in accordance with, the provisions of Section 262 of the DGCL (collectively, the &ldquo;<U>Dissenting
Shares</U>&rdquo;) shall not be converted into or represent the right to receive the Participating Holder Per Share Closing Consideration
or Non-Participating Holder Per Share Closing Consideration, as the case may be, or the Additional Per Share Consideration, if any. Such
Company Stockholders shall be entitled only to such rights as are granted by Section 262 of the DGCL to a holder of Dissenting Shares,
unless and until such Company Stockholders fail to perfect or effectively withdraw or otherwise lose their appraisal rights under the
DGCL. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At the First Merger Effective Time, the Dissenting
Shares, if any, will no longer be outstanding and will automatically be canceled and will cease to exist, and each holder of Dissenting
Shares will cease to have any rights with respect thereto, except the right to receive the fair value of such shares in accordance with
the provisions of Section 262 of the DGCL. Notwithstanding the foregoing, a<FONT STYLE="color: windowtext">ll Dissenting Shares held
by Company Stockholders who shall have failed to perfect or who effectively shall have withdrawn or lost their right to appraisal of
such shares of Company Capital Stock under the DGCL shall thereupon be deemed to have been converted into and to have become exchangeable
for, as of the First Merger Effective Time, the right to receive the Participating Holder Per Share Closing Consideration or Non-Participating
Holder Per Share Closing Consideration, as the case may be, <U>plus</U> any Additional Per Share Consideration, if any, without any interest
thereon and less any applicable Tax withholding and any amounts deducted and/or paid in accordance with <U>Section 2.9</U> through <U>Section
2.13</U>, upon the surrender of the certificate representing such shares of Company Capital Stock.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company shall give Parent (i) prompt written notice of any demands for appraisal received by the Company, withdrawals of such demands,
and any other related instruments served pursuant to the DGCL and received by the Company and (ii) the opportunity to direct all negotiations
and proceedings with respect to demands for appraisal. The Company shall not, except with the prior written consent of Parent, make any
payment with respect to any demands for appraisal or offer to settle or settle any such demands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9
<U>Additional Per Share Consideration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to <U>Section 2.9(b)</U>, <U>Section 2.9(c)</U>,
and <U>Section 2.9(d)</U>, the Additional Per Share Consideration (or any portion thereof) shall, if applicable, and subject to there
being no disagreement as regards the calculation of any part of the Contingent Payments or Accelerated Amount, as applicable, in accordance
with <U>Exhibit E</U>, be paid by Parent to the Company Securityholders no later than forty-five (45) days after the Contingent Payment
or Accelerated Amount is finally determined in accordance with <U>Section 2.6</U> and <U>Exhibit E</U>, as applicable. Notwithstanding
anything in this Agreement to the contrary, Parent shall use commercially reasonable efforts to pay the Additional Per Share Consideration
in cash to the extent permitted for a transaction qualifying under Section 368(a)(1)(A) of the Code; <U>provided</U>, that in no event,
unless a different percentage is agreed upon by Parent and the Securityholders&rsquo; Representative to ensure that the Continuity Of
Interest requirement set forth under Treasury Regulations Section 1.368-1(e) is satisfied, will less than 39% of the Additional Per Share
Consideration payable to Participating Holders in respect of Company Capital Stock be in the form of Parent Common Stock (determined
using the Parent Share Price).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to <U>Section 8.2(d)</U>, Parent shall be entitled
to retain from the Initial Contingent Payment or Accelerated Amount (in each case, net of any Development Expenses Excess and/or the
Contingent Payment Threshold Amount as provided in <U>Exhibit E</U>) a number of shares of Parent Common Stock and/or an amount in cash
having an aggregate value (in respect of shares of Parent Common Stock, based on the Additional Consideration Parent Share Price) equal
to the lesser of (i) the Initial Contingent Payment or Accelerated Amount, as applicable (in each case, net of any Development Expenses
Excess and/or the Contingent Payment Threshold Amount as provided in <U>Exhibit E</U>), and (ii) the Offset Amount (<U>provided</U>,
<U>however</U>, that, to the extent such amount retained from the Initial Contingent Payment is less than the Offset Amount (a &ldquo;<U>Reserve
Deficiency</U>&rdquo;), Parent shall be entitled to retain from the subsequent Contingent Payment (after deduction of any Development
Expenses Excess and/or the Contingent Payment Threshold Amount) an amount equal to such Reserve Deficiency, such that Parent shall be
permitted to retain, in the aggregate, a number of shares of Parent Common Stock and/or an amount in cash having an aggregate value of
up to the Offset Amount pursuant to this <U>Section 2.9(b)</U>) <FONT STYLE="color: windowtext">(such amount so retained pursuant to
this <U>Section 2.9(b)</U>, if any, the &ldquo;<U>Offset Reserve</U>&rdquo;)</FONT>. Subject to the limitations set forth in <U>Section
8</U>, in the event of any Unpaid Base Indemnity Period Claim, Parent shall: (i) retain from the Offset Reserve a number of shares of
Parent Common Stock and/or cash having an aggregate value (in respect of shares of Parent Common Stock, based on the Additional Consideration
Parent Share Price) equal to the total amount due and payable by the Company Securityholders to the Buyer Indemnified Parties pursuant
to <U>Section 8.2(a)</U> in respect of such Unpaid Base Indemnity Period Claim, as finally determined; and (ii) upon expiration of the
Base Indemnity Period, cause the remainder of the Offset Reserve, if any, less any amount that is subject to an Unpaid Base Indemnity
Period Claim, to be paid to the Company Securityholders in the manner contemplated by <U>Section 2.9(a)</U>. For the avoidance of doubt,
notwithstanding any provision hereof to the contrary, the Company Securityholders shall have no obligation or liability to any Buyer
Indemnified Party with respect to any amounts owing in respect of any Unpaid Base Indemnity Period Claim (and no amounts will be retained
from the Offset Reserve) prior to the end of the Base Indemnity Period, unless such Unpaid Base Indemnity Claim relates to a matter in
respect of which recovery directly against any Company Securityholder is permitted pursuant to the terms of <U>Section 8</U>. Subject
to the limitations set forth in <U>Section 8</U>, in the event of any Unresolved Base Indemnity Period Claim, Parent shall: (i) <FONT STYLE="color: windowtext">set
aside from the Offset Reserve a number of shares of Parent Common Stock and/or cash having an aggregate value </FONT>(in respect of shares
of Parent Common Stock, based on the Additional Consideration Parent Share Price) <FONT STYLE="color: windowtext">equal to (A) any Unpaid
Base Indemnity Period Claim, plus (B) the lesser of (1) the amount of such Unresolved Base Indemnity Period Claim and (2) the amount
of the Offset Reserve to be released when such Unresolved Base Indemnity Period Claim is finally settled (whether by agreement or the
order of a court of competent jurisdiction); and (ii) upon the resolution of such Unresolved Base Indemnity Period Claim, cause the remainder
of the Offset Reserve (if any), less any amounts payable to the Buyer Indemnified Parties in respect of such Unresolved Base Indemnity
Period Claim, to be paid to the </FONT>Company Securityholders <FONT STYLE="color: windowtext">in the manner contemplated by <U>Section
2.9(a)</U>. The Buyer Indemnified Parties hereby acknowledge and agree that the retention of the Offset Reserve by Parent (if any) in
accordance with the foregoing shall be deemed to be in full satisfaction of any and all amounts due and payable by the Company Securityholders
to the Buyer Indemnified Parties pursuant to any Offset Claim, other than in the case of Company Fraud, Securityholder Fraud or Securityholders&rsquo;
Representative Fraud (in which case, the limitations set forth in <U>Section 8.2(d)(ix</U>) would apply). For the avoidance of the doubt,
the Buyer Indemnified Parties hereby acknowledge and agree that, (i) in the event that any Offset Claim arises after the expiration of
the Base Indemnity Period, the Company Securityholders shall have no liability to the Buyer Indemnified Parties in respect of such Offset
Claim (it being understood that the foregoing shall not apply to Losses arising after the Base Indemnity Period to the extent such losses
are attributable to Offset Claims arising prior to the expiration of the Base Indemnity Period, in each case, subject to the limitations
set forth in <U>Section 8</U>), and (ii) to the extent that the total value of any Offset Claims exceeds the value of the Offset Reserve,
the Company Securityholders shall have no liability or obligation to the Buyer Indemnified Parties in respect of such excess, in either
case of clauses (i) and (ii) of the foregoing, other than in the case of Company Fraud, Securityholder Fraud or Securityholders&rsquo;
Representative Fraud (in which case, the limitations set forth in <U>Section 8.2(d)(ix</U>) would apply).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to <U>Section 8.2(d)</U>, Parent shall be entitled
to retain from any Contingent Payment or Accelerated Amount (in each case, net of any Development Expenses Excess and/or the Contingent
Payment Threshold Amount) a number of shares of Parent Common Stock and/or an amount in cash with an aggregate value (in respect of shares
of Parent Common Stock, based on the Additional Consideration Parent Share Price) equal to the total amount of any Unpaid Non-Offset
Claim or any Unresolved Non-Offset Claim existing as of the time that such Contingent Payment or Accelerated Amount becomes payable pursuant
to <U>Exhibit E</U>, but only to the extent that such Unpaid Non-Offset Claim or Unresolved Non-Offset Claim (as applicable) has not
been fully satisfied pursuant to <U>Section 2.9(b)</U> (it being acknowledged and agreed that, with respect to any Unpaid Non-Offset
Claim or Unresolved Non-Offset Claim, it shall be in the sole discretion of Parent to determine whether any shares of Parent Common Stock
and/or any amount in cash retained by Parent in respect of such Unpaid Non-Offset Claim or Unresolved Non-Offset Claim pursuant to <U>Section
2.9</U> shall be deemed to have been retained from the Offset Reserve). Subject to the limitations set forth in <U>Section 8</U> (and
after giving effect to <U>Section 2.9(b)</U>), in the event of any Unpaid Non-Offset Claim, Parent shall: (i) retain from any Contingent
Payment or Accelerated Amount (in each case, net of any Development Expenses Excess and/or the Contingent Payment Threshold Amount) due
and payable pursuant to <U>Exhibit E</U> (if any) an amount equal to the total amount due and payable by the Company Securityholders
to the Buyer Indemnified Parties pursuant to <U>Section 8.2(a)</U> in respect of such Unpaid Non-Offset Claim, as finally determined;
and (ii) cause the remainder of such Contingent Payment or Accelerated Amount, as applicable, less any amount that is subject to an Unpaid
Non-Offset Claim, to be paid to the Company Securityholders in the manner contemplated by <U>Section 2.9(a)</U>. Subject to the limitations
set forth in <U>Section 8</U>, in the event of any Unresolved Non-Offset Claim, Parent shall: (i) set aside from any Contingent Payment
or Accelerated Amount due and payable pursuant to <U>Exhibit E</U> an amount equal to (A) any Unpaid Non-Offset Claim, <U>plus</U> (B)
the lesser of (1) the amount of such Unresolved Non-Offset Claim and (2) the amount of such Contingent Payment or Accelerated Amount
to be released when such Unresolved Non-Offset Claim is finally settled (whether by agreement or the order of a court of competent jurisdiction)
(in either case, after accounting for any shares of Parent Common Stock and/or cash already set aside by Parent with respect to such
Unresolved Non-Offset Claim pursuant to <U>Section 2.9(b)</U> or this <U>Section 2.9(c)</U>); and (ii) upon the resolution of such Unresolved
Non-Offset Claim, cause the remainder of such Contingent Payment or Accelerated Amount, as applicable, less any amounts payable to the
Buyer Indemnified Parties in respect of such Unresolved Non-Offset Claim, to be paid to the Company Securityholders in the manner contemplated
by <U>Section 2.9(a)</U>. The Buyer Indemnified Parties hereby acknowledge and agree that, <FONT STYLE="color: windowtext">other than
in the case of Company Fraud, Securityholder Fraud or Securityholders&rsquo; Representative Fraud (in which case, the limitations set
forth in <U>Section 8.2(d)(ix</U>) would apply),</FONT> the total amount of shares of Parent Common Stock and/or cash withheld by Parent
pursuant to <U>Section 2.9(b)</U> and this <U>Section 2.9(c)</U> (if any) in respect of any Unpaid Non-Offset Claims and any Unresolved
Non-Offset Claims (collectively, the &ldquo;<U>Non-Offset Claim Retention Amount</U>&rdquo;) shall be deemed to be in full satisfaction
of any and all amounts due and payable by the Company Securityholders to the Buyer Indemnified Parties pursuant to any Non-Offset Claims,
and that the Company Securityholders shall not be obligated to pay any amounts owing in respect of any Unpaid Non-Offset Claims except
as provided in <U>Section 2.9(b)</U> and this <U>Section 2.9(c)</U>. <FONT STYLE="color: windowtext">For the avoidance of the doubt,
the Buyer Indemnified Parties hereby acknowledge and agree that, to the extent that the total value of any Non-Offset Claims exceeds
the value of the Contingent Payments or Accelerated Amount, as applicable, due and payable pursuant to <U>Section 2.9(a)</U> and <U>Exhibit
E</U>, the Company Securityholders shall have no have no liability or obligation to the Buyer Indemnified Parties in respect of such
excess, other than in the case of Company Fraud, Securityholder Fraud or Securityholders&rsquo; Representative Fraud (in which case,
the limitations set forth in <U>Section 8.2(d)(ix</U>) would apply).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to <U>Section 8.2(d)</U>, prior to making a
Contingent Payment or paying an Accelerated Amount, as applicable, to any Company Securityholder pursuant to <U>Section 2.9(a)</U>, Parent
shall be entitled to retain from such Contingent Payment or Accelerated Amount (in each case, net of such Company Securityholder&rsquo;s
Pro Rata Share of any Development Expenses Excess and/or the Contingent Payment Threshold Amount) a number of shares of Parent Common
Stock and/or cash with an aggregate value (in respect of shares of Parent Common Stock, based on the Additional Consideration Parent
Share Price) equal to the total amount of any Unpaid Securityholder Claim or Unresolved Securityholder Claim against such Company Securityholder
existing as of the time that such Contingent Payment becomes payable to such Company Securityholder pursuant to <U>Exhibit E</U>. Subject
to the limitations set forth in <U>Section 8</U>, in the event of any Company Securityholder Claim, prior to making a Contingent Payment
or payment of an Accelerated Amount (in each case, net of such Company Securityholder&rsquo;s Pro Rata Share of any Development Expenses
Excess and/or the Contingent Payment Threshold Amount) to the Company Securityholder pursuant to <U>Section 2.9(a)</U> against whom such
Unpaid Securityholder Claim has been made, Parent shall: (i) retain from the portion of the Contingent Payment (if any) or Accelerated
Amount, as applicable, due and payable pursuant to <U>Section 2.9(a)</U> and <U>Exhibit E</U> an amount equal to the total amount due
and payable by such Company Securityholders to the Buyer Parties pursuant to <U>Section 8.2(c)</U> in respect of such Unpaid Securityholder
Claim, as finally determined; and (ii) cause the remainder of such Contingent Payment or Accelerated Amount, in each case, less any amount
that is subject to an Unpaid Securityholder Claim against such Company Securityholder, to be paid to such Company Securityholder in the
manner contemplated by <U>Section 2.9(a)</U>. Subject to the limitations set forth in <U>Section 8</U>, in the event of any Unresolved
Securityholder Claim, Parent shall: (i) set aside from the portion of the Contingent Payment or Accelerated Amount (in each case, net
of such Company Securityholder&rsquo;s Pro Rata Share of any Development Expenses Excess and/or the Contingent Payment Threshold Amount),
if any, due and payable to such Company Securityholder pursuant to <U>Section 2.9(a)</U> and <U>Exhibit E</U> an amount equal to (A)
any Unpaid Securityholder Claim against such Company Securityholder, plus (B) the lesser of (1) the amount of such Unresolved Securityholder
Claim and (2) the amount of the portion of the Contingent Payment (if any) or Accelerated Amount, as applicable, to be released to such
Company Securityholder when such Unresolved Securityholder Claim is finally settled (whether by agreement or the order of a court of
competent jurisdiction); and (ii) upon the resolution of such Unresolved Securityholder Claim, cause the remainder of the portion of
the Contingent Payment (if any) or Accelerated Amount, as applicable, payable pursuant to <U>Section 2.9</U> and <U>Exhibit E</U>, less
any amounts payable to the Buyer Parties in respect of such Unresolved Securityholder Claim, to be paid to such Company Securityholder
in the manner contemplated by <U>Section 2.9(a)</U>. The Buyer Indemnified Parties hereby acknowledge and agree that, with respect to
any specified Company Securityholder, <FONT STYLE="color: windowtext">other than in the case of Securityholder Fraud by such Company
Securityholder (in which case, the limitations set forth in <U>Section 8.2(d)(ix</U>) would apply),</FONT> the total amount of shares
of Parent Common Stock and/or cash withheld by Parent pursuant to this <U>Section 2.9(d)</U> (with respect to such Company Securityholder,
the &ldquo;<U>Company Securityholder Retention Amount</U>&rdquo;) shall be deemed to be in full satisfaction of any and all amounts due
and payable by such Company Securityholder to the Buyer Parties pursuant to any Company Securityholder Claims against Company Securityholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">2.10
<U>Payments at Closing for Indebtedness of the Company</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the third Business Day immediately preceding the Closing, the Company shall deliver to Parent payoff letters (the &ldquo;<U>Payoff Letters</U>&rdquo;)
from each Person to whom the Company owes any portion of the Closing Indebtedness, addressed to Parent (or on which the Buyer Parties
are otherwise expressly granted the right to rely), signed by the Persons to which such Indebtedness is payable, setting forth, among
other things (i) the amount required to pay off in full at the First Merger Effective Time all Indebtedness (including, but not limited
to, the outstanding principal, accrued and unpaid interest and prepayment and other penalties), (ii) wire transfer instructions for the
payment of such amounts, and (iii) the commitment upon receipt of the payoff amount to release all Liens, if any, which such Person may
hold on any of the Company Capital Stock or any of the assets of the Company and, to the extent applicable, release all guarantors who
have entered into guarantees in connection therewith, upon receipt of the payoff amount set forth therein. At Closing, Parent will (or
will cause Buyer to) deliver (or cause the First Merger Surviving Entity to deliver) to the recipients thereof specified in the Payoff
Letters to whom the Company owes any portion of the Closing Indebtedness the amounts set forth in the applicable Payoff Letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11
<FONT STYLE="color: windowtext"><U>Payments at Closing for Company Transaction Expenses</U>. </FONT>At the Closing, Parent will (or will
cause Buyer or the First Merger Surviving Entity to) deliver to the recipients who have provided a Fee Statement Letter, for and on behalf
of the Company, such recipient&rsquo;s portion of the Closing Transaction Expense. On the third (3<SUP>rd</SUP>) Business Day immediately
preceding the Closing, the Company shall deliver to the Buyer Parties a fee statement letter from each such recipient (the &ldquo;<U>Fee
Statement Letters</U>&rdquo;) in a form reasonably satisfactory to Parent. The Fee Statement Letters shall: (i) collectively account
for the payment in full of all of the Closing Transaction Expenses; (ii) contain wire transfer instructions for the payment of such amounts
and (iii) contain an acknowledgement from each such recipient that such recipient is not owed any further amounts from the Company other
than as set forth on the Fee Statement Letter<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12
<FONT STYLE="color: windowtext"><U>Payment for Securities; Exchange Mechanics</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="color: windowtext">&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the First Merger Effective Time, Parent and the Securityholders&rsquo; Representative shall appoint and retain the Exchange
Agent to act as paying agent in the First Merger for the purposes outlined in this <U>Section 2.12</U>, in each case, pursuant to the
Exchange Agent Agreement. As promptly as reasonably practicable after the First Merger Effective Time, Parent shall make, or cause to
be made, for the benefit of Persons entitled to receive the Aggregate Consideration pursuant to this Agreement, deposits of the Aggregate
Consideration to the Exchange Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
As promptly as reasonably practicable after the First Merger Effective Time, Parent shall cause the Exchange Agent to mail or otherwise
deliver to each holder of Company Warrants a letter of transmittal in a form reasonably acceptable to Parent and the Company (the &ldquo;<U>Warrantholder
Letter of Transmittal</U>&rdquo;) to the address set forth opposite such holder&rsquo;s name on the Spreadsheet. After receipt of such
Warrantholder Letter of Transmittal, such holder of Company Warrants shall surrender the Company Warrant to the Exchange Agent for cancellation
together with a duly completed and validly executed Warrantholder Letter of Transmittal. Subject to <U>Section 2.8</U>, upon surrender
of the Company Warrant (or an affidavit of loss as provided in <U>Section 2.12(g)</U> below) and the Warrantholder Letter of Transmittal,
the Exchange Agent shall deliver to the holder of such Company Warrants, (i) if such holder is an Accredited Investor, in exchange therefor
the Participating Warrant Closing Consideration in respect of such Company Warrant so surrendered for cancellation for such holder, or
(ii) if such holder is not an Accredited Investor, an amount in cash equal to the Non-Participating Warrant Closing Consideration in
respect of such Company Warrant so surrendered for cancellation for such holder. The Company Warrant so surrendered shall be canceled.
Until so surrendered, after the First Merger Effective Time, each Company Warrant will be deemed, for all corporate purposes thereafter,
to evidence only the right to receive the consideration provided for in this <U>Section 2.12</U>. No portion of the Participating Warrant
Closing Consideration or Non-Participating Warrant Closing Consideration, as the case may be, shall be paid to any holder of Company
Warrants that has not surrendered his, her or its Company Warrant (or an affidavit of loss as provided in <U>Section 2.12(g)</U> below)
to the Exchange Agent and shall have delivered to the Exchange Agent the Warrantholder Letter of Transmittal pursuant hereto.</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until so surrendered, the Company Warrants will, from and after
the First Merger Effective Time, represent for all purposes only the right to receive payment, if any, as provided in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
As promptly as reasonably practicable after the First Merger Effective Time, Parent shall cause the Exchange Agent to mail or otherwise
deliver to each Company Stockholder a stockholder letter of transmittal in a form reasonably acceptable to Parent and the Company (the
&ldquo;<U>Stockholder Letter of Transmittal</U>&rdquo; and together with the Warrantholder Letter of Transmittal, the &ldquo;<U>Letters
of Transmittal</U>&rdquo;) to the address set forth opposite such holder&rsquo;s name on the Spreadsheet. After receipt of such Stockholder
Letter of Transmittal, such Company Stockholder shall submit to the Exchange Agent a duly completed and validly executed Stockholder
Letter of Transmittal. Subject to <U>Section 2.8</U>, upon submission of the Stockholder Letter of Transmittal, the Exchange Agent shall
deliver to the holder of the shares of Company Capital Stock referenced in such Stockholder Letter of Transmittal, (i) if such holder
is an Accredited Investor, in exchange therefor the Participating Holder Per Share Closing Consideration in respect of such share of
Company Capital Stock or (ii) if such holder is not an Accredited Investor, an amount in cash equal to the Non-Participating Holder Per
Share Closing Consideration in respect of each share of Company Capital Stock so surrendered for cancellation by such holder. No portion
of the Participating Holder Per Share Closing Consideration, any Non-Participating Holder Per Share Closing Consideration or any Additional
Per Share Consideration, as the case may be, shall be paid to any Company Stockholder that has not submitted his, her or its Stockholder
Letter of Transmittal pursuant hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any portion of the Aggregate Consideration to which
a Person is entitled to pursuant to <U>Section 2.6</U> of this Agreement is to be paid to a Person other than the Person in whose name
the shares of Company Capital Stock or Company Warrant, as applicable, is registered on the books and records of the Company, it will
be a condition to such payment that: (i) the Company Warrant so surrendered will be properly endorsed or otherwise be in proper form
for transfer, (ii) the Stockholder Letter of Transmittal so surrendered will be otherwise in proper form as required by the terms therein
in respect of any shares of Company Capital Stock, and (iii) that the Person requesting such payment will pay to the First Merger Surviving
Entity any transfer or other taxes required as a result of such payment to a Person other than the registered holder of such shares of
Company Capital Stock or Company Warrant, as applicable, or establish to the satisfaction of the First Merger Surviving Entity that such
tax has been paid or is not payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Return of the Aggregate Consideration</U>. Any portion of the Aggregate Consideration that becomes due and payable to the Company
Securityholders and remains unclaimed by the former holders of the Company Capital Stock or holders of Company Warrants for one (1) year
after the First Merger Effective Time shall be delivered to Parent. Any former holder of Company Capital Stock or holder of Company Warrants
that has not complied with this <U>Section 2.12</U> prior to the end of such one-year period shall thereafter look only to Parent (subject
to abandoned property, escheat or other similar laws) but only as a general creditor thereof for payment of its claim for its portion
of the Aggregate Consideration. Any portion of the Aggregate Consideration that remains unclaimed immediately prior to the date on which
it would otherwise become subject to any abandoned property, escheat or similar law, shall, to the extent permitted by applicable Law,
become the property of Parent, free and clear of all claims or interest of any Person previously entitled thereto. No interest shall
be payable for any shares of Parent Common Stock delivered to Parent pursuant to this <U>Section 2.12(e)</U> or cash which is subsequently
delivered to any former holder of Company Capital Stock or holder of Company Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>No Further Rights in the Company Capital Stock or Company Warrants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Non-Participating Holder Per Share Closing Consideration or Participating Holder Per Share Closing Consideration, as applicable,
and Additional Per Share Consideration, if any, paid or payable in respect of the surrender for exchange of shares of the Company Capital
Stock in accordance with the terms hereof shall be deemed to have been paid in full satisfaction of all rights pertaining to such shares
and there shall be no further registration of transfer on the records of the First Merger Surviving Entity of such shares that were outstanding
immediately prior to the First Merger Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Non-Participating Warrant Closing Consideration or Participating Warrant Closing Consideration, as applicable, and Additional Per
Share Consideration, if any, paid or payable in respect of the surrender for exchange of the Company Warrant in accordance with the terms
hereof shall be deemed to have been paid in full satisfaction of all rights pertaining to such Company Warrant and there shall be no
further registration of transfer on the records of the First Merger Surviving Entity of such Company Warrants that were outstanding immediately
prior to the First Merger Effective Time. If, after the First Merger Effective Time, the Company Warrants are presented to the First
Merger Surviving Entity for any reason, they shall be canceled and exchanged as provided in this <U>Section 2.12</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
After the First Merger Effective Time, there will be no further registration of transfers of Company Capital Stock. All Company Warrants
presented to the Exchange Agent or the First Merger Surviving Entity, as contemplated by this <U>Section 2.12(f)</U>, will be canceled
upon such presentment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Lost Documentation</U>. If any Company Warrant shall have been lost, stolen or destroyed, Parent may, as a condition precedent to
the payment of any portion of the Participating Holder Per Share Closing Consideration, Non-Participating Holder Per Share Closing Consideration,
Participating Warrant Closing Consideration or Non-Participating Warrant Closing Consideration (as the case may be) to the holder of
such Company Warrant, require the owner thereof to provide an affidavit and indemnification agreement, in form and substance reasonably
satisfactory to Parent, certifying as to the loss, theft, or destruction of such Company Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>No Fractional Shares</U>. Notwithstanding any other provision of this Agreement, no fractional shares of Parent Common Stock shall
be issued and allotted in exchange for any Company Capital Stock or Company Warrant, and no holder of any of the foregoing shall be entitled
to receive a fractional share of Parent Common Stock. In the event that any holder of Company Capital Stock or Company Warrant would
otherwise be entitled to receive a fractional share of Parent Common Stock (after aggregating all shares and fractional shares of Parent
Common Stock issuable to such holder), then such holder shall be paid an amount in Dollars (without interest) determined by multiplying
(i) the Parent Share Price by (ii) the fraction of a share of Parent Common Stock to which such holder would otherwise be entitled, in
which case Parent shall make available to the Exchange Agent the amount of cash necessary to make such payments. The Parties acknowledge
that payment of cash consideration in lieu of issuing fractional shares of Parent Common Stock was not separately bargained for consideration
but represents merely a mechanical rounding off for purposes of simplifying the problems that would otherwise be caused by the issuance
of fractional shares of Parent Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Adjustments</U>. If during the period between the
date of this Agreement and the First Merger Effective Time any change in the outstanding shares of Company Capital Stock occurs by reason
of any reclassification, recapitalization, stock split or combination, exchange or readjustment of Company Capital Stock or stock dividend
thereon with a record date during such period, or any similar transaction relating to the Company Capital Stock, any applicable portion
of the Aggregate Consideration payable pursuant to this Agreement will be appropriately adjusted; <U>provided</U>, that no such change
or event contemplated by this <U>Section 2.12(i)</U> will give rise to a change to the aggregate amount to be paid by or on behalf of
Parent under this Agreement. If, at any time after the First Merger Effective Time, any further action is determined by Parent to be
necessary or desirable to carry out the purposes of this Agreement or any Ancillary Agreement in order to vest the First Merger Surviving
Entity with full right, title and possession of and to all rights and property of Merger Sub I and the Company, or to vest the Second
Merger Surviving Entity with full right, title and possession and to all rights and property of the First Merger Surviving Entity, Merger
Sub I, Merger Sub II and the Company, the officers and directors of each of the First Merger Surviving Entity, the Second Merger Surviving
Entity and Parent shall be fully authorized (in the name of Merger Sub I, Merger Sub II, the First Merger Surviving Entity, Buyer or
in the name of the Company) to take such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13
<FONT STYLE="color: windowtext"><U>Withholding Taxes</U>. Notwithstanding any other provision of this Agreement, the Company, Parent,
Buyer, the First Merger Surviving Entity, the Second Merger Surviving Entity and the Exchange Agent shall be entitled to deduct and withhold
from any consideration payable or otherwise deliverable pursuant to this Agreement, such amounts as are required to be deducted or withheld
therefrom under any provision of the U.S. federal, state, local or non-U.S. Tax law or under any applicable legal requirement and to
request any necessary Tax forms, including IRS Form W-9 or the appropriate series of IRS Form W-8, as applicable, or any similar information;
</FONT><U>provided</U>, that, Parent will use commercially reasonable efforts to, at least three (3) Business Days prior to any deduction
or withholding, cause the applicable withholding agent to notify the Securityholders&rsquo; Representative and the applicable Company
Securityholder of any required withholding (other than withholding on amounts properly treated as compensation for Tax purposes or as
a result of a failure of the applicable Company Securityholder to provide necessary Tax forms as required by this Agreement or as timely
requested by the relevant withholding agent pursuant to this <U>Section 2.13</U>) and will reasonably cooperate with the Securityholders&rsquo;
Representative to reduce or eliminate any such withholding, to the extent permitted by applicable Law<FONT STYLE="color: windowtext">.
To the extent such amounts are so deducted or withheld and, to the extent required under applicable Law properly remitted to the appropriate
Governmental Authority, such amounts shall be treated for all purposes under this Agreement as having been paid to the Person to whom
such amounts would otherwise have been paid. Except as expressly provided in this Agreement, the parties make no representations or warranties
to any holders of any Company Capital Stock, holders of Company Options or holders of Company Warrants regarding the tax treatment of
the Mergers, or any of the tax consequences to the Company or any such holder of this Agreement, the Mergers or any of the other Contemplated
Transactions.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14
<FONT STYLE="color: windowtext"><U>Closing Spreadsheet</U>. The Company shall deliver to Parent, not less than five (5) Business Days
prior to the Closing Date, a spreadsheet in a form acceptable to Parent, which shall include the information set forth below and shall
be certified as complete, true and correct as of the Closing Date by the Chief Executive Officer of the Company (the &ldquo;<U>Spreadsheet</U>&rdquo;):</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
With respect to each holder of Company Capital Stock, (i) such Person&rsquo;s name, domicile address, and email address, (ii) the number,
class and series of Company Capital Stock held by such Person, (iii) the respective certificate number(s) representing such shares, (iv)
respective date(s) of acquisition of such shares, (v) the aggregate amount of the Non-Participating Holder Per Share Closing Consideration,
the Participating Holder Per Share Closing Consideration, and/or the Participating Holder Per Share Closing Stock Consideration to be
paid to such Person at the Closing in respect of such shares, (vi) such Person&rsquo;s Pro Rata Share of the Additional Per Share Consideration,
if any, and the portion of such Additional Per Share Consideration represented by such Pro Rata Share, and (vii) such other relevant
information that Parent or the Exchange Agent may reasonably require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
With respect to each holder of unexercised Company Warrants, (i) such Person&rsquo;s name, domicile address, and email address, (ii)
the type and number of shares of Company Capital Stock issuable upon the exercise of each unexercised Company Warrant held by such Person,
(iii) the respective exercise price per share of Company Capital Stock purchasable under such unexercised Company Warrants, (iv) the
respective date(s) of issuance of such Company Warrants and the term of such Company Warrants, (v) the aggregate amount of the Non-Participating
Warrant Closing Consideration and/or Participating Warrant Closing Consideration to be paid to the holder at Closing, and (vi) such other
relevant information that Parent or the Exchange Agent may reasonably require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
With respect to each holder of an unexercised Company Option (i) such Person&rsquo;s name, domicile address, and email address, (ii)
the type and number of shares of Company Capital Stock issuable upon the exercise of each unexercised Company Option held by such Person,
(iii) the respective exercise price per share of Company Capital Stock purchasable under such unexercised Company Options, (iv) the respective
grant date(s) of such unexercised Company Options and the term of such Company Options (including the vesting schedule and any acceleration
provisions), (v) whether such unexercised Company Options are incentive stock options or non-qualified stock options, and (vi) such other
relevant information that Parent or the Exchange Agent may reasonably require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15
<U>Drag-Along Sale</U>. The Company shall take all commercially reasonable actions necessary under the Voting Agreement and as reasonably
requested by Parent to enforce the &ldquo;Drag-Along Right&rdquo; as described in Section 3 of the Voting Agreement in order to cause
each applicable Company Securityholder to (a) execute and deliver a Letter of Transmittal and any additional documents that, in the reasonable
discretion of Parent, may be required in connection with the transactions contemplated herein, and (b) take the other actions described
in Section 3.2 of the Voting Agreement, as reasonably requested by Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3. REPRESENTATIONS AND WARRANTIES CONCERNING THE COMPANY</U>.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to such exceptions as are set forth in the Disclosure Schedule and delivered herewith by the Company to the Buyer Parties with schedules
and references corresponding to the applicable section, subsection or clause of this <U>Section 3</U>, the Company hereby represents
and warrants to each of the Buyer Parties, as of the date hereof and as of the Closing Date (except to the extent such representations
and warranties are made as of a specified date, in which case as though made as of such date), as hereafter set forth in this <U>Section
3</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
item disclosed in the Disclosure Schedule shall constitute an exception to the representations and warranties to which it makes reference
and shall be deemed to be disclosed and incorporated by reference with respect to each Disclosure Schedule to this Agreement and/or representation
and warranty herein given to which it relates so long as the relevance of such item or information is reasonably apparent on its face.
The inclusion of information in the Disclosure Schedule shall not be construed as an admission to any third party that such information
is or is not material or is required to be disclosed by this Agreement. Capitalized terms used and not otherwise defined in the Disclosure
Schedule shall have the meanings specified in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<FONT STYLE="color: windowtext"><U>Organization and Corporate Power</U>. The Company is a corporation duly organized, validly existing
and in good standing under the laws of the State of Delaware. The Company does not have, and has never had, any Subsidiaries. The Company
is qualified to do business in every jurisdiction in which such qualification is necessary, except where the failure to so qualify has
not had or would not reasonably be expected to have a Company Material Adverse Effect. All jurisdictions in which the Company is qualified
to do business are set forth on <U>Schedule 3.1</U>. The Company has full organizational power and authority to own and operate its properties
and to carry on its business as now conducted and currently proposed to be conducted. The Company has delivered to the Buyer Parties
correct and complete copies of its certificate of incorporation and bylaws (each as amended to date). The minute books (containing the
records of meetings of the stockholders, the board of directors and any committees of the board of directors) and the stockholder record
books for the Company are correct and contain copies of all organizational documents and actions taken by the Company&rsquo;s board of
directors and stockholders. The Company is not in default under or in violation of any provision of its certificate of incorporation
or bylaws.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<FONT STYLE="color: windowtext"><U>Authorization of Transactions</U>. The Company has the requisite corporate power and authority to
execute and deliver this Agreement and each of the Ancillary Agreements to which it is a party and, subject to the Stockholder Approval,
to consummate the transactions contemplated hereunder and thereunder and to perform its obligations hereunder and thereunder. The board
of directors of the Company and, as of the Closing, the stockholders of the Company, have duly approved this Agreement and all Ancillary
Agreements to which the Company is a party and have duly authorized the execution and delivery of this Agreement and all Ancillary Agreements
to which the Company is a party and the consummation of the transactions contemplated hereby and thereby. Other than the Stockholder
Approval, no other proceedings on the part of the Company are necessary to approve and authorize the execution and delivery of this Agreement
or the Ancillary Agreements to which the Company is a party and the consummation of the transactions contemplated hereby and thereby.
This Agreement has been, and upon their execution the Ancillary Agreements to which the Company is a party shall have been, duly executed
and delivered by the Company, and, assuming the due execution and delivery by the other parties hereto and thereto, this Agreement constitutes,
and upon their execution the Ancillary Agreements shall constitute, valid and binding obligations of the Company, enforceable against
the Company in accordance with their respective terms (except to the extent that enforceability may be limited by applicable bankruptcy,
insolvency, moratorium, reorganization, relief of debtors, or similar Laws affecting the enforcement of creditors&rsquo; rights generally
or by general principles of specific performance, injunctive relief and other equitable remedies). Assuming the accuracy of the representations
and warranties of the Buyer Parties set forth herein, no State Takeover Law, takeover provisions in the certificate of incorporation
or bylaws of the Company or any takeover provision in any Contracts under which the Company is bound applies to the Mergers, this Agreement,
the Ancillary Agreements, or any of the transactions contemplated hereby or thereby or would otherwise restrict, impair or delay the
ability of any of the Buyer Parties to engage in any transaction with the Company.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<FONT STYLE="color: windowtext"><U>Required Vote of Company Stockholders and Board of Directors</U>. </FONT>In accordance with the <FONT STYLE="color: windowtext">Charter
Documents</FONT> of the Company, the Company&rsquo;s Board of Directors has unanimously (i) adopted and approved a resolution approving
and authorizing this Agreement and the Ancillary Agreements to which it is (or will be) a party in accordance with the provisions of
the DGCL and declaring that the Mergers and the other transactions contemplated hereby and thereby are advisable, fair and in the best
interests of the Company and its shareholders, (ii) resolved to recommend that the Company Stockholders approve and adopt this Agreement,
the Mergers and other Contemplated Transactions, and (iii) directed that this Agreement and the Contemplated Transactions be submitted
for a vote of the shareholders of the Company in order to obtain the Stockholder Approval, and no such determination, recommendation
or direction of the Board of Directors of the Company has been withdrawn, amended, modified or terminated. The Written Consent, when
executed, dated and delivered, shall constitute a valid, enforceable and effective adoption of this Agreement by the Stockholder Approval
in compliance with applicable Law and the Charter Documents of the Company. The Stockholder Approval is the only approval of any Company
Stockholders that are necessary in connection with the consummation by the Company of the Contemplated Transactions (including the Mergers),
whether pursuant to applicable Laws, the Charter Documents of the Company, Contracts or otherwise. No other corporate proceedings on
the part of the Company are necessary to authorize this Agreement or to consummate the Mergers and the other Contemplated Transactions
(other than the filing and recordation of the First Merger Certificate of Merger and such other documents as required by the DGCL).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<FONT STYLE="color: windowtext"><U>Non-Contravention</U>. The execution, delivery and performance by the Company of this Agreement, the
Ancillary Agreements and all agreements, documents and instruments executed and delivered by the Company pursuant hereto and the performance
of the transactions contemplated by this Agreement, the Ancillary Agreements and such other agreements, documents and instruments contemplated
herein and thereby do not and will not: (i) violate or result in a violation of, conflict with or constitute or result in a default (whether
after the giving of notice, lapse of time or both) under, accelerate any obligation under, or give rise to a right of termination of,
any Contract, Permit, license or authorization to which the Company is a party or by which the Company or its assets are bound, except
for such violations, conflicts, defaults, accelerations, or terminations </FONT>that, individually or in the aggregate, would not reasonably
be expected to prevent or materially impair or delay the ability of the Company to consummate the transactions contemplated by this Agreement
or any of the Ancillary Agreements or perform its obligations hereunder and thereunder<FONT STYLE="color: windowtext">; (ii) violate
or result in a violation of, conflict with or constitute or result in a default (whether after the giving of notice, lapse of time or
both) under, or accelerate any obligation under, any provision of the Company&rsquo;s Charter Documents; (iii) violate or result in a
violation of, or constitute a default (whether after the giving of notice, lapse of time or both) under, any provision of any Law, regulation
or rule, or any Governmental Order of, or any restriction imposed by, any Governmental Authority applicable to the Company; or (iv) require
from the Company any notice to, declaration or filing with, or consent or approval of, any Governmental Authority, except </FONT>for
(a) such filings as may be required under applicable requirements of the Exchange Act, and under state securities or &ldquo;blue sky&rdquo;
laws, (b) such filings, notices, approvals or consents required under the rules and regulations of the Securities and Exchange Commission
or any other applicable regulatory or self-regulatory organization, (c) the filing of the First Merger Certificate of Merger with the
Secretary of State of the State of Delaware as required by the DGCL, and (d) such notices, consents, declarations, and filings that,
if not obtained or made would not, individually or in the aggregate, reasonably be expected to prevent or materially impair or delay
the ability of the Company to consummate the transactions contemplated by this Agreement or any of the Ancillary Agreements or perform
its obligations hereunder and thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<U>Capitalization</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
The authorized capital stock of the Company consist of (i)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000,000
<FONT STYLE="color: windowtext">shares of Company Common Stock, none of which are issued and outstanding, (ii) </FONT>895,000 <FONT STYLE="color: windowtext">shares
of Series Seed Preferred Stock, all of which are issued and outstanding, (iii) </FONT>600,000 <FONT STYLE="color: windowtext">shares
of Series A Preferred Stock, of which </FONT>166,250 <FONT STYLE="color: windowtext">shares are issued and outstanding, (iv) </FONT>127,500
<FONT STYLE="color: windowtext">shares of Series A-1 Preferred Stock, all of which are issued and outstanding, and (v) </FONT>650,000
<FONT STYLE="color: windowtext">shares of Series A-2 Preferred Stock, of which </FONT>550,000 <FONT STYLE="color: windowtext">shares
are issued and outstanding. With respect to such authorized Company Common Stock, </FONT>879,105 <FONT STYLE="color: windowtext">shares
are duly reserved for future issuance pursuant to Company Options outstanding as of this date of this Agreement and no shares of Company
Common Stock or Company Preferred Stock are owned beneficially or of record by the Company. <U>Schedule 3.5(a)</U> sets forth the name
of each record holder of Company Capital Stock and the number of shares held of record by each such stockholder. All outstanding shares
of Company Capital Stock are validly issued, fully paid and nonassessable. The shares of Company Capital Stock are uncertificated and
held in book entry form. </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
None of the outstanding shares of Company Capital Stock are subject to, nor were they issued in violation of, any purchase option, call
option, right of first refusal, first offer, co-sale or participation, preemptive right, subscription right or any similar right. Except
for shares disclosed on <U>Schedule 3.5(b)</U>, no shares of voting or non-voting capital stock, other equity interests or other voting
securities of the Company are issued, reserved for issuance or outstanding. All Company Options have been granted under the 2020 Stock
Plan. <U>Schedule 3.5(b)</U> sets forth a true and complete list of all outstanding Company Options and all other options and rights
to purchase Company Capital Stock, together with the number of shares of Company Capital Stock subject to such security, the date of
grant or issuance, the exercise price, the expiration date of such security, the number of vested and unvested shares subject to such
security as of the date hereof and the vesting schedule thereof (including any accelerated vesting provisions). Except as set forth in
<U>Section 2.6</U>, no Company Option shall entitle the holder thereof to receive anything after the Merger in respect of such Company
Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
Except as described in <U>Sections 3.5(a)</U> and <U>(b)</U> or as set forth on <U>Schedule 3.5(c)</U>, there are no outstanding securities,
options, warrants, calls, rights, convertible or exchangeable securities or Contracts or obligations of any kind (contingent or otherwise)
to which the Company is a party or by which it is bound obligating the Company, directly or indirectly, to issue, deliver or sell, or
cause to be issued, delivered or sold, additional shares of capital stock or other voting securities of the Company or obligating the
Company to issue, grant, extend or enter into any such security, option, warrant, call, right, Contract or obligation. Except as set
forth in the Company&rsquo;s certificate of incorporation, there are no outstanding obligations of the Company (contingent or otherwise)
to repurchase, redeem or otherwise acquire, directly or indirectly, any shares of capital stock (or options or warrants to acquire any
such shares) of the Company. There are no stock-appreciation rights, stock-based performance units, &ldquo;phantom&rdquo; stock rights
or other Contracts or obligations of any character (contingent or otherwise) pursuant to which any Person is or may be entitled to receive
any payment or other value based on the revenues, earnings or financial performance, stock price performance or other attribute of the
Company or its business or assets or calculated in accordance therewith (other than payments or commissions to sales representatives
of the Company based upon revenues generated by them without augmentation as a result of the transactions contemplated hereby, in each
case in the Ordinary Course of Business) to cause the Company to register its securities or which otherwise relate to the registration
of any securities of the Company. There are no voting trusts, proxies or other Contracts of any character to which the Company or any
of the Stockholders is a party or by which any of them is bound with respect to the issuance, holding, acquisition, voting or disposition
of any shares of capital stock or similar interests of the Company. There are no bonds, debentures, notes, other Indebtedness or any
other securities of the Company with voting rights on any matters on which stockholders may vote. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
outstanding Company Securities have been issued and granted in compliance with: (i) all applicable Laws; and (ii) all rights of other
holders of Company Securityholders (including the right to approve such issuance and any preemptive or other rights to participate in
such issuance).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company does not own or control, directly or indirectly, any interest in any other corporation, or any limited liability company,
partnership, trust, joint venture, association or any other business entity, and the Company does not own any shares of capital stock
or any other securities of, and has not at any time made any other material investment in, any other Person. The Company is not a participant
in any joint venture, partnership or similar arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Each Company Option (i) was granted in compliance in all material respects with all applicable Laws and all of the terms and conditions
of the stock option plan of the Company pursuant to which it was issued, (ii) has an exercise price per share of Company Common Stock
equal to or greater than the fair market value of a share of Company Common Stock on the date of such grant (and as of each later modification
thereof within the meaning of Section 409A of the Code) determined in a manner consistent with Section 409A of the Code, and (iii) qualifies
for the tax and accounting treatment afforded to such Company Option in the Company&rsquo;s Tax Returns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The only issued and outstanding Company Warrants are set forth on <U>Schedule 3.5(f)</U>. Each holder of Company Warrants has waived
any prior notice requirements (if any) under the Company Warrants with respect to the Mergers and agreed that such Company Warrants will
be subject to the provisions of and treated as described in <U>Section 2.14</U> in connection with the Mergers and shall cease to be
outstanding following the First Merger Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(g)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Spreadsheet, as delivered pursuant to <U>Section
2.14</U>, will be true, accurate and complete as of the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<U>Financial Statements</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
The Company has delivered to the Buyer Parties the Company&rsquo;s unaudited consolidated balance sheets as of (i) December 31, 2020,
and (ii) December 31, 2021 (the &ldquo;<U>Reference Balance Sheet</U>&rdquo;), and the related consolidated statement of operations,
stockholders&rsquo; equity and cash flows for each the foregoing fiscal years then ended, together with the notes thereto. Each of deliverables
in clauses (i) and (ii) (including in all cases the notes thereto, if any) (the &ldquo;<U>Financial Statements</U>&rdquo;) is consistent
with the books and records of the Company </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">(which
such books and records are correct and complete in all material respects)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">,
presents fairly in all material respects the financial condition and results of operations and cash flows of the Company as of and for
the periods referred to therein, and have been prepared in accordance with the Accounting Principles, subject in the case of the unaudited
interim Financial Statements to changes resulting from normal year-end adjustments (none of which are material, individually or in the
aggregate) and the absence of footnote disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company maintains accurate books and records reflecting its assets and liabilities and maintains a system of internal controls over
financial reporting that provides reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for internal purposes in accordance with the Accounting Principles, and includes those policies and procedures that provide
reasonable assurance: (i) that records are maintained in reasonable detail such that they accurately and fairly reflect the transactions
and dispositions of the assets of the Company in all material respects; (ii) that transactions are recorded as necessary to permit preparation
of financial statements in conformity with the Accounting Principles and applicable Law, and that expenditures are made only in accordance
with management&rsquo;s general or specific authorization; and (iii) regarding prevention or timely detection of unauthorized acquisition,
use or disposition of the assets of the Company that could have a material effect on the Company&rsquo;s financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has never made any assignment in favor of
its creditors or a proposal in bankruptcy to its creditors or any class thereof, had any petition for a receiving order presented in
respect of it, or has initiated proceedings with respect to a compromise or arrangement with its creditors or for its winding up, liquidation
or dissolution. No receiver has been appointed in respect of the Company or any of its property or assets and no execution or distress
has been levied upon any of the property or assets of the Company. Except as contemplated by this Agreement, no act or proceeding has
been taken or authorized by or against the Company with respect to any merger, consolidation, arrangement or reorganization of, or relating
to, the Company nor have any such proceedings been authorized by any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
<U>Absence of Undisclosed Liabilities</U>. The Company does not have any Liabilities of any type other than (i) obligations to perform
under the Company Contracts or under Contracts that are not required to be disclosed on the Disclosure Schedules (but not Liabilities
for breaches thereof), (ii) Liabilities reflected on the Reference Balance Sheet, (iii) Liabilities that have been incurred since the
date of the Reference Balance Sheet in the Ordinary Course of Business and that would not reasonably be expected to, individually or
in the aggregate, adversely impact the business of the Company as presently conducted in any material respect, and (iv) Liabilities disclosed
on <U>Schedule 3.7</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8
<U>Accounts Receivable; Accounts Payable</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All of the accounts receivable of the Company are valid and enforceable claims, are not subject to any set-off or counterclaim and are
fully collectible in the Ordinary Course of Business. The Financial Statements do not reserve for doubtful accounts. Since the date of
the Reference Balance Sheet, the Company has collected its accounts receivable in the Ordinary Course of Business and has not accelerated
any such collections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All accounts payable and notes payable of the Company arose in bona fide arm&rsquo;s length transactions in the Ordinary Course of Business
and no such account payable or note payable is delinquent in its payment. Since the date of the Reference Balance Sheet, the Company
has paid its accounts payable in the Ordinary Course of Business and in a manner which is consistent with its past practices and has
not delayed or postponed the payment of its accounts payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9
<U>Customers and Suppliers</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company does not have and has not had since the date of its incorporation, any customers and/or distributors and/or any material
strategic partnership or similar relationship with any Person other than Parent or Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Schedule 3.9(b)</U> lists the name and address of each vendor, supplier, service provider and other similar business relation of the
Company (collectively, &ldquo;<U>Suppliers</U>&rdquo;) from whom the Company purchased greater than $250,000 in goods and/or services
(i) over the course of the Company&rsquo;s fiscal year ended December 31, 2020, and (ii) over the course of the period commencing on
January 1, 2021 and ending on the date hereof including, in each case, the total amount owed to each such person during the specified
period and whether such amounts are past due. The Company has not received any indication from any such Person to the effect that, and,
to the knowledge of the Company, there is no reason to believe that, any Supplier will stop, materially decrease the rate of, or materially
change the terms (whether related to payment, price or otherwise) with respect to, supplying materials, products or services to the Company
(whether as a result of the consummation of the transactions contemplated by this Agreement, the Ancillary Agreements or otherwise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10
<U>Absence of Changes</U>. Since the date of the Reference Balance Sheet, the Company has conducted its business only in the Ordinary
Course of Business, the Company has not suffered a Material Adverse Effect or any material loss, damage, destruction or other casualty
affecting any of its material properties or assets (whether or not covered by insurance) and, except as set forth on <U>Schedule 3.10
</U>or as contemplated by the terms of this Agreement, the Company has not:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
redeemed or repurchased, directly or indirectly, or declared, set aside or paid any dividends on (other than dividends paid to the Company)
or made any other distributions (whether in cash or in kind) with respect to, any of its equity securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
issued, sold or transferred any notes, bonds or other debt securities, any equity securities, or any securities convertible, exchangeable
or exercisable into, directly or indirectly, any of its equity securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
borrowed any amount or incurred or become subject to any Indebtedness (including contingently as a guarantor or otherwise) or other Liabilities,
except current liabilities incurred in the Ordinary Course of Business (and not constituting Indebtedness);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
discharged or satisfied any Lien or paid any Liability related to the Company (other than Liabilities paid in the Ordinary Course of
Business), or prepaid any amount of Indebtedness or subjected any portion of its properties or assets to any Lien or other encumbrance
(other than Permitted Liens and Liens that will be released at or prior to the Closing);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
sold, leased, subleased, licensed, assigned, transferred or otherwise disposed of (including transfers to Company Securityholders or
any Insider) any of its material tangible or intangible assets (including Company Intellectual Property Assets), except for non-exclusive
licenses granted in the Ordinary Course of Business to customers on an arms&rsquo; length basis;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
waived, canceled, compromised or released any rights or claims of material value, whether or not in the Ordinary Course of Business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
except in the Ordinary Course of Business, entered into any material Contract or amended or terminated the Company&rsquo;s rights thereunder,
or entered into any other material transaction;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
made, granted or promised any wage, salary, commissions or compensation increase in excess of $50,000 per year to, or made any other
change in employment terms for, any director, officer, employee, sales representative or consultant paid, or made any new commitment
to pay, any bonus or made any profit-sharing payment, cash incentive payment or similar payment granted or promised any increase in any
employee benefit plan or arrangement, amended, established or terminated any Company Employee Program (other than an amendment required
by Law), or adopted any new Employee Program;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
made any material change in its business practices, including, without limitation, any change in accounting methods or practices or collection,
credit, pricing or payment policies of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(j)
except in the Ordinary Course of Business, made any capital expenditures in excess of $</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000
<FONT STYLE="color: windowtext">in the aggregate or any investments;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(k)
made any loans or advances to, or guarantees for the benefit of, any Persons (other than advances to employees for travel and business
expenses incurred in the Ordinary Course of Business that do not exceed $</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000
<FONT STYLE="color: windowtext">in the aggregate);</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
changed, amended or modified or authorized any change, amendment or modification in its certificate of incorporation, bylaws or other
governing or organizational documents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
instituted or settled any claim or lawsuit for an amount involving in excess of $5,000 in the aggregate or involving equitable or injunctive
relief;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
acquired any other business or Person (or any significant portion or division thereof), whether by merger, consolidation or reorganization
or by purchase of its assets or stock or acquired any other material assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
materially amended any Permit other than routine renewals or failed to maintain any Permit or timely obtain any Permit that is material
to the ongoing operations of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
outside the Ordinary Course of Business, made or changed any Tax election, changed any annual Tax accounting period, adopted or changed
any method of Tax accounting, filed any amended Tax Return, entered into any closing agreement with respect to Taxes, settled or compromised
any Tax claim or assessment, surrendered any right to claim a material Tax refund, received or requested any Tax ruling, or consented
to any extension or waiver of the limitations period applicable to any material Tax claim or assessment;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
entered into any Contract or other transaction with an Insider not at arms&rsquo; length; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
committed or agreed, in writing or otherwise, to any of the foregoing, except as expressly contemplated by this Agreement and the Ancillary
Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.11
<U>Indebtedness</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">. All of the Company&rsquo;s Indebtedness
is listed on <U>Schedule 3.11</U>. For each item of Indebtedness, <U>Schedule 3.11</U> correctly sets forth the debtor, the Contract
governing the Indebtedness, and the principal amount of the Indebtedness. The Company has no Liability in respect of a guarantee of any
Indebtedness or other liability or obligation of any other Person. All relevant documentation associated with the Indebtedness of the
Company has been Made Available<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.12
<U>Assets</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company owns and has good, valid
and marketable title to, or, in the case of leased or licensed property and assets, has the right to use pursuant to a valid and enforceable
lease, license or similar Contract, all of its material tangible properties, rights and assets, whether real or personal, including all
assets reflected in the Reference Balance Sheet or acquired after the date of the Reference Balance Sheet (in each case, free and clear
of any Liens (other than Permitted Liens <FONT STYLE="color: windowtext">and Liens that will be released at or prior to the Closing</FONT>)),
except (a) to the extent the enforceability of any such leases or other Contracts <FONT STYLE="color: black">may be limited by bankruptcy,
insolvency, reorganization, moratorium or similar Laws affecting creditors&rsquo; rights generally and by general equitable principles,
</FONT>and (b) for assets that have been sold or otherwise disposed of since September 30, 2021 in the Ordinary Course of Business. The
foregoing tangible properties, rights and assets constitute all the assets, properties, rights and goodwill necessary to carry on the
business of the Company as currently conducted and as presently proposed to be conducted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13
<U>Real Property</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company does not own any real property, nor has the Company ever owned, any real property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Leased Real Properties held by the Company are listed
on <U>Schedule 3.13(b)</U>. The Company has Made Available to the Buyer Parties true and complete copies of the leases relating to such
Leased Real Property and all extensions, amendments and other modifications (the &ldquo;<U>Real Property Leases</U>&rdquo;), if any,
thereof and subordination and non-disturbance agreements, if any, relating thereto. Except as set forth on <U>Schedule 3.13(b)(i)</U>,
none of the Leased Real Property is occupied by the Company pursuant to a sublease. With respect to each lease listed on <U>Schedule
3.13(b)(i)</U>, except as set forth on <U>Schedule 3.13(b)(ii)</U>, the Company has not assigned, transferred, conveyed, mortgaged, deeded
in trust or encumbered any interest in the lease<FONT STYLE="color: windowtext">. </FONT>There are no parties in possession at the Leased
Real Property other than the Company. The Leased Real Property constitutes all interests in real property currently used, occupied or
held for use in connection with the business of the Company and which is necessary for the continued operation of the businesses of the
Company as such business is currently conducted. The Company does not own or hold, nor is it obligated under or a party to, any option,
right of first refusal, right of first offer or other contractual right to purchase, acquire, sell, assign or dispose of any real estate
or any portion thereof or interest therein. There are no unpaid charges, costs, or expenses for the Leased Real Property made on behalf
of any Company which would reasonably be likely to give rise to any mechanic&rsquo;s or materialmen&rsquo;s or other statutory liens.
There are no unpaid commissions due to or payable by the Company to any other Person becoming due after the Closing Date under any the
Real Property Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.14
<U>Personal Property</U>. The Company owns good and marketable title to, or a valid leasehold interest in, free and clear of all Liens
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(other than Permitted Liens <FONT STYLE="color: windowtext">and
Liens that will be released at or prior to the Closing</FONT>)<FONT STYLE="color: windowtext">, all of the personal property and assets
of the Company. The machinery, equipment, personal properties and other tangible assets of the Company are in good condition and repair
(normal wear and tear excepted), and are usable in the Ordinary Course of Business. The Company does not own or lease any improvements
or vehicles.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.15
<U>Contracts and Commitments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except as set forth on <U>Schedule 3.15</U>, the Company is not a party to, or bound by, whether written or oral, any active, ongoing
or otherwise in effect:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
Contract involving a potential commitment or payment by the Company in excess of $</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000
(<FONT STYLE="color: black">excluding purchase orders entered into in the Ordinary Course of Business)</FONT><FONT STYLE="color: windowtext">;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Collective bargaining agreements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Agency (foreign or domestic), broker, dealer, distributor, sales representative, marketing or other similar Contracts with any party
other than Parent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Contract for the employment of any officer, individual employee or other Person on a full-time, consulting or independent contractor
basis involving payment by the Company in excess of $50,000 in the aggregate during any twelve (12) month period (other than any employment
offer letter or consulting Contract in such form as has been Made Available and is terminable &ldquo;at will&rdquo; without any contractual
obligation on the part of the Company to provide for severance, retention, change-of-control or similar compensation or benefits);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(v)
Contract relating to Indebtedness (including guaranty arrangements) or to mortgaging, pledging or otherwise placing a Lien (</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
than Permitted Liens<FONT STYLE="color: windowtext">) on any of its assets, or any guaranty of an obligation of a third party;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
Contract relating to Company Transaction Expenses;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
royalty, dividend or similar arrangement based on the revenues or profits of the Company or any contract or agreement involving fixed
price or fixed volume arrangements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
Contract which contains any provisions requiring the Company to indemnify any other party, except for indemnification obligations undertaken
by the Company in the Ordinary Course of Business to its customers and suppliers on an arms&rsquo; length basis;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
Contract under which the Company is lessee of, or holds or operates, any property, real or personal, owned by any other party calling
for payments in excess of $10,000 annually or under which it is lessor of or permits any third party to hold or operate any property,
real or personal, owned or controlled by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(x)
Contract or group of related Contracts </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<FONT STYLE="color: black">excluding
purchase orders entered into in the Ordinary Course of Business with customers and/or suppliers on an arms&rsquo; length basis)</FONT>
<FONT STYLE="color: windowtext">that are not cancelable by the Company without penalty on not less than ninety (90) days&rsquo; notice;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
Contract relating to the ownership of or investment in any business or enterprise (including investments in joint ventures and minority
equity investments);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)
Contract limiting the ability of the Company, or that would limit the ability of Buyer or any of its Affiliates after the Closing Date,
to freely engage in any line of business or with any Person anywhere in the world or during any period of time, including any Contract
containing an exclusivity obligation, most-favored-nation provision or &ldquo;best price&rdquo; obligation enforceable against the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)
Settlement document or Contracts with respect to any Legal Proceeding that contain any outstanding obligations of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)
Contract pursuant to which it subcontracts work to third parties;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)
Contract with any Governmental Authority;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)
power of attorney;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvii)
acquisition agreement, whether by merger, stock or asset sale or otherwise;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xviii)
Contract contemplating the collection, transfer and/or processing by the Company of identified or identifiable data of any natural person;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xix)
Real Property Leases;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx)
Contracts with Licensed Providers, hospitals, health systems and other health care provider organizations, including but not limited
to advisory board agreements and medical director agreements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxi)
Contracts that support or are otherwise related to clinical research or trials;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxii)
Contracts that are or contain business associate agreements; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxiii)
Contracts with any Third Party Payor, charitable fund, or similar organization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
The Contracts required to be disclosed on <U>Schedule 3.15</U> or <U>Schedule 3.26</U>, are referred to herein as the &ldquo;<U>Company
Contracts</U>&rdquo;. The Company has Made Available true and correct copies of each Company Contract, together with all amendments,
waivers and other changes thereto (all of which are disclosed on <U>Schedule 3.15</U> or <U>Schedule 3.26</U>). <U>Schedule 3.15</U>
contains an accurate and complete description of all material terms of all oral Contracts referred to therein. Except as disclosed on
<U>Schedule 3.15</U>, (i) no Company Contract has been, to the Company&rsquo;s knowledge, breached by the other party, and the Company
has no knowledge of any planned breach by any other party to any Company Contract, (ii) the Company has performed all of the obligations
required to be performed by it on or before the date hereof in connection with the Company Contracts and is not in material default under
or in breach of any Company Contract, (iii) to the Company&rsquo;s knowledge, no event or condition has occurred or arisen which, with
the passage of time or the giving of notice or both, would reasonably be expected to result in a material default or breach thereunder,
and (iv) each Company Contract is in full force and effect and is a legal, valid, binding, and enforceable obligation of the Company
and, to the knowledge of the Company, the other party, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">except
as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar Laws affecting creditors&rsquo;
rights generally and by general equitable principles</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16
<U>Intellectual Property</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Schedule 3.16(a)</U> contains a complete and accurate list of all (i) Patents owned or purported to be owned by or filed in or issued
under the name of the Company or used or held for use by the Company (&ldquo;<U>Company Patents</U>&rdquo;), registered and unregistered
Marks owned or purported to be owned by or filed in or issued under the name of the Company or used or held for use by the Company (&ldquo;<U>Company
Marks</U>&rdquo;), and registered and material unregistered Copyrights owned or purported to be owned by or filed in or issued under
the name of the Company or used or held for use by the Company (&ldquo;<U>Company Copyrights</U>&rdquo;), in each case including, to
the extent applicable, the date of filing, issuance or registration, the filing, issuance or registration number and the name of the
body where the filing, issuance or registration was made, and (ii) products (including computer programs and applications) and/or services
currently or previously developed, researched, designed, manufactured, performed, licensed, sold, distributed and/or otherwise made commercially
available by the Company (the &ldquo;<U>Company IP Products</U>&rdquo;), (iii) active or ongoing licenses, sublicenses or other agreements
under which the Company is granted rights by others in Company Intellectual Property Assets, other than &ldquo;off the shelf&rdquo; software
that is generally commercially available for a total of cost of less than $20,000 (&ldquo;<U>Licenses In</U>&rdquo;), and (iv) licenses,
sublicenses or other agreements under which the Company has granted rights to others in Company Intellectual Property Assets (&ldquo;<U>Licenses
Out</U>&rdquo; and, collectively with the Licenses In, the &ldquo;<U>Company Licenses</U>&rdquo;) (other than customer agreements entered
into in the Ordinary Course of Business, substantially in the form of the Company&rsquo;s form of customer agreement, copies of which
have been Made Available). All Company Licenses are non-exclusive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Except as set forth on <U>Schedule 3.16(b)</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the Company exclusively owns all Company Intellectual Property Assets owned or purported to be owned by the Company, free and clear of
all Liens other than Permitted Liens;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all Company Intellectual Property Assets owned or purported to be owned by the Company that have been issued by, or registered with,
or the subject of an application filed with, as applicable, the U.S. Patent and Trademark Office, the U.S. Copyright Office or any similar
office or agency anywhere in the world are registered in the name of the Company; all Company Intellectual Property Assets owned by or
exclusively licensed to the Company are subsisting and, to the knowledge of the Company, valid and enforceable, and all Company Patents,
Company Marks and Company Copyrights that have been issued by, or registered, or are the subject of an application filed with, as applicable,
the U.S. Patent and Trademark Office, the U.S. Copyright Office or any similar office or agency anywhere in the world are currently in
material compliance with formal legal requirements (including, as applicable, the payment of filing, examination and maintenance fees,
inventor declarations, proofs of working or use, timely post-registration filing of affidavits of use and incontestability and renewal
applications);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
none of the Company Intellectual Property Assets owned by or exclusively licensed to the Company that has been issued by, or registered
or the subject of an application filed with, as applicable, the U.S. Patent and Trademark Office, the U.S. Copyright Office or in any
similar office or agency anywhere in the world is subject to any maintenance fee or Tax or action falling due within ninety (90) days
following the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
to the knowledge of the Company, no Company Patent has been or is now involved in any interference, derivation, reissue, re-examination,
inter parties review, post-grant review, covered business method review or opposition proceeding, and, to the knowledge of the Company,
all products made, used or sold under the Company Patents have been marked with the proper patent notice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
there are no pending or, to the knowledge of the Company, threatened claims against the Company or any of its employees alleging that
any of the operation of the Company&rsquo;s business, either as currently conducted or as presently planned to be conducted, or any activity
by the Company infringes or violates (or in the past infringed or violated) the rights of others in or to any Intellectual Property Assets
(&ldquo;<U>Third Party IP Assets</U>&rdquo;) or constitutes a misappropriation of (or in the past constituted a misappropriation of)
any Intellectual Property Assets of any person or entity or that any of the Company Intellectual Property Assets is invalid or unenforceable;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
neither the operation of the Company&rsquo;s business, as currently conducted, nor any activity by the Company, as currently conducted,
infringes or violates (or in the past infringed or violated) any Third Party IP Asset or constitutes a misappropriation of (or in the
past constituted a misappropriation of) any Third Party IP Asset, provided that the representation and warranty in this subsection (vi)
is made to the knowledge of the Company with respect to the rights of others in or to any Patents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
the Company does not have any obligation to compensate any Person for the use of any Intellectual Property Assets; the Company has not
entered into any agreement to indemnify any other Person against any claim of infringement or misappropriation of any Intellectual Property
Assets; there are no settlements, covenants not to sue, consents, judgments, or orders or similar obligations that: (A) restrict the
Company&rsquo;s rights to use any Intellectual Property Assets, (B) restrict the Company&rsquo;s Business, in order to accommodate a
third party&rsquo;s Intellectual Property Assets, or (C) permit third parties to use any Company Intellectual Property Assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
the Company has obtained and possesses valid licenses to use all of the software programs present on the computers and other software
enabled electronic devices that it owns or leases or that it has otherwise provided to its employees and contractors for their use;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
all former and current employees, consultants and contractors of the Company have executed written instruments with the Company that
assign to the Company all rights, title and interest in and to any and all (A) inventions, improvements, ideas, discoveries, developments,
writings and other works of authorship, know-how, processes, methods, technology, data and information relating to the business of the
Company or any of the products or services being researched, developed, manufactured or sold by the Company or that may be used with
any such products or services and (B) Intellectual Property Assets relating thereto; and in each case a valid and enforceable assignment
to the Company for each Company Patent has been duly recorded with the U.S. Patent and Trademark Office and all similar offices and agencies
anywhere in the world in which foreign counterparts are registered or issued;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
to the Knowledge of the Company, (A) there is no, nor has there been any, infringement or violation by any person or entity of any of
the Company Intellectual Property Assets or the Company&rsquo;s rights therein or thereto, and (B) there is no, nor has there been any,
misappropriation by any person or entity of any of the Company Intellectual Property Assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
the Company has taken all reasonable security measures to protect the confidentiality of all Trade Secrets owned or purported to be owned
by the Company, or used or held for use by the Company in the business of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)
(A) the Company has not collected or used any data and information related to an identified or identifiable natural person, including,
without limitation, any information specifically defined or identified in any Privacy Policy, or that can be used to contact an individual
or serve advertisements to an individual, or any information under applicable Law as &ldquo;personal information,&rdquo; &ldquo;personally
identifiable information,&rdquo; &ldquo;protected health information,&rdquo; &ldquo;PHI,&rdquo; &ldquo;individually identifiable information,&rdquo;
&ldquo;PII,&rdquo; &ldquo;personal data&rdquo; or a similar term (&ldquo;<U>Personal Data</U>&rdquo;) from any third parties; (B) in
connection with the collection, use or other processing of Personal Data, the Company has complied in all material respects with (1)
all applicable Laws, statutes, directives, rules, regulations, industry self-regulatory codes, guidance and best practices, (2) contractual
obligations (including, but not limited to, those with customers), (3) internal and public-facing privacy, data handling or processing
and/or security policies of the Company (each, a &ldquo;<U>Privacy Policy</U>&rdquo;), (4) public statements that the Company has made
regarding its privacy, data handling and/or data security policies or practices, and (5) the Payment Card Industry Data Security Standard,
and all other rules and requirements of payment card brands (the &ldquo;<U>Privacy Requirements</U>&rdquo;) relating to (a) the privacy
of users of any web properties, products and/or services of the Company; (b) the collection, use, storage, retention, disclosure, transfer,
disposal, or any other processing of any Personal Data collected or used by the Company; and (c) the transmission of marketing and/or
commercial messages through any means, including, without limitation, via email, text message and/or any other means; (C) the execution,
delivery and performance of this Agreement, including the transfer of Personal Data in connection with the transactions contemplated
by this Agreement, complies with all Privacy Requirements; (D) the Company has all reasonable and appropriate security measures in place
to protect all Personal Data under its control and/or in its possession and to protect such Personal Data from unauthorized access by
any parties; (E) the Company&rsquo;s hardware, software, encryption, systems, policies and procedures are sufficient to protect the privacy,
security and confidentiality of all Personal Data in accordance with the Privacy Requirements; (F) the Company has not suffered any breach
in security or security incident that has permitted any unauthorized access to any data possessed or under the control of the Company,
including any Personal Data or Customer Data; (G) the Company has not received any written correspondence or notice relating to, and
there is no formal action or, to the Company&rsquo;s knowledge, allegation, claim, or investigation currently pending against, the Company
by any private party, the Federal Trade Commission, any state attorney general or similar state official, or any other Governmental Authority,
foreign or domestic, or any other third party, with respect to the Personal Data of any Person, and, to the Company&rsquo;s knowledge
there are no facts or circumstances which could reasonably form the basis for any such action, allegation, investigation or claim; and
(H) the Company has required and does require all third parties to which it provides Personal Data and/or access thereto to maintain
the privacy and security of such Personal Data, including by contractually obligating such third parties to implement all reasonable
and appropriate security measures to protect such Personal Data from unauthorized access by and/or disclosure to any unauthorized third
parties;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)
the Company is not subject to the European General Data Protection Regulation or any other privacy laws of any jurisdictions outside
of the United States;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)
the Company has not granted, directly or indirectly, any current or contingent right, license or interest in or to any source code of
any of the Company IP Products (including through an escrow arrangement), and has not provided or disclosed any source code of any of
the Company IP Products to any person or entity;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)
in all material respects, (A) the Company IP Products perform in accordance with their documented specifications and as the Company has
warranted to its customers, and (B) the Product Support Items contain all the information necessary to sell, maintain and support the
Company IP Products;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)
to the knowledge of the Company, the Company IP Products do not contain any &ldquo;viruses&rdquo;, &ldquo;worms&rdquo;, &ldquo;time bombs&rdquo;,
&ldquo;key-locks&rdquo;, or any other devices created that could disrupt or interfere with the operation of the Company IP Products or
equipment upon which the Company IP Products operate, or the integrity of the data, information or signals the Company IP Products produce
in a manner adverse to the Company or any customer, licensee or recipient. The Company uses commercially reasonable methods to (A) detect
and prevent viruses and any third-party software routines designed to permit unauthorized access, disable or erase software, hardware
or data, or perform any other similar actions that may be present in the Company IP Products, and (B) promptly correct or remove such
viruses and subroutines. The Company IP Products do not include or install any spyware, adware, or other similar software that monitors
the use of the Company IP Products or contacts any remote computer without the knowledge and express consent of the user(s) of the applicable
Product or remote computer, as applicable;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvii)
(A) none of the Company IP Products were developed with or contain, incorporate, link or call to, are distributed with, or otherwise
use any Open Source Software, and (B) the development of any Product with any such Open Source Software, and the incorporation, linking,
calling, distribution or other use in, by or with any such Product of any such Open Source Software, does not obligate the Company to
disclose, make available, offer or deliver any portion of the source code of such Product or component thereof to any third party other
than the applicable Open Source Software, and the Company is in compliance with all licenses for such Open Source Software;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xviii)
(A) the Company has security measures in place to protect information relating to its customers (&ldquo;<U>Customer Data</U>&rdquo;)
under its and its service providers&rsquo; possession or control from unauthorized access; and (B) the Company&rsquo;s, and to the knowledge
of the Company, its service providers&rsquo;, hardware, software, encryption, systems, policies and procedures are sufficient to protect
the security and confidentiality of all Customer Data;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xix)
The Company IT Systems have been properly maintained by technically competent personnel, in accordance with standards set by the manufacturers
or otherwise in accordance with standards prudent in the industry, to ensure proper operation, monitoring and use and are sufficient
to operate the Company&rsquo;s business and the Company owns or has valid and enforceable rights to use the Company IT Systems. The Company
has appropriate data backup and disaster recovery plans and procedures for the Company&rsquo;s business and has taken commercially reasonable
efforts to safeguard the Company IT Systems, including the use of commercially available antivirus software with the intention of protecting
the Company IT Systems from becoming infected by viruses and other harmful code. There have not been any breaches of the security of
the Company IT Systems, and there have been no unauthorized intrusions of the Company IT Systems or infections by viruses or other harmful
code. The Company IT Systems are fully functional and operate in a reasonable manner and there has not been any material malfunction
with the Company IT Systems that has not been remedied or replaced in all material respects, or any material unplanned downtime or material
service interruption. The Company IT Systems are sufficient to conduct the Company&rsquo;s business as currently conducted and as currently
proposed to be conducted;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(xx)
the Company has delivered to Buyer true and correct copies of each Company License, together with all amendments, waivers and other changes
thereto (all of which are disclosed on <U>Schedule 3.16(a)</U>). <U>Schedule 3.16(a)</U> contains an accurate and complete description
of all material terms of all oral Company License referred to therein. Except as disclosed on <U>Schedule 3.16(a)</U>, (i) no Company
License has been, to the Company&rsquo;s knowledge, breached by any other party thereto, and the Company has no knowledge of any planned
breach by any other party to any Company License, (ii) the Company has performed all of the obligations required to be performed by it
in connection with the Company Licenses and is not in default under or in breach of any Company License, (iii) to the Company&rsquo;s
knowledge, no event or condition has occurred or arisen which with the passage of time or the giving of notice or both would reasonably
be expected to result in a default or breach by the thereunder, and (iv) each Company License is in full force and effect and is a legal,
valid, binding and enforceable obligation of the Company and, to the knowledge of the Company, any other party thereto, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">except
as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar Laws affecting creditors&rsquo;
rights generally and by general equitable principles</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxi)
immediately following the Closing, Buyer will have the same rights and privileges in the Company Intellectual Property Assets, Customer
Data and Company IT Systems as the Company had in the Company Intellectual Property Assets, Customer Data and Company IT Systems immediately
prior to the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.17
<U>Litigation; Proceedings</U>. Except as set forth on <U>Schedule 3.17</U>, there are no Legal Proceedings or Governmental Orders pending
or, to the Company&rsquo;s knowledge, threatened against or affecting the Company or any of the Company&rsquo;s directors, officers or
employees, in their capacity as such, at law or in equity, or before or by any Governmental Authority and, to the knowledge of the Company,
there is no reasonable basis for any of the foregoing. The Company is not subject to any Legal Proceeding under any Contracts or, to
the Company&rsquo;s knowledge, any investigation or inquiry by a Governmental Authority; and, to the Company&rsquo;s knowledge, there
is no reasonable basis for any of the foregoing. The Company is not subject to any outstanding Governmental Order issued by any Governmental
Authority. <U>Schedule 3.17</U> includes a description of all Legal Proceedings or, to the Company&rsquo;s knowledge, investigations
involving the Company or any of its directors, officers or employees, in their capacity as such, occurring, arising or existing during
the past two (2) years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18
<U>Governmental Licenses and Permits</U>. <U>Schedule 3.18</U> contains a complete listing of all permits, licenses, franchises, certificates,
approvals, clearances, consents, certificates of authorization, registrations, filings and other authorizations of any Governmental Authority
(including all applications therefor), or other similar rights, together with any renewals, extensions, or modifications thereof and
additions thereto (collectively, the &ldquo;<U>Permits</U>&rdquo;) owned or possessed by the Company or used by the Company in the conduct
of its business, including the promotion and distribution of the Company&rsquo;s products and services. Except as set forth on <U>Schedule
3.18</U>, the Company owns or possesses, and has owned or possessed, all right, title and interest in and to all Permits that are necessary
to conduct its business as currently conducted. Each Permit is valid and in full force and effect, and is not subject to any restrictions
or conditions except as set forth on <U>Schedule 3.18</U>. In all materials respects, the Company is in compliance with the terms and
conditions of such Permits. No loss, expiration, revocation, suspension, lapse or limitation of any Permit is pending or, to the Company&rsquo;s
knowledge, threatened (including as a result of the transactions contemplated hereby), with or without notice or lapse of time or both,
other than expiration in accordance with the terms thereof, which terms do not expire as a result of the consummation of the transactions
contemplated hereby. To the Company&rsquo;s knowledge, no event has occurred that (including the consummation of the transactions contemplated
by the Ancillary Agreements), with or without notice or lapse of time or both, would reasonably be expected to result in the revocation,
suspension, lapse or limitation of any Permit. Except as indicated on <U>Schedule 3.18</U>, all of the Permits are transferable to Parent,
Buyer and/or their respective Affiliates and will be transferred by the Company to Parent, Buyer and/or their respective Affiliates on
the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19
<U>Compliance with Laws</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except as disclosed on <U>Schedule 3.19(a)</U>, the Company and each of the Company&rsquo;s officers, directors, employees and control
persons is in compliance with, and has complied with and is in compliance with, in all material respects, all laws, regulations and ordinances
of foreign, federal, state and local governments and all agencies thereof that are applicable to the business, business practices (including
the Company&rsquo;s production, marketing, sales and distribution of its products and services) and any owned or leased properties of
the Company to which the Company may be subject, and no claims have been filed against the Company alleging a violation of any such laws,
regulations or ordinances, and the Company has not received notice of any such violation. No event or condition has occurred that that
can be reasonably expected to constitute a material violation of applicable Law by the Company or, to the Company&rsquo;s knowledge,
any of its officers, directors, employees, or control persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company and each of its officers, directors, employees, and control persons is, and has been in material compliance with all applicable
Laws relating to the issuance, maintenance, and servicing of any payments-related products or services, as well as any products or services
related to money transmission, remittances, the issuance, storage, exchange, and the rights of customers who use such products and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company and each of its officers, directors, employees, and control persons is, and has been, in material compliance with all applicable
federal, state and foreign anti-money laundering rules and regulations, including, but not limited to, the United States Bank Secrecy
Act, as amended by the USA PATRIOT Act of 2001, and the United States Money Laundering Control Act of 1986 (18 U.S.C. &sect;&sect;1956
and 1957), as amended, as well as the implementing rules and regulations promulgated thereunder, and the applicable money laundering
statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines,
issued, administered or enforced by any governmental agency or self-regulatory body (collectively, the &ldquo;<U>Anti-Money Laundering
Laws</U>&rdquo;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Neither the Company nor any of its officers, directors, employees, or control persons has conducted any transactions directly or indirectly
with (A) any countries subject to United States Government export embargoes at the time of such embargo, including Cuba, Iran, North
Korea, Sudan, Crimea (Ukraine) or Syria, (B) individuals or entities identified on the SDN List or Consolidated Sanctions List administered
by the U.S. Treasury Department&rsquo;s Office of Foreign Assets Control, and the Denied Parties List, Unverified List and Entity List
administered by the U.S. Commerce Department&rsquo;s Bureau of Industry and Security (each, a &ldquo;<U>Restricted Party</U>&rdquo;)
or (C) entities owned in the aggregate fifty percent (50%) or more by entities on the SDN List. The Company has not sold, licensed, supplied,
exported, re-exported, transferred or furnished any of the Company products, or any software code, technology or services, directly or
indirectly to (x) any Person located in any country that is subject to a United States government export embargo or (y) any Restricted
Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
All product candidates currently being, or that have been, manufactured, tested, developed, processed, labeled, stored, or distributed
by or on behalf of the Company, including, but not limited to all therapeutic or diagnostic product candidates and software (collectively,
the &ldquo;<U>Products</U>&rdquo;), are being, and have, at all times, been, manufactured, tested, developed, processed, labeled, stored,
and distributed in compliance with all applicable Laws governing medical products and related activities, including, but not limited
to, the Federal Food, Drug &amp; Cosmetic Act (&ldquo;<U>FDCA</U>&rdquo;) and related regulations administered or issued by the United
States Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) (collectively, &ldquo;<U>Medical Product Laws</U>&rdquo;). All clinical
trials that were, or are being, conducted by or on behalf of the Company or regarding any Product were, or are being, conducted in compliance
with all applicable Medical Product Laws, including without limitation, the FDA&rsquo;s good clinical practice and good laboratory practice
regulations and federal and state Laws governing the use and disclosure of individually identifiable health information. No Product has
been seized, withdrawn, recalled, detained, or subject to a clinical hold or suspension of manufacturing or distribution, and, to the
knowledge of the Company, there are no facts or circumstances reasonably likely to result in the seizure; withdrawal; recall; detention;
field notification; field correction; safety alert; clinical hold; suspension of manufacturing or distribution; or a change in the labeling
of any Product. No Products are being, or have been, marketed, advertised, promoted, or sold in the U.S. or to U.S. consumers, nor has
the Company made any explicit or implicit representations that any of its Products is safe and effective for the targeted use(s) or indication(s)
or that the FDA has authorized such Product for commercial use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(f)
<U>Schedule 3.19(f)</U> contains a list of all serious adverse events that have been reported in connection with the use or administration
of any Product (including during clinical trials). The Company has reported all such adverse events to the FDA, to the extent required
by, and in accordance with, applicable Medical Product Laws. The Company: (</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A)
has not received any FDA Form 483, notice of adverse finding, warning letter, untitled letter, or other correspondence or notice from
the FDA or any Governmental Authority alleging or asserting noncompliance with any applicable Medical Product Law or any Permits held
by the Company in relation to any Product, including, but not limited to, marketing approvals or clearances issued by the FDA and any
amendments or supplements thereto; (B) <FONT STYLE="color: windowtext">is not subject to any obligation arising under an administrative
or regulatory action, FDA inspection, FDA warning letter, FDA notice of violation letter, or other notice, response, or commitment made
to or with the FDA or any comparable Governmental Authority with respect to the Products; and (C) has made all required notifications,
submissions, and reports to the FDA or any comparable Governmental Authority, and all such notifications, submissions, and reports were
true, complete, and correct as of the date of submission to the FDA or comparable Governmental Authority. </FONT>Neither the Company
nor any of its employees, agents, or other persons engaged by the Company has provided false or misleading information or made any significant
omission in any communication or submission to any Governmental Entity. Neither the Company nor any of its directors, officers, employees,
or agents, has been debarred or excluded under 21 U.S.C. &sect; 355a or any similar Law or engaged in conduct that could result in debarment
or exclusion under 21 U.S.C. &sect; 355a or any similar Law, and there are no pending or, to the knowledge of the Company, threatened
claims, actions, proceedings, or investigations that would reasonably be expected to result in such a debarment or exclusion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20
<U>Taxes.</U> Except as provided as set forth on <U>Schedule 3.20:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company has timely filed (taking into account valid extensions of time with respect to filing made in the Ordinary Course of Business)
all income and other material Tax Returns that are required to be filed by or with respect to it, and all such Tax Returns were filed
in compliance with applicable Law and are true, correct and complete in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All Taxes due and payable by the Company, whether or not shown or required to be shown on any Tax Return, have been paid and no income
or other Taxes are delinquent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
There are no Liens for Taxes upon any of the assets or the equity of the Company, other than Taxes not yet due and payable and for which
adequate reserves have been established.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company has withheld and paid all Taxes required to have been withheld and paid in connection with amounts paid or owing to any employee,
independent contractor, creditor, securityholder or other third party, including federal and state income Taxes, Federal Insurance Contribution
Act, Medicare, Federal Unemployment Tax Act, relevant state income and employment Tax withholding laws, and all material withholding
Tax Returns required with respect thereto have been properly completed and timely filed, and all amounts withheld have been paid over
to the proper Governmental Authorities (or are properly being held for such timely payment) to the extent required by applicable Law.
Without limitation of the foregoing, the Company has collected all sales and use Taxes required to be collected, and has remitted, or
will remit on a timely basis, such amounts to the appropriate Governmental Authority, as required under applicable Law, or has been furnished
properly completed exemption certificates and has maintained all such records and supporting documents in the manner required by all
applicable sales and use tax statutes and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
No deficiency for any amount of Tax has been threatened, proposed, asserted, written or orally, to the Company or assessed by a Governmental
Authority against the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
There is no action, suit, proceeding or audit or any notice of inquiry of any of the foregoing pending against or with respect to the
Company regarding any Taxes or any Tax Return and no action, suit, proceeding or audit has been threatened in writing against or with
respect to the Company regarding Taxes or any Tax Return.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
To the knowledge of the Company, no claim has been made by a Governmental Authority in a jurisdiction where the Company does not file
Tax Returns that the Company is or may be subject to taxation by that jurisdiction or may be required to file a Tax Return in that jurisdiction.
The Company does not have a permanent establishment or conduct business through any branch other than in its country of formation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
The Company has delivered to Buyer correct and complete copies of all income and other material Tax Returns, examination reports, and
statements of deficiencies assessed against, agreed to, or filed by the Company for all taxable years beginning with the taxable year
ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Company has not submitted a request for a private letter ruling, a request for administrative relief, a request for technical advice,
a request for change of any method of accounting, or any other material request with any Governmental Authority that relates to Taxes
or Tax Returns of the Company, other than such rulings, reliefs, advices or other requests that are no longer in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Since the date of the Reference Balance Sheet, the Company has not incurred any material Liability for Taxes outside of the Ordinary
Course of Business other than as a result of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
No extension or waiver of any statute of limitations on the assessment, reassessment or collection of, or any claim for, any Taxes granted
by the Company is currently in effect, and no agreement to any extension of time for filing any income or other material Tax Return that
has not been filed is currently in effect. No request for any such extension or waiver is currently pending, other than extensions filed
in the Ordinary Course of Business for which no approval is required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
The Company has not participated in any &ldquo;listed transactions&rdquo; within the meaning of Treasury Regulations Section 1.6011-4(b)(2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
Neither the Company nor any predecessor of the Company has been a member of a consolidated combined, unitary or aggregate group of which
the Company or any predecessor of the Company was not the ultimate tax reporting corporation. The Company does not have any Liability
for the Taxes of any Person under Section 1.1502-6 of the Treasury Regulations (or any corresponding or similar provision of state, local
or non-U.S. Law), as a transferee or successor, by Contract (other than a Contract entered into in the Ordinary Course of Business, the
principal purpose of which is not Taxes) or otherwise outside of the Ordinary Course of Business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
The Company has not constituted either a &ldquo;distributing corporation&rdquo; or a &ldquo;controlled corporation&rdquo; in a distribution
of stock qualifying, or purported to or intended to qualify, for tax free treatment under Sections 355 or 361 of the Code (i) in the
two years prior to the date of this Agreement or (ii) in a distribution that could otherwise constitute part of a &ldquo;plan&rdquo;
or &ldquo;series of related transactions&rdquo; (within the meaning of Section 355(e) of the Code) in conjunction with the Contemplated
Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
The Company is now, and has been, treated as a corporation for all applicable federal, state, local and non-U.S. Tax purposes since August
2020, before which it was treated as an entity disregarded as separate from its regarded owner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
The Company does not have any Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
The Company is not a party to or bound by any Tax sharing, Tax indemnity, or Tax allocation agreement, other than customary contracts
entered into in the Ordinary Course of Business, a principal purpose of which does not relate to Tax, nor does the Company have any Liability
or potential Liability to another party under any such agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
The Company will not be required to include any item of income or gain in, or exclude any material item of deduction or loss from, taxable
income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (i) change in method of accounting
for a taxable period ending on or prior to the Closing Date; (ii) use of an improper method of accounting for a taxable period ending
on or prior to the Closing Date; (iii) &ldquo;closing agreement&rdquo; as described in Section 7121 of the Code (or any corresponding
or similar provision of U.S. state, local or non-U.S. Tax Law) executed on or prior to the Closing Date; (iv) intercompany transactions
or any excess loss account described in Treasury Regulations promulgated under Section 1502 of the Code (or any corresponding or similar
provision of state, local or non-U.S. income Tax law); (v) installment sale or open transaction disposition made on or prior to the Closing
Date; (vi) prepaid amount received on or prior to the Closing Date outside of the Ordinary Course of Business; (vii) election made under
Section 108(i) of the Code prior to the Closing; or (viii) the application of Code Section 965.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
[<U>Reserved</U>].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
The taxable year of the Company is (and always has been) the calendar year ending December 31. The Company uses the accrual method of
accounting for U.S. federal income Tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
Neither the Company nor any of its Affiliates have deferred any Taxes under Section 2302 of the CARES Act or IRS Notice 2020-65 (or any
corresponding or similar provision of state, local or non-U.S. Law). The Company has properly complied with all applicable Laws and duly
accounted for any available Tax credits under Section 7001 through 7005 of the Families First Coronavirus Response Act for 2020 (or any
corresponding or similar election under state, local or non-U.S. Law) and Section 2301 of the CARES Act (or any corresponding or similar
election under state, local or non-U.S. Law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything to the contrary in this <U>Section 3</U>.20, nothing in this Agreement (including this Section 3.20) shall be construed as providing
a representation or warranty with respect to the existence, amount, expiration date or limitations on (or availability of) any Tax attribute
(including methods of accounting or net operating losses) of the Company for any Post-Closing Tax Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21
<U>Employees</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Schedule 3.21(a)</U> contains a complete and accurate list of all of the officers and other employees of the Company as of the date
of this Agreement, describing for each such employee: name, position or title, whether classified as exempt or non-exempt for wage and
hour purposes, whether paid on a salary, hourly or commission basis and the actual annual base salary, hourly rate, or other rates of
compensation, bonus potential, date of hire, business location, status (i.e., active or inactive and if inactive, the type of leave and
estimated duration), any visa or work permit status and the date of expiration, if applicable, and the total amount of bonus, severance
and other amounts to be paid to such employee at the Closing or otherwise in connection with the transactions contemplated hereby. <U>Schedule
3.21(a)</U> also contains a complete and accurate list of all of the independent contractors, consultants, temporary employees, leased
employees or other servants or agents employed or used with respect to the operation of the business of the Company and classified by
the Company as other than employees or compensated other than through wages paid by the Company through the Company&rsquo;s payroll department
and reported on a Form W-4 (&ldquo;<U>Contingent Workers</U>&rdquo;), showing for each Contingent Worker such individual&rsquo;s name,
role in the business, fee or compensation arrangements and other contractual terms or terms of engagement with the Company. Except as
contemplated by this Agreement or as set forth on <U>Schedule 3.21(a)</U>, (i) no officer or Key Employee, or group of employees or Contingent
Workers, has notified the Company of any plans to terminate his, her or their employment or service arrangement with the Company and
(ii) in the past twelve (12) months no officer&rsquo;s or Key Employee&rsquo;s employment with the Company has been terminated for any
reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Currently and during the past six years: (i) the Company is and has been in compliance with all applicable Laws and regulations respecting
labor and/or employment matters, including laws and regulations respecting fair employment practices, work place safety and health, terms
and conditions of employment, wages and hours, including, without limitation, with respect to the classification of employees for purposes
of federal, state and local law and the payment of employee overtime and minimum wage, pay equity, restrictive covenants, immigration
and work authorization, discrimination, harassment, retaliation, background and credit checks, defamation and other torts and breach
of employee agreements; (ii) the Company is not, nor has been, delinquent in any payments to any employee or Contingent Worker for any
wages, salaries, commissions, bonuses, fees or other direct compensation due with respect to any services performed for it or amounts
required to be reimbursed to such employees or Contingent Workers; (iii) there are no, and there have been no, formal or informal litigation,
arbitration, demands, disputes, mediation, governmental investigations, governmental audits, grievances, complaints or charges with respect
to employment or labor matters (including allegations of employment discrimination, violation of wage and hour laws, harassment, breach
of restrictive covenants, pay equity violations, misclassification of independent contractors, retaliation or unfair labor practices)
pending or, to the knowledge of the Company, threatened against the Company in any judicial, regulatory or administrative forum, under
any private dispute resolution procedure or internally; (iv) none of the employment policies or practices of the Company is currently
being or has been audited or investigated or, to the knowledge of the Company, is subject to imminent audit or investigation by any Governmental
Authority; (v) none of the Company or any of its officers or senior managers, is or has been, subject to any order, decree, injunction
or judgment by any Governmental Authority or private settlement contract in respect of any labor or employment matters concerning or
with respect to the Company; (vi) the Company is and has been in compliance with the requirements of the Immigration Reform Control Act
of 1986; and (vii) all employees are and have been employed at-will and no employee is subject to any employment contract with the Company
that provides for a fixed term of employment, whether oral or written, express or implied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
(i) There is no, and during the past four (4) years there has not been, any labor strike, picketing of any nature, organizational campaigns,
labor dispute, slowdown or any other concerted interference with normal operations, stoppage or lockout pending or, to the knowledge
of the Company, threatened against or affecting the business of the Company; (ii) the Company does not have any duty to bargain with
any union or labor organization or other person purporting to act as exclusive bargaining representative (&ldquo;<U>Union</U>&rdquo;)
of any employees or Contingent Workers with respect to the wages, hours or other terms and conditions of employment of any employee or
Contingent Worker; (iii) there is no collective bargaining agreement or other contract with any Union, or work rules or practices agreed
to with any Union, binding on the Company, or being negotiated, with respect to the Company&rsquo;s operations or any employee or Contingent
Worker; and (iv) the Company has not engaged in any unfair labor practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company has not experienced a &ldquo;plant closing,&rdquo; &ldquo;business closing,&rdquo; or &ldquo;mass layoff&rdquo; or similar
group employment loss as defined in the WARN Act or any similar state, local or foreign law or regulation affecting any site of employment
of the Company or one or more facilities or operating units within any site of employment or facility of the Company. During the ninety
(90) day period preceding the date hereof, no employees of the Company have suffered an &ldquo;employment loss&rdquo; as defined in the
WARN Act with respect to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Schedule 3.21(e)</U> identifies each employee of the Company who is subject to a non-competition, non-solicitation, nondisclosure
or invention assignment agreement with the Company and a form of each such agreement has been Made Available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Except as set forth on <U>Schedule 3.21(f)</U>, at no time in the past two (2) years have any allegations been made within or outside
the Company alleging conduct that, if confirmed, would constitute violations, in any material respect, of any applicable Law, with respect
to, concerning, or otherwise related to the Company. There (i) are no allegations of sexual harassment or other sexual misconduct that
have been made to the Company involving any director, officer, or managerial or supervisory employee of the Company in connection with
such individual&rsquo;s provision of services to the Company and (ii) to the knowledge of the Company, there are no facts that could
reasonably be expected to give rise to a claim of sexual harassment or other discriminatory harassment against or involving the Company
or any employee, director or Contingent Worker. To the knowledge of the Company, no senior level employees, director or Contingent Worker
has engaged in any sexual interactions, or is or has been involved in any romantic or other intimate interpersonal relationship with
any employee, director or Contingent Worker.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
The Company currently classifies and has properly classified each of its employees as exempt or non-exempt for the purposes of the Fair
Labor Standards Act and state, local and foreign wage and hour laws, and is and has been otherwise in compliance with such laws. The
Company currently classifies and has properly classified all independent contractors, consultants, and temporary employees correctly
pursuant to applicable Law. To the extent that any Contingent Workers are employed, the Company has properly classified and treated them
in accordance with applicable Laws and for purposes of all employee benefit plans and perquisites.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Except as set forth on <U>Schedule 3.21(h)</U>, the consummation of the transactions contemplated in this Agreement will not (i) entitle
any employee of the Company to severance, change of control compensation or benefits, bonus payment or any other payment, (ii) accelerate
the time of payment for vesting of, or increase the amount of compensation due to, any such employee, or (iii) entitle any such employee
to terminate, shorten or otherwise change the terms of his or her employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.22
<U>Employee Benefit Plans</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Schedule 3.22(a)</U> sets forth a true, complete and correct list of every Company Employee Program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
True, complete and correct copies of the following documents, with respect to each Company Employee Program, where applicable, have previously
been Made Available to Parent: (i) all documents embodying or governing such Company Employee Program and any amendments thereto (or
for unwritten Company Employee Programs, a written description of the material terms of such Company Employee Program) and any trust
documents, insurance policies or other funding medium for the Company Employee Program; (ii) the current summary plan description (or
other descriptions provided to employees) and all summaries of material modification related thereto; (iii) </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
most recent determination letter from the IRS or, in the case of a prototype or volume submitter plan, the favorable opinion letter(s)
issued to the prototype or volume submitter plan sponsor; (iv) copies of all required annual nondiscrimination or other testing for the
prior three plan years; and (v) any other documents or information related to each Company Employee Program as reasonably requested by
Parent<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
With respect to each Company Employee Program that is intended to be qualified within the meaning of Section 401(a) of the Code, the
IRS has issued a favorable determination letter or opinion letter or advisory letter upon which the Company is entitled to rely under
IRS pronouncements, that such plan is qualified under Section 401(a) of the Code, and to the knowledge of the Company, no act or omission
has occurred since the date of the most recent determination, opinion or advisory letter which could reasonably be expected to adversely
affect such program&rsquo;s qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Each Company Employee Program is, and has been established, operated, and administered in all material respects in compliance with applicable
Laws and regulations, any applicable collectively bargained agreements and with its terms, including without limitation ERISA, the Code,
and the Affordable Care Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
No Company Employee Program is, or within the past six (6) years has been, the subject of an application or filing under a government
sponsored amnesty, voluntary compliance, or similar program, or been the subject of any self-correction under any such program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
No litigation or governmental administrative proceeding, audit or other proceeding (other than those relating to routine claims for benefits)
is pending or, to the knowledge of the Company, threatened with respect to any Company Employee Program or any fiduciary or service provider
thereof, and, to the knowledge of the Company, there is no reasonable basis for any such litigation, audit or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
All payments and/or contributions required to have been made with respect to all Company Employee Programs either have been timely made
or accrued for in accordance with the terms of the applicable Company Employee Program and applicable Law. To the knowledge of the Company,
there has not been any non-exempt prohibited transactions (within the meaning of Section 406 of ERISA or Section 4975 of the Code), and
the Company has not received written notice that there are any matters pending or threatened in connection with any Company Employee
Program before the IRS, the Department of Labor, the Pension Benefit Guaranty Corporation or any other Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
The Company Employee Programs satisfy in all material respects the minimum coverage, affordability and non-discrimination requirements
under the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Neither the Company nor any ERISA Affiliate has ever maintained, contributed to or had any obligation to contribute to or had any Liability
or obligation (whether contingent or otherwise), including on account of any ERISA Affiliate, with respect to (i) any employee benefit
plan that is or was subject to Title IV of ERISA, Section 412 of the Code, Section 302 of ERISA, (ii) a Multiemployer Plan, (iii) any
funded welfare benefit plan within the meaning of Section 419 of the Code, (iv) any &ldquo;multiple employer plan&rdquo; (within the
meaning of Section 210 of ERISA or Section 413(c) of the Code), or (v) any &ldquo;multiple employer welfare arrangement&rdquo; (as such
term is defined in Section 3(40) of ERISA), and neither the Company nor any ERISA Affiliate has ever incurred any Liability under Title
IV of ERISA that has not been paid in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
None of the Company Employee Programs provides, and neither the Company nor any ERISA Affiliate provides, health care or any other non-pension
benefits to any employees after their employment is terminated (other than as required by Part 6 of Subtitle B of Title I of ERISA or
similar state Law) and the Company has never promised to provide such post-termination benefits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Subject to <U>Section 5.11</U>, each Company Employee Program may be amended, terminated, or otherwise modified (including cessation
of participation) by the Company to the greatest extent permitted by applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Neither the Company nor any of its ERISA Affiliates has announced, whether in writing or orally, its intention to modify or terminate
any Company Employee Program or adopt any arrangement or program which, once established, would come within the definition of a Company
Employee Program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Each asset held under each Company Employee Program may be liquidated or terminated without the imposition of any redemption fee, surrender
charge or comparable liability other than ordinary administration expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
No Company Employee Program provides health or welfare benefits that are not fully insured through an insurance contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
No Company Employee Program is subject to the laws of any jurisdiction outside the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
No Company Employee Program provides for any tax &ldquo;gross-up&rdquo; or similar &ldquo;make-whole&rdquo; payments, including any Taxes
under Section 409A or Section 4999 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Neither the execution and delivery of this Agreement, the Stockholder Approval, nor the consummation of the transactions contemplated
hereby could (either alone or in conjunction with any other event) (i) except as set forth on <U>Schedule 3.22(j)</U>, result in, or
cause the accelerated vesting, payment, funding or delivery of, or increase the amount or value of, any payment or benefit to any employee,
officer, director or other service provider of the Company; (ii) further restrict any rights of the Company to amend or terminate any
Company Employee Program; (iii) result in the forgiveness of any indebtedness of any employee, officer, director or other service provider
of the Company; or (iv) cause, directly or indirectly, any amount paid or payable by the Company being classified as an excess parachute
payment under Section 280G of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(k)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Company Employee Program that is subject to Section
409A of the Code has been administered in all material respects in compliance with its terms and the operational and documentary requirements
of Section 409A of the Code and all applicable regulatory guidance (including notices, rulings and proposed and final regulations) thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.23
<U>Insurance</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule 3.23</U> sets forth a
complete and correct list of all insurance policies and all fidelity bonds held by or applicable to the Company, and which sets forth,
in respect of each such policy, the policy name, policy number, carrier, term, type and amount of coverage and annual premium, whether
such policies may be terminated upon consummation of the Contemplated Transactions and if and to what extent events being notified to
the insurer after the Closing Date are generally excluded from the scope of the respective policy. The Company has Made Available true
and accurate copies of all such policies or bonds. Each such policy is in full force and effect (or has been renewed in the Ordinary
Course of Business) and the Company has not received written notice of a material default with respect to its obligations under, or notice
of cancellation or nonrenewal of, any of such policies or bonds. The Company has not failed to give notice or present a claim under an
insurance policy in a due and timely fashion that could result in a breach of such insurance policy. To the Company&rsquo;s knowledge,
no event relating to the Company has occurred which would reasonably be expected to result in a retroactive upward adjustment in premiums
under any such insurance policies or which could reasonably be expected to result in a prospective upward adjustment in such premiums.
Except as set forth on <U>Schedule 3.23</U>, all such insurance policies will remain in full force and effect immediately following the
consummation of the Contemplated Transactions and the Company will, after the Closing, continue to have coverage under such insurance
policies with respect to events occurring at, or prior to, the Closing. To the Company&rsquo;s knowledge, no event has occurred, including
the failure by the Company to give any notice or information or the Company giving any inaccurate or erroneous notice or information,
which limits or impairs the rights of the Company under any such insurance policies. There is no claim by the Company pending under any
such insurance policies as to which coverage has been questioned, denied or disputed by the underwriters of such insurance policies or
bonds or in respect of which such underwriters have reserved their rights<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.24
<U>Environmental Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company has complied, in all material respects, with and is currently in compliance with all Environmental Requirements and has no
Liabilities, including corrective, investigatory or remedial obligations arising under Environmental Requirements, and the Company has
not received (i) any oral or written notice, report or information regarding any Liabilities, including corrective, investigatory or
remedial obligations arising under Environmental Requirements which relate to the Company or any of their properties or facilities, or
(ii) any written request for information or indication that the Company is a responsible party under CERCLA or analogous state or local
Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Without limiting the generality of the foregoing, the Company has obtained and complied with, and is currently in compliance with, all
Permits and other authorizations that may be required pursuant to any Environmental Requirements for the occupancy of its properties
or facilities or the operation of its business and no proceeding is pending or, to the Company&rsquo;s knowledge, threated to terminate,
revoke or adversely modify such Permit. A list of all such permits, licenses and other authorizations which are material to the Company
is set forth on <U>Schedule 3.24</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
None of this Agreement, any Ancillary Agreement or the consummation of the transactions contemplated hereby and thereby shall impose
any Liability on the Company or otherwise for site investigation or cleanup, or notification to or consent of any government agencies
or third parties under any Environmental Requirements (including any so called &ldquo;transaction-triggered&rdquo; or &ldquo;responsible
property transfer&rdquo; laws and regulations).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
There has been no Release of any Hazardous Substances on, at, under, to or about (i) any property currently owned, operated or leased
by the Company or during the time of such ownership, operation or lease, any property formerly owned, operated or leased by the Company,
or (ii) any location where Hazardous Substances from the operations or activities of the Company have come to be located.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(e)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not assumed, undertaken or provided
an indemnity with respect to any liability of any other Person relating to <FONT STYLE="color: windowtext">Environmental</FONT> Law or
Hazardous Materials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(f)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has Made Available all environmentally related
Permits, governmental submissions, audits, studies, reports, analyses, and <FONT STYLE="color: windowtext">results</FONT> of investigations
that have been performed with respect to or that relate to the currently or previously owned, operated or leased properties of the Company
or the operation of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.25
<U>Names and Location</U>. Except as set forth on <U>Schedule 3.25</U>, (i) during the preceding two-year period, the Company has not
used any name or names under which the Company has invoiced account debtors, maintained records concerning its assets or otherwise conducted
its business, other than the exact name under which it has executed this Agreement, and (ii) all of the Company&rsquo;s assets are located
at the premises disclosed on <U>Schedule 3.25</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.26
<U>Affiliate Transactions</U>. Except as disclosed on <U>Schedule 3.26</U>, no officer, director, employee, securityholder or other Affiliate
of the Company or any individual related by blood, marriage or adoption to any such Person or any entity in which any such Person owns
any beneficial interest (collectively, the &ldquo;<U>Insiders</U>&rdquo;), is a party to any Contract or transaction with the Company
or which is pertaining to the business of the Company or has any interest in any property, real or personal or mixed, tangible or intangible,
used in or pertaining to the business of the Company, other than agreements with officers, directors, and employees of the Company related
to matters concerning their employment by the Company or their providing services to the Company on an arms&rsquo; length basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.27
<U>Brokerage</U>. There is no investment banker, broker, finder or other intermediary who has been retained by or is authorized to act
on behalf of the Company or any of its Affiliates who might be entitled to any fee or commission from Buyer or any of its Affiliates
in connection with the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.28
<U>Illegal Payments</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Neither the Company nor any
of its directors, officers, employees or, to the knowledge of the Company, agents have offered, authorized, made or received on behalf
of the Company any illegal payment or contribution of any kind, including any payment in violation of any Laws of any Governmental Authority,
directly or indirectly, including, without limitation, payments, gifts or gratuities, to any Person, entity, or United States or foreign
national, state or local government officials, employees or agents or candidates therefor or other Persons. The Company has maintained
systems of internal controls (including, but not limited to, accounting systems, purchasing systems and billing systems) to provide reasonable
assurance that all books and records accurately and fairly reflect, in reasonable detail, all transactions and dispositions of funds
and assets. Neither the Company nor any of its directors, officers, employees or, to the knowledge of the Company, agents, are the subject
of any allegation, voluntary disclosure, investigation, prosecution or other enforcement action related to illegal payment laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.29
<U>COVID-19</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has complied in all material
respects with, is not in violation in any material respect of, and has not received any notices of violation with respect to, any COVID-19
Measures<FONT STYLE="color: windowtext">. <U>Schedule 3.29</U> sets forth a true and complete list of all COVID-19 Funds that have been
requested and/or received by the Company, including the name of the distribution, allocation, grant or other program under which such
COVID-19 Funds were received, and the amount (if any) of such COVID-19 Funds that have been returned to, recouped or forgiven by, the
applicable Governmental Authority. The Company has used, plans to use, and/or has returned COVID-19 Funds received and have prepared
and/or maintained all financial and accounting records relating to such COVID-19 Funds, in each case, in compliance with applicable Law.
The Company has not been made the subject of or received any notice of any audit or review by any Governmental Authority in connection
with the COVID-19 Funds.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.30
<U>HSR Act</U>. As of the Closing, all of the following conditions relating to the Hart-Scott-Rodino Antitrust Improvements Act of 1976,
as amended (&ldquo;<U>HSR Act</U>&rdquo;) and the ultimate parent entity (as such term is defined in 16 C.F.R. &sect; 801.1(a)(3) and
is interpreted by the Premerger Notification Office of the United States Federal Trade Commission (&ldquo;<U>PNO</U>&rdquo;)) of the
Company will be true: (i) the annual net sales (as such term is defined in 16 C.F.R. &sect; 801.11 and is interpreted by the PNO) for
the most recent fiscal year prior to the Closing was below $184 million; (ii) the total assets (as such term is defined in 16 C.F.R.
&sect; 801.11 and is interpreted by the PNO) as of the Closing were below $18.4 million; and (iii) the ultimate parent entity is not
engaged in manufacturing (as such term is defined in 16 C.F.R. &sect; 801.1(j) and is interpreted by the PNO).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.31
<U>Healthcare Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and each of its officers, owners, directors,
and personnel is and at all times has been in material compliance with all applicable Healthcare Laws. There is no Legal Proceeding pending
or, to the Company&rsquo;s knowledge, threatened against the Company alleging or giving rise to any material noncompliance with any Healthcare
Law or Health Care Permit requirement, and the Company has not been and is not subject to any Governmental Order with respect to its
compliance with applicable Healthcare Laws or any of the Health Care Permits. The Company (i) has not received any notice from any Governmental
Authority, and to the knowledge of the Company none is threatened, that the Company has failed to comply in any material respect with
any applicable Healthcare Law, and (ii) has not received any notice of any Legal Proceeding by any Governmental Authority, and to the
knowledge of the Company none is threatened, having jurisdiction over the Health Care Permits to revoke, suspend, withdraw or otherwise
restrict any Health Care Permit. With regard to the Company, and to the Company&rsquo;s knowledge, no event has occurred, and no condition
exists, that with or without the lapse of time, the giving of notice or both, would constitute a material breach or violation of, or
would constitute grounds for an adverse Legal Proceeding with respect to, applicable Healthcare Laws or any Health Care Permits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither the Company nor any of the Company&rsquo;s officers,
owners, directors or personnel, (A) have been (i) excluded, suspended, debarred, or otherwise restricted from participation in any Government
Healthcare Program, (ii) subject to a civil monetary penalty assessed under Section 1128A of the Social Security Act, (iii) listed on
the Office of Inspector General of the Department of Health and Human Services (the &ldquo;<U>OIG</U>&rdquo;) List of Excluded Individuals/Entities
or on the General Services Administration published list of parties excluded from federal procurement programs and non-procurement programs,
(iv) convicted of a crime described at 42 U.S.C. &sect;1320a-7b or any other federal or state law relating to the furnishing of, or billing
for, health care goods and services, (B) nor is such is such debarment, exclusion suspension, termination, sanction or conviction pending
or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not: (i) been a party or subject to
a corporate integrity agreement with the OIG or to a consent decree, settlement, or similar agreement with the OIG or any other Governmental
Authority, (ii) had any ongoing reporting obligations pursuant to any deferred prosecution, settlement or other similar agreement with
any Governmental Authority, (iii) to the knowledge of Company, been the subject of any investigation by a Governmental Authority alleging
any failure to comply with any applicable Healthcare Law, (iv) been served with or received any search warrant, subpoena, or civil investigative
demand from any Governmental Authority that may involve any Healthcare Laws or from any Governmental Authority that has oversight or
regulatory authority over any Healthcare Laws, a Government Healthcare Program, or a Health Care Permit, (v) made a voluntary disclosure
pursuant to the OIG&rsquo;s &ldquo;Provider Self-Disclosure Protocol&rdquo;, the CMS &ldquo;Self-Referral Disclosure Protocol&rdquo;,
(vi) made a self-disclosure to a CMS Medicare administrative contractor, or (vii) otherwise made a disclosure to a Governmental Authority
relating to potential material repayment obligations arising out of any actual or potential violation of Healthcare Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Company officer, owner, director or personnel (i)
has been convicted of, charged with, entered into any settlement or deferred prosecution agreement with any Governmental Authority to
avoid conviction of, or, to the knowledge of the Company, has been investigated or threatened with prosecution for, a violation of any
Healthcare Law, or (ii) has knowingly made a fraudulent statement, including certification, to any Governmental Authority or agent thereof
or knowingly failed to disclose a material fact required to be disclosed to a Governmental Authority, in each case, related to any applicable
Healthcare Law or Health Care Permit. None of the Company officers, owners, directors or personnel are or have been subject to a corporate
integrity agreement, monitoring agreement, consent decree, settlement, or similar agreement with or imposed by any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(e)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has never participated in, prepared claims
for submission to or submitted claims to, Medicare, Medicaid, or any other Third Party Payor program. The Company has timely filed all
notices, reports and other documents required to be filed with respect to all Third Party Payors, and all such reports and other documents
are and have been complete and accurate in all material respects and have been prepared in compliance with all applicable Healthcare
Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(f)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule 3.31(f)</U> sets forth true and complete
list of all Permits owned or possessed by the Company or used by the Company in the conduct of its business or required for the conduct
of its business that are required by or in compliance with applicable Healthcare Laws (each, a &ldquo;<U>Health Care Permit</U>&rdquo;).
All applications currently due for the renewal or extension of any Health Care Permit have been duly filed with the appropriate Governmental
Authority. The Health Care Permits listed on <U>Schedule 3.31(f)</U> are in full force and effect and the Company is, and has at all
times been, in material compliance with all requirements of each Health Care Permit that the Company holds. No loss, denial, rejection
or expiration of any Health Care Permit is pending or, to the knowledge of the Company, threatened. The Company has made all filings
with Governmental Authorities and third parties required for the conduct of the Company&rsquo;s business and maintenance of the Health
Care Permits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(g)
</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Licensed Provider has at all times been duly licensed
or registered and otherwise holds all necessary Permits and credentials to engage in, and is in good standing to engage in, the practice
of the Licensed Provider&rsquo;s profession and to provide services to or on behalf the Company and such Permits have not, at any time
during which the Licensed Provider provided services to or on behalf of the Company, been suspended, revoked, or restricted in any material
respect, and have been and remain in good standing. To the Company&rsquo;s knowledge, no Licensed Provider has been a party or subject
to: (A) any disciplinary, peer review or professional review investigation or action instituted by any licensure board, hospital, professional
school, health care facility or entity, professional society or association, Third Party Payor, peer review or professional review committee
or body, or Governmental Authority; (B) any criminal complaint, indictment or criminal action; (C) any investigation or action, whether
administrative, civil or criminal, relating to an allegation of filing false health care claims, violating anti-kickback or fee-splitting
laws, or engaging in other billing improprieties; (D) any malpractice suit, claim (whether or not filed in court), settlement, settlement
allocation, judgment, verdict or decree; (E) any allegation, or any investigation or action based on any allegation of violating professional
ethics or standards, or engaging in illegal, immoral or other misconduct (of any nature or degree), relating to his or her profession;
or (F) any denial of an application in any state for a Health Care Permit as a Licensed Provider, for participation in any third party
payment program, or for malpractice insurance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(h)
</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither the Company nor any of its officers, owners,
directors, or personnel (including but not limited to any Licensed Provider) has engaged in any activities which are prohibited under
the federal Anti-Kickback Statute, as codified in 42 U.S.C. &sect;1320a-7b, the Federal Stark Law, as codified in 42 U.S.C. &sect;1395nn
and the regulations promulgated thereunder, and similar and other healthcare fraud and abuse Laws and regulations. Neither the Company
nor, to the Company&rsquo;s knowledge, any other Person acting on the Company&rsquo;s behalf, has made, directly or indirectly, with
respect to the Company&rsquo;s business, any remuneration, bribes or kickbacks, payments from their funds not recorded on their books
and records or payments from corporate funds to any Licensed Provider or any other Person for the purpose of obtaining or retaining business
or inducing the referral of any patients. The Company has not established or participated in, directly or indirectly, any discount program,
copay waiver or reduction, charitable fund, patient assistance program, or other financial incentive for the purchase or use of Products.
Except as set forth on <U>Schedule 3.31(h)</U>, no &ldquo;physician&rdquo; (as defined at 42 C.F.R. &sect;411.351) or any immediate family
member of a physician has a direct or indirect ownership interest in, or compensation arrangement with, the Company, and no other Person
that could otherwise make or influence referrals for items or services payable by Government Healthcare Programs to the Company or its
customers has any direct or indirect ownership interest in, or financial arrangement with, the Company. The Company maintains a compliance
plan and program that materially addresses all of the compliance plan elements recommended by the OIG, and the Company conducts its business
in all material respects in accordance with such compliance plans and programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is not a &ldquo;business associate&rdquo;
or &ldquo;covered entity&rdquo; (as such terms are defined at 45 C.F.R. &sect;160.103). The Company has complied in all material respects
with all Privacy Laws. The Company is not under investigation by any Governmental Authority for a violation of HIPAA or Privacy Laws
and has not received any notices, claims or complaints from the U.S. Department of Health and Human Services Office for Civil Rights,
the Justice Department, the Federal Trade Commission, the Attorney General of any state, or any other Person relating to any such violations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.32
<U>Disclosure</U>. None of this Agreement, the Ancillary Agreements or any of the Schedules, attachments or Exhibits hereto, contains
any untrue statement of a material fact or omits a material fact necessary to make each statement contained herein or therein, not misleading
in light of the circumstances in which they were made. There is no fact that has not been disclosed to any of the Buyer Parties or their
respective Affiliates of which the Company has knowledge that has had or could reasonably be expected to have a Company Material Adverse
Effect. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Information Statement: (i) complies with
the Charter Documents of the Company and all applicable Laws; (ii) contains all information about the Company and the Contemplated Transactions
and the transactions contemplated by the Ancillary Agreements necessary for the Company Stockholders to make an informed decision with
respect to whether to approve the Mergers; and (iii) does not (A) contain any information regarding the Company, the Mergers or any of
the other transactions contemplated hereby or by any Ancillary Agreement or any other information that is false or misleading with respect
to any material fact, or (B) omit to state any material fact necessary in order to make the information regarding the Company, the Mergers
or any of the other transactions contemplated hereby or by any Ancillary Agreement or any other information contained therein, in light
of the circumstances under which such information will be made or provided, not false or misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.33
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No Other Representations and Warranties; Acknowledgement</U><FONT STYLE="color: windowtext">.
</FONT>EXCEPT AS EXPRESSLY SET FORTH IN THIS <U>SECTION 3</U>, THE CERTIFICATES DESCRIBED IN <U>SECTION 7</U>, AND THE SPREADSHEET, THE
COMPANY MAKES NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, AT LAW OR IN EQUITY, IN RESPECT OF THE COMPANY OR ANY OF ITS ASSETS,
LIABILITIES OR OPERATIONS, INCLUDING WITH RESPECT TO MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, AND ANY SUCH OTHER REPRESENTATIONS
OR WARRANTIES ARE HEREBY EXPRESSLY DISCLAIMED. The Company acknowledges and agrees that the representations and warranties made by the
Buyer Parties in this Agreement, any Ancillary Agreements and any other agreements and certificates contemplated by this Agreement, as
applicable, are the sole representations and warranties made by the Buyer Parties to the Company in connection with this Agreement and
the Contemplated Transactions. Each of the Company and the Company Securityholders further acknowledge and agree that it is not relying
on any statement, representation or warranty made by or on behalf of any Buyer Party, the First Merger Surviving Entity, the Second Merger
Surviving Entity or any of their respective Affiliates, or any other information or document provided by or on behalf of any of the foregoing,
except as specifically set forth in this Agreement, any Ancillary Agreements, or any other agreements and certificates contemplated by
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4. REPRESENTATIONS AND WARRANTIES OF THE BUYER PARTIES.</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to such exceptions as are set forth in the Disclosure Schedule and delivered herewith by the Buyer Parties to the Company or in the Parent
SEC Documents (other than in any risk-factor disclosure or any other forward-looking statements set forth therein), each of the Buyer
Parties hereby represent and warrant to the Company, as of the date hereof and as of the Closing Date (except to the extent such representation
and warranties are made as of a specified date, in which case as though made as of such date), that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.1
<U>Organization and Corporate Power</U>. Parent is duly organized, validly existing and in good standing under the laws of the State
of Texas and Buyer, Merger Sub I and Merger Sub II are each duly organized, validly existing and in good standing under the laws of the
State of Delaware and each of the Buyer Parties has the requisite corporate power and authority to own, lease and operate its assets
and properties and to carry on its business as it is now being conducted. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Each
of Parent and Buyer is duly qualified, licensed or admitted to do business as a foreign company and is in good standing in every jurisdiction
in which the operation of its respective businesses or the ownership of its respective assets requires it to be so qualified, licensed,
admitted or in good standing, except where the failure to be so qualified, licensed, admitted or in good standing would not be materially
adverse to the business of Parent or Buyer, as applicable.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">No
Buyer Party is in default under or in violation of any provision of such Buyer Party&rsquo;s Charter Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Authorization of Transactions</U>. Each Buyer Party has full organizational power and authority to execute and deliver this Agreement
and each of the Ancillary Agreements to which it is a party and to consummate the transactions contemplated hereby and thereby. The execution
and delivery by each Buyer Party of this Agreement and any Ancillary Agreements to which it is a party and the consummation of the transactions
contemplated hereby and thereby have been duly authorized by all necessary corporate or limited liability company action on the part
of each Buyer Party. No other organizational proceedings on the part of any Buyer Party are necessary to approve and authorize the execution
and delivery of this Agreement or the Ancillary Agreements to which it is a party and the consummation of the transactions contemplated
hereby and thereby. This Agreement and all Ancillary Agreements to which each of the Buyer Parties is a party have been duly executed
and delivered by each of the Buyer Parties and constitute the valid and binding agreements of the Buyer Parties enforceable against each
of the Buyer Parties in accordance with their terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Non-Contravention</U>. The execution, delivery and performance by each of the Buyer Parties of this Agreement and all agreements,
documents and instruments executed and delivered by it pursuant hereto and the performance of the transactions contemplated by this Agreement
and such other agreements, documents and instruments do not and will not: (i) violate or result in a violation of, conflict with or constitute
or result in a default or breach of any provision of, result in any acceleration of, create in any Person the right to accelerate, terminate,
modify or cancel, require any notice under, or result in the imposition or creation of a Lien (other than a Permitted Lien) upon or with
respect to any equity interests or assets of a Buyer Party under (in each case, whether after the giving of notice, lapse of time, or
both), any note, bond, mortgage, indenture, deed of trust, permit, license, obligation, authorization, lease, Contract or other agreement
to which a Buyer Party, or by which a Buyer Party or any of their respective assets or properties, are bound, except for such violations,
conflicts, defaults, accelerations or terminations that, individually or in the aggregate, would not reasonably prevent or materially
impair or delay the ability of such Buyer Party to consummate the transactions contemplated by this Agreement or the Ancillary Agreements
or perform its obligations hereunder and thereunder; (ii) violate or result in a violation of, conflict with or constitute or result
in a default (whether after the giving of notice, lapse of time or both) under, or accelerate any obligation under, any provision of
any Buyer Party&rsquo;s Charter Documents; (iii) violate, conflict with, or result in a violation of, or constitute a default (whether
after the giving of notice, lapse of time or both) under, any provision of any Law, or any Governmental Order of, or any restriction
imposed by, any Governmental Authority or Governmental Order applicable to any of the Buyer Parties; or (iv) require from any Buyer Party
any notice to, declaration or filing with, or consent or approval of, any Governmental Authority or other third party, except for (a)
such filings as may be required under applicable requirements of the Exchange Act, and under state securities, takeover or &ldquo;blue
sky&rdquo; laws, (b) such filings, notices, approvals or consents required under the rules and regulations of the Securities and Exchange
Commission or any other applicable regulatory or self-regulatory organization, (c) the filing of the First Merger Certificate of Merger
with the Secretary of State of the State of Delaware as required by the DGCL, and (d) such notices, consents, declarations, and filings
that, if not obtained or made would not, individually or in the aggregate, reasonably prevent or materially impair or delay the ability
of such Buyer Party to consummate the transactions contemplated by this Agreement or the Ancillary Agreements or perform its obligations
hereunder and thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.4
<U>Share Capital</U>. The share capital of Parent, including all outstanding shares of Parent capital stock and securities convertible
into outstanding shares of Parent capital stock, is as set forth on <U>Schedule 4.4(a)</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no other classes of capital stock of Parent and no bonds, debentures, notes or other Indebtedness or securities of Parent having
the right to vote (or convertible into or exercisable for securities having the right to vote) on any matters on which holders of capital
stock of Parent may vote, authorized, issued or outstanding. Parent has and shall have at the Closing sufficient authorized but unissued
shares of Parent Common Stock to enable it to consummate the Mergers, including the payment of the Participating Holder Per Share Closing
Stock Consideration. The shares of Parent Common Stock subject to issuance pursuant to this Agreement, upon issuance on the terms and
conditions specified in the instruments pursuant to which they are issuable, will be duly authorized, validly issued, fully paid and
non-assessable, free and clear of all Liens (other than Permitted Liens), and not subject to or issued in violation of any purchase option,
call option, right of first refusal, preemptive right, subscription right or any similar right under any provision of the DGCL, the Parent
Charter Documents or any similar agreement to which Parent is a party or is otherwise bound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Brokerage</U>. Except as set forth on <U>Schedule 4.5</U>, there is no investment banker, broker, finder or other intermediary who
has been retained by or is authorized to act on behalf of any Buyer Party who might be entitled to any fee or commission from any Buyer
Party in connection with the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.6
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>[Reserved</U>].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.7
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Parent SEC Documents; Financial Statements</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Parent has filed all forms, reports, statements, schedules and other documents required to be filed by it, including, without limitation,
all contracts required to be filed by Parent as a &ldquo;material contract&rdquo; pursuant to Item 601(b)(10) of Regulation S-K under
the Securities Act, with the SEC since December 31, 2020. The Parent SEC Documents (i) at the time they were filed and, if amended, as
of the date of such amendment, complied in all material respects with all applicable requirements of the Securities Act or the Exchange
Act or the Sarbanes-Oxley Act of 2002, as amended, as the case may be, and the rules and regulations promulgated thereunder, and (ii)
did not, at the time they were filed, and, if amended, as of the date of such amendment, contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary in order to make the statements made therein, in the light
of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each of the consolidated financial statements (including, in each case, any notes thereto) contained (or incorporated by reference) in
the Parent SEC Documents was prepared in accordance with GAAP applied on a consistent basis throughout the periods indicated (except
as may be indicated in the notes thereto or, in the case of unaudited statements, as permitted by Form 10-Q of the SEC) and each fairly
presents, in all material respects, the consolidated financial condition, results of operations, changes in stockholders&rsquo; equity
and cash flows of Parent and its consolidated Subsidiaries as of the respective dates thereof and for the respective periods indicated
therein (subject, in the case of unaudited financial statements, to normal year-end adjustments).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Parent maintains disclosure controls and procedures required by Rule 13a-15 or Rule 15d-15 under the Exchange Act and such controls and
procedures are effective to ensure that all material information concerning Parent and its Subsidiaries is made known on a timely basis
to the individuals responsible for the preparation of Parent&rsquo;s SEC filings and other public disclosure documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Neither Parent nor any of its Subsidiaries has any liabilities or obligations of any nature (whether accrued, absolute, contingent or
otherwise), except liabilities (i) reflected or reserved in accordance with GAAP against in the consolidated balance sheet (or the notes
thereto) of Parent as of September 30, 2021, included in the Parent SEC Documents, (ii) incurred after September 30, 2021 in the ordinary
course of business, (iii) incurred in connection with the negotiation, execution, delivery or performance of, or pursuant to the terms
of, this Agreement or the Ancillary Agreements (for clarity, any liability caused by or resulting from a breach by Parent of this Agreement
shall not be deemed a liability incurred in connection with the negotiation, execution, delivery or performance of, or pursuant to the
terms of, this Agreement) or (iv) that would not, individually or in the aggregate, reasonably be expected to have a material adverse
effect on the business, assets (including intangible assets), liabilities, financial condition, property, prospects or results of operations
of Parent (a &ldquo;<U>Parent Material Adverse Effect</U>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.8
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>[Reserved]</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.9
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Litigation; Compliance with Laws</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
There is no Legal Proceeding pending or, to the actual knowledge of Parent, threatened against any Buyer Party or any of their respective
material assets or properties that would reasonably be expected to have a material adverse effect on Parent. There is no Governmental
Order outstanding against Parent, its, Subsidiaries, or any of their respective material assets or properties that would reasonably be
expected to have a material adverse effect on Parent. To the actual knowledge of Parent, there are no presently existing facts or circumstances
that would reasonably form the basis for any such Legal Proceeding or Governmental Order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Parent has complied in all material respects with, is not in violation in any material respect of, and has not received any written (or,
to the actual knowledge of Parent, oral) notices of violations with respect to, applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.10
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Operation of Merger Subsidiaries</U>. Each of Merger
Sub I and Merger Sub II is a direct wholly owned subsidiary of Buyer and has not engaged in any business activities or conducted any
operations of any kind, entered into any agreement or arrangement with any Person, or incurred, directly or indirectly, any liabilities,
in each case except in connection with its incorporation and the negotiation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.11
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Due Diligence Review</U>. Each of Parent and Buyer
acknowledges and agrees that it has made its own inquiry and investigation into, and, based thereon, has formed an independent judgment
concerning the Company. Assuming that the Company has provided to Parent and Buyer access to all information about the Company as Parent
and Buyer have requested, each of Parent and Buyer acknowledges and agrees that it has been furnished with or given such access. Parent
and Buyer further acknowledge and agree that, (a) except for the representations and warranties of the Company and the Company Securityholders
set forth in this Agreement, any certificate delivered under <U>Section 7</U>, the Spreadsheet and/or any Ancillary Agreement, Parent
and Buyer are not relying on the Company, any Company Securityholder, any of their respective Affiliates or any of their respective employees,
directors, agents, stockholders or representatives, nor will they hold the Company or any Company Securityholder or any such Persons
liable for any inaccuracies, misstatements or omissions with respect to information Made Available by the Company, its Affiliates or
representatives, including any information in any information memorandum, virtual or physical data rooms or in any management presentations;
and (b) Buyer agrees to acquire the outstanding equity interests of the Company based on its own inspection, examination and determination
with respect to all matters, and without reliance upon any express or implied representations or warranties whatsoever, whether at law
or in equity, of any nature made or provided by or on behalf of or imputed to the Company, any of its Subsidiaries or any other Person,
except for the representations and warranties of the Company and the Company Securityholders set forth in this Agreement, any certificate
delivered under <U>Section 7</U>, the Spreadsheet and/or any Ancillary Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.12
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No Other Representations and Warranties</U><FONT STYLE="color: windowtext">.
</FONT>The representations and warranties made by any Buyer Party in this <U>Section 4</U> are the exclusive representations and warranties
made by the Buyer Parties. Each Buyer Party hereby disclaims any other express or implied representations or warranties with respect
to itself<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5. ADDITIONAL AGREEMENTS.</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Maintenance of Business</U>. Except as expressly permitted by this Agreement, required by any applicable Law (including, without limitation,
COVID-19 Measures) or Contract, or with the Parent&rsquo;s prior written consent (which consent may not be unreasonably withheld, conditioned,
or delayed), during the time period from the date of this Agreement until the earlier to occur of (i) the First Merger Effective Time
and (ii) the valid termination of this Agreement in accordance with <U>Section 9</U>, the Company shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
conduct the Company&rsquo;s businesses in the Ordinary Course of Business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
use commercially reasonable efforts to preserve intact the Company&rsquo;s existing business organizations and relations with its employees,
customers, suppliers and others with whom the Company had a business relationship in the Ordinary Course of Business; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
use commercially reasonable efforts to preserve intact and protect its programs and properties and conduct its business in material compliance
with applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
limiting the generality of the foregoing, during the time period from the date of this Agreement until the earlier to occur of (i) the
First Merger Effective Time and (ii) the valid termination of this Agreement in accordance with <U>Section 9</U>, the Company shall not,
without Parent&rsquo;s prior written consent (which consent may not be unreasonably withheld, conditioned, or delayed), or except as
specifically set forth on <U>Schedule 5.1</U> hereto, take any action that, had it been taken after the date of the Reference Balance
Sheet but before the execution of this Agreement, would have been required to be disclosed in the Disclosure Schedules pursuant to <U>Section
3.10</U>; <U>provided</U>, that, to the extent any provision of <U>Section 3.10</U> refers to a Company Contract or Company Employee
Program, such provision shall be deemed to apply to any Company Contract or Company Employee Program as well as any contract, plan, policy
or other instrument that would have been a Company Contract or Company Employee Program had it been entered into or adopted by the Company
as of the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>No Solicitation</U>. Until the earlier of (i) the Closing, or (ii) the date of the valid termination of this Agreement pursuant to
the provisions of <U>Section 9</U> hereof, the Company shall not, and shall not authorize or permit any of its Representatives to, directly
or indirectly, take any of the following actions with any Person other than the Buyer Parties and their designees: (A) solicit, initiate
or knowingly encourage any inquiry, proposal, request or offer, directly or indirectly, relating to an Alternative Transaction (each,
a &ldquo;<U>Proposal</U>&rdquo;), (B) participate in any discussions or negotiations relating to, assist or cooperate with any Person
to make, or furnish any Person with information in connection with, or take any other action to knowingly facilitate, any Proposal or
Alternative Transaction, (C) disclose any information to any Person concerning the business, technologies or properties of the Company,
or afford to any Person access to the Company&rsquo;s properties, technologies, books or records, other than in the Ordinary Course of
Business in connection with ongoing commercial transactions, or (D) propose, authorize or enter into any agreement or understanding (whether
binding or nonbinding, written or oral) relating to, or engage in or consummate, any Alternative Transaction or requiring the Company
to abandon, terminate or fail to consummate the Contemplated Transactions or breach its obligations hereunder. If the Company or any
Company Representative receives or has received, prior to the Closing or the valid termination of this Agreement in accordance with <U>Section
9</U> hereof, any Proposal, or any request for disclosure or access as referenced in clause (C) above, the Company shall, or shall cause
such Company Representative to, (x) immediately suspend any discussions with regard to such Proposal and (y) promptly (and in any event
within twenty-four (24) hours) notify Parent in writing thereof, and, subject to the terms of any confidentiality agreements in place
as of the date hereof, furnish to Parent any information it may reasonably request, including information as to the identity of the Person
making any such inquiry, offer or proposal and the specific terms of such inquiry, offer or proposal, and all written documentation relating
thereto. The Board of Directors of the Company shall unanimously recommend that the Company Stockholders vote in favor of, and adopt
and approve, this Agreement and the Mergers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.3
<U>Access to Information</U>. Subject to restrictions imposed by applicable Law (including, without limitation, COVID-19 Measures), and
upon reasonable advance notice to the Company, the Company shall afford Buyer and its accountants, counsel and other representatives,
reasonable access during normal business hours during the period from the date hereof and prior to the Closing to (a) the Company&rsquo;s
properties, personnel, books, Contracts and records and (b) all other information concerning the business, properties and personnel of
the Company as Parent may reasonably request. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No information
or knowledge obtained by Parent in any investigation pursuant to this <U>Section 5.3</U> or otherwise shall affect or be deemed to modify
any representation, warranty, covenant, agreement, obligation or condition set forth herein. The Company shall use its reasonable best
efforts to keep Parent promptly informed of any material development related to the suppliers listed on <U>Schedule 3.9(b)</U>. Notwithstanding
anything herein to the contrary, no such investigation or examination shall be permitted to the extent that (a) it would require the
Company to disclose information (i) subject to attorney-client privilege, (ii) which would conflict with any confidentiality obligations
to which the Company is bound and pursuant to a Contract Made Available, or (iii) in violation of applicable Law, or (b) such access
would unreasonably interfere with the conduct of the Company&rsquo;s business or impose undue hardship on the Company. Further, the Company
must approve in writing in advance (which approval may not be unreasonably withheld, conditioned or delayed), and an officer of the Company
must be present and included in, any communications between the Buyer Parties and any employees or personnel of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.4
<U>Notification of Certain Matters</U>. The Company or Parent, as the case may be, shall give prompt notice to the other Party of: (a)
the occurrence of any event that is likely to cause any representation or warranty of the Company or the Buyer Parties, respectively
and as the case may be, contained in this Agreement to be untrue or inaccurate at or prior to the Closing as if such representation or
warranty was made at the Closing (except for representations and warranties that speak as of an earlier date) such that any of the conditions
set forth in <U>Section 7</U> hereof, as applicable, would not be satisfied, (b) any failure of the Company or Buyer Parties, as the
case may be, to comply with or satisfy any covenant, condition or agreement to be complied with or satisfied by it hereunder such that
any of the conditions set forth in <U>Section 7</U> hereof, as applicable, would not be satisfied, (c) </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
receipt of any notice or other communication received by the notifying party from any Governmental Authority or other Person with respect
to this Agreement or any Ancillary Agreement or the transactions contemplated hereby or thereby, and (d) any event, condition, fact or
circumstance of which the notifying Party has knowledge that would make the timely satisfaction of any condition to Closing set forth
in <U>Section 7</U> that the notifying Party is required to satisfy impossible or unlikely<FONT STYLE="color: windowtext">; <U>provided</U>,
that the delivery of any notice or the making of any disclosure pursuant to this <U>Section 5.4</U> shall not (i) limit or otherwise
affect any rights or remedies available to the Party receiving such notice or (ii) be deemed to amend or supplement the Disclosure Schedules
or prevent or cure any misrepresentation, breach of warranty or breach of covenant.</FONT> Each Party may, as it deems advisable and
necessary, reasonably designate material provided to the other party as &ldquo;Outside Counsel Only Material,&rdquo; and also may reasonably
redact the material as necessary to (A) remove personally sensitive information, (B) prevent the loss of a legal privilege or (C) comply
with applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.5
<U>Consents; Other Actions</U>. Before the Closing, the Company will use commercially reasonable efforts to obtain all necessary consents,
waivers and approvals of any third parties to any Required Contract Consent, as are required thereunder in connection with the transactions
contemplated by this Agreement, or for any of these Contracts or Permits to remain in full force and effect to preserve all rights of,
and benefits to, the Company under these Contracts or Permits from and after the Closing. These consents, waivers and approvals will
be in a form and substance reasonably acceptable to Parent. The Company will send each of the notices described on <U>Schedule 7.1(f)
</U>promptly following the execution of this Agreement. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Party shall promptly deliver to the other a copy of each filing made, each notice given, and each Required Contract Consent obtained
by such Party in connection with the Mergers. Each Buyer Party and the Company shall use commercially reasonable efforts: (i) to cause
the conditions set forth in <U>Section 7</U>, as applicable, to be satisfied as soon as practicable after the date hereof; and (ii) to
otherwise take, or cause to be taken, all actions and to do, or cause to be done, all things necessary or desirable under applicable
Law to consummate the Mergers and make effective the other Contemplated Transactions as soon as practicable after the date hereof. Without
limiting the generality of the foregoing, each Party to this Agreement shall use commercially reasonable efforts to lift any restraint,
injunction or other legal bar to the Mergers; <U>provided</U>, that neither Buyer Party, the Company nor any of their respective Affiliates
shall be required to take any action, agree to any restriction or condition or enter into any agreement that relates to or affects in
any manner any business or assets of any Buyer Party, the Company or their respective Affiliates (as applicable), including any obligation
(whether before or after the Closing Date): (A) to dispose of any assets; (B) discontinue offering any product; (C) to license or otherwise
make available to any Person, any Intellectual Property Assets; (D) to hold separate any assets or operations; or (E) to make any commitment
(to any Governmental Authority or otherwise) regarding its future operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Termination of Certain Agreements</U>. Before the Closing, the Company will terminate as of the Closing, effective as of the Effective
Time, the Contracts listed on <U>Schedule 5.6</U>, in each case without any further Liability to the Company, the First Merger Surviving
Entity or the Second Merger Surviving Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Approval of Company Stockholders</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From and after the date of this Agreement and prior
to the Closing (or the earlier termination of this Agreement), the Company shall take all action reasonably necessary to obtain duly
executed Securityholder Joinder Agreements and (with respect to Company Stockholders) duly executed Written Consents from the Company
Stockholders representing the Stockholder Approval as expeditiously as possible after the due execution and delivery hereof (whether
any such holder holds Company Capital Stock and Company Options as of the date hereof or acquires Company Capital Stock and Company Options
between the date hereof and the First Merger Effective Time), and the Company shall promptly deliver such executed documents to Parent.
The Company shall, through its Board of Directors, recommend to the Company Stockholders that such holders approve and consent to the
Mergers, this Agreement, each Ancillary Agreement and the transactions contemplated hereby and thereby, and the Company shall use its
reasonable best efforts to obtain the Stockholder Approval. Immediately following the execution of this Agreement (but in no event later
than 24 hours thereafter), the Company shall deliver to Parent a complete and correct copy of (i) the Written Consents that have been
duly executed and delivered by the Company Stockholders constituting the Stockholder Approval, and (ii) Securityholder Joinder Agreements
that have been executed and delivered by each such consenting holder, including the Company Stockholders constituting the Stockholder
Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any Company Stockholder does not sign the Written
Consent and Securityholder Joinder Agreement, as applicable, within twenty-four (24) hours of the date hereof, then promptly thereafter
(but in any event no later than ten (10) days after the receipt by the Company of the Stockholder Approval), the Company shall prepare
and deliver to each such Company Stockholder an information statement, in the form and substance attached hereto as <U>Exhibit D</U>,
in compliance with all applicable Laws and the Charter Documents of the Company for the purpose of, among other things, soliciting entry
into Securityholder Joinder Agreements and containing (i) notice of the receipt of the Stockholder Approval, (ii) notice of the Contemplated
Transactions, and (iii) such other information as may be required to be included therein by applicable Law and the Charter Documents
of the Company (the &ldquo;<U>Information Statement</U>&rdquo;). The Company shall solicit the execution and delivery of the Securityholder
Joinder Agreements and all other consents contemplated by the Information Statement in compliance with applicable Laws and the Charter
Documents of the Company and shall take all other actions reasonably necessary to secure each such consent from each Company Stockholder,
as applicable. Buyer Parties and their counsel shall be given a reasonable opportunity to review and comment on the Information Statement
and any amendment or supplement thereto before they are mailed to the Company Stockholders, and the Company shall consider in good faith
all comments of Buyer Parties and their counsel in connection therewith; <U>provided</U>, <U>however</U>, that Buyer Parties shall in
no way be responsible for any of the content of the Information Statement except for information supplied in writing by Buyer Parties
expressly for inclusion therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.8
<U>Confidentiality</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Buyer Party will treat,
and will cause their respective Affiliates, counsel, accountants and other advisors and Representatives to treat, all Confidential Information
obtained in connection with this Agreement and the Contemplated Transactions as confidential, subject to, and in accordance with, the
terms of the Confidentiality Agreement. The terms of the Confidentiality Agreement are hereby incorporated by reference and will continue
in full force and effect until the Closing, at which time such Confidentiality Agreement will terminate<FONT STYLE="color: windowtext">.
</FONT>From and after the Closing, each Company Securityholder shall not and shall cause its, his or her Affiliates not to, directly
or indirectly, disclose, reveal, divulge or communicate to any Person other than authorized officers, directors and employees of the
Buyer Parties or the Company or use or otherwise exploit for such Company Securityholder&rsquo;s own benefit or for the benefit of anyone
other than the Company and Buyer Parties, any Confidential Information. Each Company Securityholder shall not have any obligation to
keep confidential (or cause its, his or her Affiliates to keep confidential) any Confidential Information if and to the extent disclosure
thereof is specifically required by applicable Law; <U>provided</U>, that in the event disclosure is required by applicable Law, such
Company Securityholder shall, to the extent reasonably possible, (i) provide Parent with prompt notice of such requirement prior to making
any disclosure so that the Buyer Parties may seek an appropriate protective order, and (ii) cooperate with the Buyer Parties concerning
any such protective order sought. The Securityholders&rsquo; Representative, on behalf of each Company Securityholder, acknowledges that
(A) following the Closing, each Buyer Party and its Affiliates will be vested with the goodwill of, and will carry on, the business of
the Company, and (B) this <U>Section 5.8</U> and the other agreements contained herein constitute a material inducement to the Buyer
Parties to consummate the Contemplated Transactions, and the Buyer Parties will rely on the enforceability of the restrictive covenants
contained herein in consummating the Contemplated Transactions. The Securityholders&rsquo; Representative, on behalf of each Company
Securityholder, acknowledges that the restrictions contained in this <U>Section 5.8</U>, in view of the nature of the Company&rsquo;s
business and the investment Parent is making pursuant to this Agreement, are reasonable and necessary to protect the Company&rsquo;s
legitimate business interests and that any violation of this <U>Section 5.8</U> would result in irreparable injury to the Buyer Parties,
the Company or their Affiliates. In the event of a breach by any Company Securityholder of this <U>Section 5.8</U>, then Buyer Parties
or the Company, as the case may be, shall be entitled to (1) seek an injunction, restraining order or other equitable relief from any
court of competent jurisdiction from the commission of any breach, without the necessity of proving actual damages or posting any bond
whatsoever, (2) recover reasonable attorneys&rsquo; fees, expenses and costs Buyer Parties or the Company or their Affiliate incur in
such action, and/or (3) recover any and all other damages to which Buyer Parties or the Company or their Affiliates may be entitled at
law or in equity as a result of a breach of this <U>Section 5.8</U>. Notwithstanding their agreement that such limitations are reasonable,
the Parties acknowledge that it is possible that a court of competent jurisdiction could differ on the limitations for any restrictive
covenant. Accordingly, if any Governmental Authority determines that any of the limitations herein shall exceed the maximum permitted
by applicable Law, then such Governmental Authority shall reform such provision to be enforceable to the maximum extent permitted by
applicable Law. The Securityholders&rsquo; Representative, on behalf of each Company Securityholder, covenants and acknowledges that
the restrictions in this <U>Section 5.8</U> are reasonable in scope and duration and are necessary to protect Buyer Parties, the Company
and their Affiliates, including but not limited to Buyer Parties&rsquo;, the Company&rsquo;s and their Affiliates&rsquo; confidential
information. Each Company Securityholder further covenants and acknowledges that the restrictions in this Agreement do not create an
undue hardship on such Company Securityholder and are not injurious to the public.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Tax Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transfer Taxes</U>. The Buyer Parties and Company Securityholders shall each be liable for half of and shall hold each other harmless
against any transfer, documentary, sales, use, value added, excise, stock transfer, stamp, recording, registration and any similar Taxes
and fees, including any penalties and interest thereon, that become payable in connection with the transactions contemplated by this
Agreement (&ldquo;<U>Transfer Taxes</U>&rdquo;). The applicable Parties shall cooperate in filing such forms, Tax Returns, and documents
as may be necessary, including to permit any such Transfer Tax to be assessed and paid on or prior to the Closing Date in accordance
with any available pre-sale filing procedure, and to obtain any exemption or refund of any such Transfer Tax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Cooperation on Tax Matters</U>. The Parties shall cooperate fully, as and to the extent reasonably requested by any other Party, in
connection with the filing of Tax Returns, and any audit, litigation or other proceeding with respect to Taxes and in connection with
minimizing withholding Taxes and Transfer Taxes. Such cooperation shall include the retention and (upon the other Party&rsquo;s request)
the provision of records and information which are reasonably relevant to any such audit, litigation or other proceeding and making employees
available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder. Each Party
shall provide to the others, within ten (10) Business Days of the receipt thereof, any tax related communications and notices it receives
which may impact the other Party&rsquo;s Tax Liability or filing responsibilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Responsibility for Filing Tax Returns</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Parent shall prepare and file, or cause the Company to prepare and timely file, all Tax Returns of the Company required to be filed after
the Closing Date. To the extent such Tax Returns relate to Pre-Closing Tax Periods, such Tax Returns shall be prepared on a basis consistent
with existing procedures, practices and accounting methods of the Company unless otherwise required by applicable Law or this Agreement.
Such Tax Returns that are Income Tax Returns or with respect to which the Company Securityholders are reasonably expected to be liable
under this Agreement (including in connection with Indebtedness and Company Transaction Expenses, as finally determined) shall be submitted
to the Securityholders&rsquo; Representative for review and approval (not to be unreasonably withheld, conditioned or delayed). Each
such Tax Return that is an Income Tax Return shall be submitted for the Securityholders&rsquo; Representative&rsquo;s review at least
twenty (20) days prior to the due date of such Tax Return (taking into account extensions), and if the due date of any such Income Tax
Return is within 20 days following the Closing Date, as promptly as reasonably practicable following the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
In the case of any taxable period that includes (but does not end on) the Closing Date (a &ldquo;<U>Straddle Period</U>&rdquo;), the
amount of any Taxes based on or measured by income, receipts, sales, use or payroll of the Company for the Pre-Closing Tax Period shall
be determined based on an interim closing of the books as of the close of business on the Closing Date (and for such purpose, the taxable
period of any partnership or other pass-through entity in which the Company holds a beneficial interest shall be deemed to terminate
at such time); <U>provided</U>, that exemptions, allowances or deductions that are calculated on an annual basis (including, but not
limited to, depreciation and amortization deductions) shall instead be apportioned on a per diem basis, <U>provided</U>, <U>further</U>,
that any Transaction Tax Deductions shall be treated as deductions of the Company and its Subsidiaries in Pre-Closing Tax Periods to
the greatest extent permitted under applicable Law, and the amount of other Taxes of the Company for a Straddle Period that relates to
the Pre-Closing Tax Period shall be deemed to be the amount of such Tax for the entire taxable period multiplied by a fraction the numerator
of which is the number of days in the taxable period ending on and including the Closing Date and the denominator of which is the number
of days in such Straddle Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
For the avoidance of doubt, (i) the Buyer Parties and the Securityholders&rsquo; Representative shall treat the Closing Date as the last
day of the taxable period of the Company for all U.S. federal and applicable state, local and non-U.S. Income Tax purposes, allocating
all items accruing on the Closing Date to the Company&rsquo;s taxable period ending on the Closing Date pursuant to Treasury Regulations
Section 1.1502-76(b)(1)(ii)(A)(1) (and not pursuant to the &ldquo;next day&rdquo; rule under Treasury Regulations Section 1.1502-76(b)(1)(ii)(B)
or pursuant to the ratable allocation method under Treasury Regulations Section 1.1502-76(b)(2)(ii) or 1.1502-76(b)(2)(iii)), and Parent
shall cause the Company to join Parent&rsquo;s &ldquo;consolidated group&rdquo; (as defined in Treasury Regulations Section 1.1502-76(h))
as of the beginning of the date following the Closing Date and (ii) any Transaction Tax Deductions shall be reported as deductions of
the Company and its Subsidiaries in Pre-Closing Tax Periods in connection with the filing of any Tax Return pursuant to this <U>Section
5.9(c)</U> to the greatest extent permitted by Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Tax Claims</U>. Notwithstanding anything herein to the contrary, from and after the Closing, Parent shall control the conduct and
resolution of any Tax-related claim which involves the assertion of any claim or the commencement of any action, in respect of which
an indemnity may be sought pursuant to <U>Section 8.2</U> or with respect to which the Company Securityholders are otherwise reasonably
expected to be liable under this Agreement (including in connection with Indebtedness and Company Transaction Expenses, as finally determined)
(a &ldquo;<U>Tax Claim</U>&rdquo;); <U>provided</U>, that the Securityholders&rsquo; Representative will be entitled to participate fully
in the defense of such Tax Claim at its own expense, and to employ counsel of its choice for such purpose at its own expense and Parent
shall not settle or compromise any Tax Claim without the Securityholder&rsquo;s Representative consent (which shall not be unreasonably
withheld, conditioned or delayed). Buyer Parties, the Company, and the Securityholders&rsquo; Representative agree to give prompt written
notice to each other of the receipt of any written notice by any of them which involves a Tax Claim; <U>provided</U>, that the failure
to give such notice shall not affect the indemnification provided hereunder, unless the party who was supposed to receive such notice
has been materially prejudiced by such failure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(e)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except with the prior written approval of the Securityholders&rsquo;
Representative (not to be unreasonably withheld, delayed or conditioned), Parent shall not, and shall not permit any of its Affiliates
(including the Company and its Subsidiaries) to, (i) file, refile or amend any Tax Return of or with respect to the Company or any of
its Subsidiaries for any Pre-Closing Tax Period or Straddle Period, (ii) enter or permit the Company or any of its Subsidiaries to enter
into any discussions or initiate any contact with any Governmental Authority regarding any voluntary disclosure or similar procedures
involving, or grant an extension of any applicable statute of limitations that relates to, Taxes for any Pre-Closing Tax Period or Straddle
Period, (iii) make, change or revoke any Tax election that has retroactive effect to any Pre-Closing Tax Period or the pre-Closing portion
of any Straddle Period, (iv) make any election under Sections 338 or 336 of the Code with respect to the Company or any of its Subsidiaries
in respect of the transactions contemplated by this Agreement, or (v) take any action on the Closing Date after the Closing that is outside
the Ordinary Course of Business of the Company or any of its Subsidiaries that is expected to give rise to a Tax allocable to a Pre-Closing
Tax Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(f)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent and the Company shall promptly notify the other
party if, at any time before the First Merger Effective Time, Parent or the Company becomes aware of any fact or circumstance that could
reasonably be expected to prevent or impede the Mergers, taken together, from qualifying as a &ldquo;reorganization&rdquo; within the
meaning of Section 368(a) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(g)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent that the provisions of this <U>Section
5.9</U> conflict with the provisions of <U>Section 8.2</U>, this <U>Section 5.9</U> shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>[Reserved</U>].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Officers and Directors Indemnification</U><FONT STYLE="color: windowtext">. Prior to the Closing Date, the Company shall obtain a
prepaid extended reporting period or &ldquo;tail&rdquo; policy insuring the current and former officers and directors of the Company
(the &ldquo;<U>D&amp;O Indemnified Persons</U>&rdquo;) under the current program of directors&rsquo; and officers&rsquo; liability insurance
maintained by the Company which shall be effective commencing with the Closing Date and ending on the sixth (6<SUP>th</SUP>) anniversary
of the Closing Date and which shall afford coverage customary for such policy for actual or alleged acts or omissions occurring at, during,
or prior to the Closing Date including, without limitation, with respect to the Contemplated Transactions (including the Mergers) (the
&ldquo;<U>D&amp;O Tail Insurance</U>&rdquo;). Parent and Buyer shall cause the First Merger Surviving Entity and the Second Merger Surviving
Entity, as applicable, to enforce the D&amp;O Tail Insurance upon request of the D&amp;O Indemnified Parties and will not allow the First
Merger Surviving Entity or the Second Merger Surviving Entity, as applicable, to cancel the D&amp;O Tail Insurance during the term thereof.
</FONT>For a period of six (6) years following the Closing Date, Buyer, the First Merger Surviving Entity and the Second Merger Surviving
Entity agree that all rights to indemnification, advancement of expenses and exculpation by the Company now existing in favor of each
D&amp;O Indemnified Person as provided in the Company Charter Documents or written agreement providing for indemnification of such individual
and Made Available, in each case as in effect on the date of this Agreement, shall be assumed by the First Merger Surviving Entity in
the First Merger and by the Second Merger Surviving Entity in the Second Merger, without further action, and shall remain in full force
and effect in accordance with their terms other than in connection with any amendment, replacement or modification that would not materially
and adversely affect the rights of the D&amp;O Indemnified Persons thereunder or an amendment, replacement or modification which is required
by applicable Law, and, in the event that any proceeding is pending or asserted or any claim made during such period, until the final
disposition of such proceeding or claim. The provisions of this <U>Section 5.11</U> are intended for the benefit of, and shall be enforceable
by, each D&amp;O Indemnified Person. The obligations of the Buyer Parties and their respective successors under this <U>Section 5.11
</U>shall not be terminated, amended or otherwise modified in such a manner as to materially and adversely affect any D&amp;O Indemnified
Person (or his or her heirs, personal representatives, successors or assigns) without the prior written consent of such D&amp;O Indemnified
Person (or his or her heirs, personal representatives, successors or assigns, as applicable), except to the extent required to comply
with applicable Law. For clarity, Buyer shall assume, and be jointly and severally liable for, and shall cause the First Merger Surviving
Entity and the Second Merger Surviving Entity to honor, each of the covenants and obligations in this <U>Section 5.11</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 74; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.12
<U>Parachute Payments</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As soon as reasonably practicable
following the date of this Agreement, but in no event later than five (5) Business Days prior to the Closing Date, the Company shall,
to the extent necessary, use its reasonable best efforts to (a) solicit and obtain, prior to the initiation of the requisite stockholder
approval procedure described in this <U>Section 5.12</U>, a waiver (in such form as prepared by the Company and approved by Parent, which
approval shall not be unreasonably withheld, conditioned, or delayed) from each individual who is or would reasonably be expected to
be, as of the Closing Date, a &ldquo;disqualified individual&rdquo; (as defined in Section 280G(c) of the Code) and (b) following the
Company&rsquo;s receipt of such waivers, solicit the approval of the Company Stockholders (in compliance with Section 280G(b)(5)(B) of
the Code and the regulations issued thereunder) of the right of each such individual who has executed a waiver to receive payments and
benefits that could be deemed a &ldquo;parachute payment&rdquo; (as defined in Section 280G(b)(2) of the Code), so as to render the parachute
payment provisions of Section 280G of the Code inapplicable to any and all payments or other benefits pursuant to Contracts or arrangements
that have been waived in accordance with this <U>Section 5.12</U> that might otherwise result, whether separately or in the aggregate,
in the payment of any amount and/or the provision of any benefit that would not be deductible by reason of Section 280G of the Code,
which determination shall be made by the Company and shall be subject to review and approval by Buyer, which such approval shall not
be unreasonably withheld, conditioned, or delayed (such payments and/or benefits being referred to herein as, the &ldquo;<U>Waived 280G
Benefits</U>&rdquo;). If any of the Waived 280G Benefits fail to be approved by the Company Stockholders as contemplated above, such
Waived 280G Benefits shall not be made or provided to the applicable individuals. At least one (1) Business Day prior to the Closing
Date, the Company shall deliver to Buyer, evidence reasonably satisfactory to Buyer that a vote of the Company&rsquo;s Stockholders was
solicited in conformance with Section 280G of the Code and the regulations promulgated thereunder and that either (x) the requisite number
of votes of the Company Stockholders was obtained with respect to the Waived 280G Benefits (the &ldquo;<U>280G Approval</U>&rdquo;) or
(y) the 280G Approval was not obtained and, as a consequence, the Waived 280G Benefits shall not be paid or provided to the applicable
individuals<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Further Assurances</U>. Each of the Parties covenants and agrees to use its best efforts to effectuate the transactions contemplated
by this Agreement and to do all acts and things as may be required to carry out their obligations hereunder and to consummate this Agreement,
including executing, sealing and delivering all such other instruments and other documents, and take all such other actions, as may be
required to carry out the provisions of this Agreement and the Ancillary Agreements and consummate and make effective the transactions
contemplated by this Agreement and the Ancillary Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.14
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Employee and Related Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
Each employee of the Company who is employed as of immediately prior to the First Merger Effective Time (each, a &ldquo;<U>Continuing
Employee</U>&rdquo;) shall become an at-will employee of Parent or one of its Affiliates as of the First Merger Effective Time, in each
case, subject to the terms of any Contract between Parent or one of its Affiliates and a Continuing Employee (each such Contract, a &ldquo;<U>Continuing
Employee Agreement</U>&rdquo;). With respect to each Continuing Employee, Parent or one of its Affiliates shall take all commercially
reasonable actions necessary to provide or cause to be provided, as of the First Merger Effective Time, (i) the same wage rate or base
salary, as applicable, in effect for each such Continuing Employee as in effect immediately prior to the First Merger Effective Time,
and (ii) such other employee benefits and compensation arrangements as Parent (or, if applicable, one of its Affiliates) provides to
its other similarly situated employees generally, as such benefits or arrangements may be modified, amended, or terminated by Parent
or, if applicable, the applicable Affiliate from time to time</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 75; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to <U>Section 5.14(a)</U>, nothing in this Agreement
shall limit Parent&rsquo;s or its Affiliates&rsquo; ability to determine the compensation and benefit structure of the Company following
the Closing or limit Parent&rsquo;s or one of its Affiliates&rsquo; ability to amend, modify or terminate any Company Employee Program
(or any employee benefit plan or program sponsored by Parent) at any time following the Closing, in each case subject to the terms of
any Continuing Employee Agreement. <FONT STYLE="color: windowtext">Except as provided in this <U>Section 5.14</U>, nothing in this Agreement
shall limit the Parent&rsquo;s or one of its Affiliates&rsquo; ability to (i) modify terms and conditions of a Continuing Employee&rsquo;s
employment, including a Continuing Employee&rsquo;s salary or wage level, or (ii) terminate the employment of any Continuing Employee
at any time and for any reason, including, without cause.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding anything in this Agreement to the contrary, no Continuing Employee, and no other employee or contractor of the Company,
shall be deemed to be a third-party beneficiary of this Agreement except as expressly contemplated by <U>Section 10.15</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.15
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Conduct of Business of Parent</U>. (i) Except as
contemplated or expressly permitted by this Agreement, (ii) with the prior written consent of the Company (which consent may not be unreasonably
withheld, conditioned or delayed), or (iii) as required by applicable Law (including COVID-19 Measures), from the date of this Agreement
until the earlier to occur of the termination of this Agreement in accordance with its terms and the First Merger Effective Time, Parent
shall use commercially reasonable efforts to (A) conduct its business in compliance with all applicable Laws, (B) maintain and preserve
intact its business organization and the goodwill of those having business relationships with it (including by using commercially reasonable
efforts to maintain the value of its assets and technology and preserve its relationships with employees, customers, suppliers, strategic
partners, licensors, licensees, regulators, landlords and others having business relationships with Parent or any Subsidiary) and (C)
maintain in full force and effect all insurance policies that are material to Parent as in effect on the date of this Agreement. In addition,
without limiting the generality of the foregoing, from the date hereof until the earlier to occur of the termination of this Agreement
in accordance with its terms and the First Merger Effective Date, except (i) as contemplated or expressly permitted by this Agreement,
(ii) with the prior written consent of the Company (which consent may not be unreasonably withheld, conditioned or delayed), or (iii)
as required by applicable Law (including COVID-19 Measures), neither Parent nor any other Buyer Party shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">split, combine, subdivide, reclassify or take any similar
action with respect to any shares of capital stock of Parent in a manner that has a material adverse effect on Parent&rsquo;s ability
to consummate the Contemplated Transactions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adopt a plan or agreement for, or carry out, (i) any
complete or partial liquidation, dissolution, restructuring or recapitalization or, (ii) to the extent it would reasonably be expected
to have a material adverse effect on Parent&rsquo;s ability to consummate the Contemplated Transactions, any merger, consolidation or
other reorganization;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acquire or agree to acquire in any manner (whether by
merger or consolidation, the purchase of an equity interest in or a material portion of the assets of or otherwise) any business or any
corporation, partnership, association or other business organization or division thereof, to the extent it would reasonably be expected
to have a material adverse effect on Parent&rsquo;s ability to consummate the Contemplated Transactions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 76; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">make any investment (by contribution to capital, property
transfers, purchase of securities or otherwise) in, or loan or advance funds to, any Person to the extent it would reasonably be expected
to have a material adverse effect on Parent&rsquo;s ability to consummate the Contemplated Transactions; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(e)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">amend the Charter Documents of Parent or any Buyer Party
in a manner that has an adverse effect on Parent&rsquo;s ability to consummate the Contemplated Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6. AGREEMENTS RELATING TO PARENT COMMON STOCK</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<U>Private Placement</U>. Parent intends to issue the shares of Parent Common Stock as provided in this Agreement pursuant to a &ldquo;private
placement&rdquo; exemption or exemptions from registration under Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder
and other applicable state securities laws. The Company agrees to fully cooperate with Parent in its efforts to ensure that such shares
of Parent Common Stock may be issued pursuant to such exemptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
<U>Restrictions on Transfer</U>. The Parent Common Stock shall be subject to any restrictions on Transfer set forth in this <U>Section
6</U> and the Securityholders Joinder Agreement. The Parent Common Stock constitutes &ldquo;restricted securities&rdquo; under the Securities
Act and may not be Transferred absent registration under the Securities Act or an exemption therefrom, and any such Transfer shall also
be conditioned on compliance with applicable state and foreign securities Laws. Each Company Securityholder who receives Parent Common
Stock and every transferee or assignee of any Parent Common Stock from any Company Securityholder shall be bound by and subject to the
terms and conditions of this <U>Section 6</U>, and Parent may require, as a condition precedent to the assignment or Transfer of any
Parent Common Stock, that any transferee or assignee must enter into an agreement with Parent, whereby such transferee or assignee agrees
in writing to be bound by, and subject to, all the terms and conditions of this <U>Section 6</U>. To ensure compliance with the restrictions
imposed by this Agreement, Parent may issue appropriate &ldquo;stop-transfer&rdquo; instructions to its transfer agent, if any, and if
Parent acts as its own transfer agent, it may make appropriate notations to the same effect in its own records. Parent shall not be required
(a) to transfer on its books any Parent Common Stock that have been Transferred in violation of any of the provisions of this Agreement
or (b) to treat as owner of such Parent Common Stock, or to accord the right to vote or pay dividends, to any transferee or assignee
to whom such shares have been purportedly so transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">6.3
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Current Public Information.</U> With a view to making
available to the Company Securityholders the benefits of SEC Rule 144, for a period of two (2) years following the First Merger Effective
Time, the Parent covenants to maintain the registration of the Parent Common Stock under Section 12(b) or 12(g) of the Exchange Act and
to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed
by the Parent after the date hereof pursuant to the Exchange Act even if the Parent is not then subject to the reporting requirements
of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4
<U>Legends</U>. Each certificate or book-entry notation representing any Parent Common Stock issued hereunder shall bear the following
legends (in addition to any other legends required by law, Parent&rsquo;s Charter Documents or any other agreement to which any such
Company Securityholder is a party):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 77; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;<U>ACT</U>&rdquo;), OR
UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED
OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE
ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY
PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
SECURITIES REPRESENTED HEREBY ARE SUBJECT TO LIMITATIONS ON TRANSFER SET FORTH IN THAT CERTAIN SECURITYHOLDERS JOINDER AGREEMENT, DATED
ON OR AROUND April 1, 2022, BETWEEN THE UNDERSIGNED THERETO UNTIL THE FIRST ANNIVERSARY OF THE FIRST MERGER EFFECTIVE TIME. A COPY OF
THE SECURITYHOLDERS JOINDER AGREEMENT IS AVAILABLE FROM THE ISSUER UPON REQUEST.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
7. CONDITIONS TO CLOSING.</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
<U>Conditions to Obligations of the Buyer Parties</U>. The obligations of the Buyer Parties to effect the Mergers and otherwise consummate
the Contemplated Transactions are subject to the satisfaction of the following conditions, any one or more of which may be waived by
the Buyer Parties in writing (to the extent permitted by applicable Law) at or prior to the First Merger Effective Time:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Representations and Warranties</U>. The representations and warranties of the Company set forth in <U>Section 3</U> shall be true
and correct in all material respects on the date hereof and as of the Closing Date as though made on and as of each such date (other
than the representations and warranties which by their express terms are as of a specified date, which shall be true and correct as of
such date, and other than each of the Company Fundamental Representations which shall be true and correct in all respects), except that
those representations and warranties that are qualified by materiality, Company Material Adverse Effect, or similar phrases shall be
true and correct in all respects as written on the date hereof and on and as of the Closing Date as if such representations and warranties
were made on and as of each such date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Covenants</U>. The Company shall have performed and complied in all material respects with all of the covenants and agreements required
to be performed by them under this Agreement before or on the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Officer&rsquo;s Certificate</U>. Buyer Parties shall have received a certificate, validly executed by the Chief Executive Officer
of the Company for and on its behalf, to the effect that, as of the Closing, the condition to the obligations of Buyer Parties set forth
in <U>Section 7.1(a)</U>, <U>Section 7.1(b)</U> and <U>Section 7.1(l)</U> have been satisfied;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Secretary&rsquo;s Certificate</U>. The Company shall have delivered to Buyer Parties a certificate of the Secretary of the Company,
dated as of the Closing Date, certifying as to (i) the incumbency, signature and authority of the officers of the Company executing,
delivering or performing this Agreement, the Ancillary Agreements and any other documents executed and delivered in connection herewith,
(ii) the copies of the Certificate of Incorporation and Bylaws, and any amendments thereto, each as in effect as of the Closing and (iii)
a copy of the votes of the Board of Directors of the Company unanimously authorizing and approving the execution, delivery and performance
of this Agreement and the Ancillary Agreements, and the consummation of the Mergers and the other transactions contemplated hereby and
thereby;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Regulatory Approvals</U>. All actions by or in respect of or filings with any Governmental Authority or official that are required
for the consummation of the transactions contemplated hereby and by the Ancillary Agreements shall have been taken or made and all authorizations,
consents, orders and approvals from such entities shall have been obtained, each in form and substance reasonably satisfactory to Parent,
and shall be in full force and effect;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 78; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Third Party Consents</U>. The Company and Buyer Parties shall have received, each in form and substance reasonably satisfactory to
Parent, all third-party consents set forth on <U>Schedule 7.1(f)</U> (the &ldquo;<U>Required Contract Consents</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Key Employees</U>. Each of the Key Employees shall have accepted employment with Parent or one of its Affiliates and shall have accepted
and delivered to Parent or one of its Affiliates (i) an employment offer letter, (ii) a form of non-competition, non-disclosure and non-solicitation
agreement, and (iii) such other agreements and documents as Parent or one of its Affiliates requires generally of its employees, including
a Continuing Employee Agreement (&ldquo;<U>New Hire Documents</U>&rdquo;). The New Hire Documents shall supersede any prior employment
agreements and other arrangements with any Key Employee in effect at or prior to the Closing, other than proprietary rights, confidentiality,
noncompetition, no solicitation and assignment of inventions agreements, which agreements shall remain in effect and shall supplement,
and not limit or be limited by, the New Hire Documents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Resignation of Company Board and Officers</U>. Buyer Parties shall have received the written resignations of the officers of the Company
and the members of the Company&rsquo;s board of directors, as requested by Parent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Payoff Letters</U>. The Company shall have obtained from each Person who, on or following the date of this Agreement, holds any Indebtedness
of the Company, a Payoff Letter and such other evidence as Parent may reasonably request to the effect that all such Indebtedness of
the Company has been paid in full and any and all Liens have been fully and finally released, with no continuing liability to any of
the Buyer Parties, the Company, the First Merger Surviving Entity, the Second Merger Surviving Entity and any of their Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>No Litigation</U>. No action, suit or proceeding shall be pending or threatened before any court or quasi-judicial or administrative
agency of any federal, state, provincial, local or foreign jurisdiction or before any arbitrator wherein an unfavorable judgment, decree,
injunction, order or ruling would prevent the performance of this Agreement or any of the transactions contemplated hereby, declare unlawful
the transactions contemplated hereby, cause such transactions to be rescinded, enjoined, restrained or materially and adversely affect
the right of Buyer to own or operate the Company, and no Law, judgment, decree, injunction, order or ruling (preliminary or otherwise)
shall have been entered that has any of the foregoing effects;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Good Standing Certificates</U>. The Company shall have delivered good standing certificates for the Company from the Secretary of
State of the State of Delaware and from the Secretary of State in each other jurisdiction in which the operation of its business in such
jurisdiction, requires the Company to qualify to do business as a foreign corporation, in each case dated as of a date not earlier than
five (5) Business Days prior to the Closing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>FIRPTA Officer&rsquo;s Certificate</U>. The Company shall deliver the FIRPTA Officer&rsquo;s Certificate, under penalties of perjury,
stating that the Company is not and has not been a United States real property holding corporation, dated as of the Closing Date and
in form and substance required under Sections 1.1445-2(c)(3) and 1.897-2(h) of the Treasury Regulations; <U>provided</U>, that if the
Company has not delivered such certificate and notice to Parent as of the Closing, Parent shall be permitted to withhold any Taxes required
to be deducted and withheld pursuant to Section 1445 of the Code;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 79; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>No Company Material Adverse Effect</U>. Since the date of this Agreement, there shall not have occurred any Company Material Adverse
Effect;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Dissenter Shares</U>. Company Stockholders holding more than 5% of the Company Capital Stock shall not have demanded in writing appraisal
for his, her or its Company Capital Stock in accordance with Section 262 of the DGCL;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Securityholder Joinder Agreement</U>. Each Company Securityholder listed on <U>Schedule 7.1(o)</U> shall have duly executed and delivered
to Buyer a Securityholder Joinder Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Stockholder Approval</U>. The Stockholder Approval shall have been obtained and shall remain valid and in full force and effect. Parent
and Buyer shall irrevocably vote, or cause to be so voted, all shares of Company Capital Stock held by the Buyer Parties in favor of
this Agreement and the Contemplated Transactions and otherwise in furtherance of the Stockholder Approval to the extent permitted by
applicable Law and the Company Charter Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Spreadsheet</U>. Not less than five (5) Business Days prior to the Closing Date, the Company shall have delivered to Buyer Parties
the Spreadsheet, which shall have been certified as true, complete, correct and in accordance with this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(r)
<U>Termination of Certain Agreements</U>. Buyer Parties shall have received </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">documentation
satisfactory to Parent evidencing the cancellation and termination of all voting agreements, investor rights agreements, right of first
refusal and co-sale agreements, capital stock purchase agreements and similar agreements providing rights to any Company Securityholders;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>First Merger Certificate of Merger</U>. The Company shall have duly executed and delivered the First Merger Certificate of Merger
to Buyer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(t)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Share Registration Exemption</U>. Parent shall be
reasonably satisfied that no more than 90% of the aggregate Company Capital Stock, Option Exercise Shares and Warrant Exercise Shares
will fail to be, at the Closing, held by an &ldquo;accredited&rdquo; investor as defined in Rule 501 promulgated under Regulation D of
the Securities Act and the issuance of all shares of Parent Common Stock in the First Merger shall validly qualify for an exemption from
the registration and prospectus delivery requirements of the Securities Act and the equivalent state &ldquo;blue-sky&rdquo; Laws; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(u)
<U>Release&mdash;Promised Options</U>. The Company shall have delivered to Buyer Parties, each in form and substance reasonably satisfactory
to Parent, a general release of claims from each of </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
Brik, Mel McCurrie, and Michael DeLuca with respect to the Promised Options and any rights or obligations relating thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
<U>Conditions to the Company&rsquo;s Obligations</U>. The obligation of the Company to effect the Mergers and otherwise consummate the
Contemplated Transactions is subject to the satisfaction of the following conditions, any one or more of which may be waived in writing
by the Company (to the extent permitted by applicable Law) at or prior to the First Merger Effective Time:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Representations and Warranties</U>. As of the date of this Agreement and as of the Closing Date as though made on and as of the Closing
Date (except to the extent such representations and warranties are made only as of a specific earlier date, in which case as though made
as of such earlier date), (i) each of the representations and warranties of the Buyer Parties that are qualified by materiality or material
adverse effect shall be true and correct in all respects, and (ii) each of the representations and warranties of the Buyer Parties that
are not so qualified shall be true and correct in all material respects;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 80; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Covenants</U>. Each of the Buyer Parties shall have performed and complied in all material respects with all of the covenants and
agreements required to be performed by it under this Agreement before or on the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Officer&rsquo;s Certificate</U>. The Company shall have received a certificate, validly executed by the Chief Executive Officer of
Parent for and on its behalf, to the effect that, as of the Closing, the condition to the obligations of Company set forth in <U>Section
7.2(a)</U> and <U>Section 7.2(b)</U> have been satisfied;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Secretary&rsquo;s Certificate</U>. Buyer Parties shall have delivered to the Company a certificate of the Secretary of the Parent,
dated as of the Closing Date, certifying as to (i) the incumbency of officers of each Buyer Party executing documents executed and delivered
in connection herewith, (ii) the copies of the Charter Documents of each Buyer Party, each as in effect as of the Closing, and (iii)
a copy of the votes of the board of directors (or its equivalent) of each Buyer Party authorizing and approving the applicable matters
contemplated hereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Regulatory Approvals</U>. All actions by or in respect of or filings with any Governmental Authority or official that are required
for the consummation of the transactions contemplated hereby and by the Ancillary Agreements shall have been taken or made and all authorizations,
consents, orders and approvals from such entities shall have been obtained, each in form and substance reasonably satisfactory to Company,
and shall be in full force and effect;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(f)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Good Standing Certificate</U>. Parent shall have
delivered to the Company a certificate of good standing regarding each of the Merger Subs from the appropriate Governmental Authority
of the jurisdiction in which they are incorporated, dated as of a date not earlier than five (5) Business Days prior to the Closing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>No Litigation</U>. No action, suit or proceeding shall be pending or threatened before any Governmental Authority, court, or quasi-judicial
or administrative agency of any federal, state, local or foreign jurisdiction or before any arbitrator wherein an unfavorable judgment,
decree, injunction, order or ruling would prevent the performance of this Agreement or any of the transactions contemplated hereby, declare
unlawful the transactions contemplated hereby, cause such transactions to be rescinded, enjoined, or restrained, and no Law, judgment,
decree, injunction, order or ruling (preliminary or otherwise) shall have been entered that has any of the foregoing effects;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>D&amp;O Tail Insurance</U>. The Company shall have obtained the D&amp;O Tail Insurance, which shall be in full force and effect in
accordance with the terms thereof as of the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>New Hire Documents</U>. The New Hire Documents shall have been executed by the Key Employees and Parent (or its Affiliate, as applicable);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>[Reserved]</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(k)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Replacement Warrants</U>. Parent shall have executed
and delivered to the Exchange Agent the Replacement Warrants, effective as of the First Merger Effective Time; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(l)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No Parent Material Adverse Effect</U>. <FONT STYLE="color: windowtext">Since
the date of this Agreement, there shall not have occurred any Parent Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 81; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
8. INDEMNIFICATION AND RELATED MATTERS.</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">8.1
<U>Survival</U>. The representations and warranties set forth in <U>Section 3</U> (as qualified by the Disclosure Schedules) and <U>Section
4</U> of this Agreement and the other covenants and agreements set forth herein or in any certificate or instrument delivered in connection
herewith shall survive the Closing Date until the Applicable Limitation Date, at which time such representations and warranties will
expire and terminate and be of no further force and effect. For purposes of this Agreement, the term &ldquo;<U>Applicable Limitation
Date</U>&rdquo; means: (i) with respect to the representations and warranties set forth in <U>Section 3</U> and <U>Section 4</U> (other
than the representations and warranties set forth in <U>Section 3.20</U> (Taxes) (the &ldquo;<U>Tax Representations</U>&rdquo;), the
representations and warranties set forth in <U>Section 3.31</U> (Healthcare Matters) (the &ldquo;<U>Healthcare Representations</U>&rdquo;),
the Company Fundamental Representations, and the Buyer Fundamental Representations), the Base Indemnity Period; (ii) with respect to
the Healthcare Representations, the Company Fundamental Representations and the Buyer Fundamental Representations, the sixth (6<SUP>th</SUP>)
anniversary of the Closing Date; (iii) with respect to the Tax Representations, sixty (60) days following the expiration of the applicable
statute of limitations with respect to a particular matter that is the subject matter thereof; (iv) with respect to the covenants, agreements
and obligations that contemplate performance on or before the Closing, the Base Indemnity Period; (v) with respect to the covenants,
agreements and obligations that contemplate performance after the Closing, the respective term specified in such covenant, agreement
or obligation or, if not specified, until the expiration of the applicable statute of limitations; and (vi) with respect to any Company
Fraud, Securityholder Fraud, Securityholders&rsquo; Representative Fraud or Buyer Parties&rsquo; Fraud, indefinitely. The Parties acknowledge
that the time periods set forth in this <U>Section 8.1</U> for the assertion of claims under this Agreement are the result of arms&rsquo;
length negotiation among the parties and that they intend for the time periods to be enforced as agreed by the parties without regard
to the applicable statute of limitations with respect to such matters (except where the applicable statute of limitations is specified
in this Agreement)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Indemnification for Company Breaches</U>. Subject to each of the limitations set forth in this <U>Section 8</U>, from and after the
Closing and until the Applicable Limitation Date, each Company Securityholder (the &ldquo;<U>Indemnifying Securityholders</U>&rdquo;)
shall, severally (based on each such Indemnifying Securityholder&rsquo;s Pro Rata Share), and not jointly, indemnify and hold harmless
each of the Buyer Parties and, effective at the Closing, without duplication, the First Merger Surviving Entity and the Second Merger
Surviving Entity, their ultimate parent entity, their Affiliates and their respective officers, directors, employees, agents, representatives,
successors and permitted assigns (collectively with the Buyer Parties, each, a &ldquo;<U>Buyer Indemnified Party</U>&rdquo;) from and
against any Losses which a Buyer Indemnified Party actually suffers, sustains or becomes subject to as a result of, arising out of or
in connection with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any inaccuracy in or breach of any representation or warranty made by the Company in <U>Section 3</U> of this Agreement (as modified
by the Disclosure Schedule) or in any Ancillary Agreement or in any certificate delivered pursuant hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a breach of any covenant or agreement made or to be performed by the Company or the Securityholders&rsquo; Representative contained in
this Agreement or in any Ancillary Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
all Indemnified Taxes (or the non-payment thereof) of the Company to the extent not otherwise included in the calculation of Closing
Indebtedness or Company Transaction Expenses, and any reasonable costs or reasonable expenses relating to any audit, contest or proceeding
relating to Indemnified Taxes;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 82; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iv)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dissenting Shares, including any demands by Company
Stockholders under the DGCL and any successor provision thereto (which shall include amounts paid to such holders with respect to such
demands in excess of such holders&rsquo; portion of the amount that otherwise would have been payable pursuant to <U>Section 2.6</U>
upon exchange of such Dissenting Shares, as well as reasonable attorneys&rsquo; fees and expenses incurred, and any interest payable,
in connection with such demands);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
any inaccuracy, error or omission in the Spreadsheet, including any amounts set forth therein that are paid to a Person in excess of
the amounts such Person is entitled to receive pursuant to the terms of this Agreement or any claim or demand for amounts a Person was
entitled to receive pursuant to the terms of this Agreement that were omitted from the Spreadsheet;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(vi)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">indemnification, exculpation or advancement/reimbursement
of expenses obligations owing by the First Merger Surviving Entity or the Second Merger Surviving Entity or any of its Subsidiaries to
any past or present officers, directors or employees of the First Merger Surviving Entity or the Second Merger Surviving Entity or any
of its Subsidiaries (whether under the DGCL, the Charter Documents of the Company, any current indemnification agreement, this Agreement
or otherwise) with respect to claims made against such past or present officers, directors or employees related to actions or omissions
prior to or on the Closing Date (in each case, in their capacity as officers, directors, or employees of the Company);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(vii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceeding, demand or claim by or on behalf of
any current or former holder of Company Capital Stock, Company Options, Company Warrants, SAFEs or Convertible Notes as of immediately
prior to the Effective Time, or any other Person related to direct or indirect equity interests in the Company (or any of his, her or
its respective Affiliates, successors or assignees, but, for the avoidance of doubt, in no case including Buyer Parties and their Affiliates)
regarding this Agreement, the Contemplated Transactions, the Mergers or any direct or indirect ownership interest in the Company, including
with respect to any claims alleging any violation of applicable Law or breach of fiduciary duty, other than, for the avoidance of doubt,
any claim a Company Securityholder has against any Buyer Party pursuant to this Agreement for payment of such Company Securityholder&rsquo;s
portion of the amount that otherwise would have been payable pursuant to <U>Section 2.6</U> and the Spreadsheet or for indemnity pursuant
to this <U>Section 8</U><FONT STYLE="color: windowtext">; and</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(viii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all Liabilities related to the Company&rsquo;s failure
to adopt, maintain, and distribute a summary plan description, as well as any corresponding summaries of material modifications, for
the applicable Company Employee Programs that are required pursuant to ERISA and the corresponding regulations and that relate to any
time on or prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
INDEMNITY OBLIGATION IS INTENDED TO ALLOCATE LIABILITY IN ACCORDANCE WITH TERMS FOR, WITHOUT LIMITATION, (I) ANY CLAIMS RESULTING FROM
THE NEGLIGENCE OR ALLEGED NEGLIGENCE OF ANY BUYER INDEMNIFIED PARTY AND (II) STATUTORY AND COMMON LAW STRICT LIABILITY CLAIMS AS WELL
AS OTHER CLAIMS ARISING UNDER ENVIRONMENTAL LAWS, INCLUDING WITHOUT LIMITATION CERCLA.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Indemnification for Buyer Breaches</U>. Subject to each of the limitations set forth in this <U>Section 8</U>, from and after the
Closing, each Buyer Party shall indemnify and hold harmless the Company Securityholders, their ultimate parent entity, their Affiliates
and their respective officers, directors, employees, agents, representatives, successors and permitted assigns (each, a &ldquo;<U>Company
Indemnified Party</U>&rdquo;, together with the Buyer Indemnified Parties, as applicable, the &ldquo;<U>Indemnified Parties</U>&rdquo;)
from and against any Losses which a Company Indemnified Party actually suffers, sustains or becomes subject to as a result of, arising
out of or in connection with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 83; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any inaccuracy or breach of any representation or warranty made by the Buyer Parties contained in <U>Section 4</U> of this Agreement
(as modified by the Disclosure Schedule) or in any Ancillary Agreement (including in any certificate delivered by or on behalf of the
Buyer Parties in connection therewith); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a breach of any covenant or agreement by any of the Buyer Parties contained in this Agreement or in any Ancillary Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Indemnification for Company Securityholder Breaches</U>. Subject to each of the limitations set forth in this <U>Section 8</U>, from
and after the Closing, each Indemnifying Securityholder shall, individually and not jointly, indemnify and hold harmless the Buyer Indemnified
Parties from and against any Losses which a Buyer Indemnified Party actually suffers, sustains or becomes subject to as a result of,
arising out of or in connection with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
any inaccuracy or breach of any representation or warranty made by such Company Securityholder in such Company Securityholder&rsquo;s
Securityholder Joinder Agreement or Letter of Transmittal (it being understood that such representations and warranties shall survive
the Closing Date until the end of the sixth (6<SUP>th</SUP>) anniversary of the Closing Date, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
which time such representations and warranties will expire and terminate and be of no further force and effect)<FONT STYLE="color: windowtext">;
or</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a breach of any covenant or agreement by such Company Securityholder in this Agreement or such <FONT STYLE="color: windowtext">Company
</FONT>Securityholder&rsquo;s Securityholder Joinder Agreement or Letter of Transmittal (it being understood that such covenants and
agreements shall survive the Closing Date until (a) <FONT STYLE="color: black">with respect to covenants or agreements </FONT><FONT STYLE="color: windowtext">that
contemplate performance on or before the Closing, the end of the Base Indemnity Period, or (b) with respect to covenants or agreements
that contemplate performance after the Closing, </FONT>the respective term specified in such covenant or agreement or, if not specified,
until the expiration of the applicable statute of limitations).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Limitations on Indemnity</U>. The indemnification provided for in <U>Section 8.2(a)</U>, <U>Section 8.2(b)</U> and <U>Section 8.2(c)
</U>above is subject to the following limitations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If notice of any claim for indemnification is given
in accordance with this Agreement on or prior to the Applicable Limitation Date and such claim has not been finally resolved by the expiration
of such Applicable Limitation Date, the representations and warranties, covenants or agreements that are the subject of such claim shall
survive for solely purposes of resolving such claim until such matters are finally resolved<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
For purposes of <U>Section 8.2(a)(i)</U> and <U>Section 8.2(b)(i)</U>, all representations and warranties set forth herein in <U>Section
3</U> and <U>Section 4</U> that are qualified by reference to &ldquo;material,&rdquo; &ldquo;materially,&rdquo; &ldquo;Material Adverse
Effect&rdquo; or any similar term (collectively, &ldquo;<U>Materiality Qualifiers</U>&rdquo;) shall be deemed to have been made without
giving effect to such Materiality Qualifiers for purposes of calculating Losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Each Indemnifying Securityholder&rsquo;s maximum aggregate Liability with respect to any Non-Offset Claims shall be limited to such Indemnifying
Securityholder&rsquo;s Pro Rata Share of the Non-Offset Claim Retention Amount. Buyer Parties&rsquo; maximum aggregate Liability with
respect to the matters described in <U>Section 8.2(b)(i)</U> that constitute a breach of the Buyer Fundamental Representations shall
be limited to the Aggregate Consideration, as finally determined.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 84; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Each Indemnifying Securityholder&rsquo;s maximum aggregate Liability with respect to any Offset Claims shall be limited to such Indemnifying
Securityholder&rsquo;s Pro Rata Share of the Offset Reserve. Each Indemnifying Securityholder&rsquo;s maximum aggregate Liability with
respect to any Company Securityholder Claims against such Indemnifying Securityholder shall be limited to the Company Securityholder
Retention Amount for such Indemnifying Securityholder as determined pursuant to <U>Section 2.9(d)</U>. Buyer Parties&rsquo; maximum aggregate
Liability with respect to the matters described in <U>Section 8.2(b)(i)</U> that constitute a breach of representations and warranties
other than Buyer Fundamental Representations shall be limited to an amount equal to the Offset Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(v)
The </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnifying Securityholders shall not be required
to indemnify any Buyer Indemnified Party under <U>Section 8.2(a)(i)</U> unless the aggregate amount of Losses the Buyer Indemnified Parties
are entitled to recover under this <U>Section 8</U> exceeds $100,000 (the &ldquo;<U>Deductible</U>&rdquo;), and then the Indemnifying
Securityholders shall, subject to each of the limitations set forth in this <U>Section 8</U>, be required to indemnify the applicable
Buyer Indemnified Parties for the full amount of Losses in excess of the Deductible; <U>provided</U>, that this <U>Section 8.2(d)(v)
</U>shall not limit any recovery for Losses related to the failure to be true and correct of any of the Company Fundamental Representations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(vi)
Buyer</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties shall not be required to indemnify any
Company Indemnified Party under <U>Section 8.2(b)(i)</U> unless the aggregate amount of Losses the Company Indemnified Parties are entitled
to recover under this <U>Section 8</U> exceeds the Deductible and then Buyer Parties shall be required to indemnify the applicable Company
Indemnified Parties, subject to this <U>Section 8.2(d)</U>, for the full amount of Losses in excess of the Deductible; <U>provided</U>,
that this <U>Section 8.2(d)(vi)</U> shall not limit any recovery for Losses related to the failure to be true and correct of any of the
Buyer Fundamental Representations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
Without prejudice to any of the other limitations set forth in this <U>Section 8.2(d)</U>, no Indemnifying Securityholder shall have
any Liability for Losses under <U>Section 8</U> in excess of such Indemnifying Securityholder&rsquo;s Pro Rata Share of the Additional
Per Share Consideration due and payable to such Indemnifying Securityholder under this Agreement, as finally determined. The Buyer Parties
shall not be required to indemnify any Company Indemnified Party under <U>Section 8.2(b)</U> for Losses under this <U>Section 8</U> in
excess of the Aggregate Consideration actually paid by the Buyer Parties under this Agreement, as finally determined.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(viii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding the fact that any Indemnified Party
may have the right to assert claims for indemnification under or in respect of more than one provision of this Agreement in respect of
any fact, event, condition or circumstance, no Indemnifying Party shall be liable to pay the same Loss to the Indemnified Parties more
than once, regardless of whether such Loss may be as a result of a breach of more than one representation or warranty or covenant or
whether such Loss may be recoverable hereunder by more than one Indemnified Party (it being understood that this <U>Section 8.2(d)(viii)
</U>is only included to prevent a duplicative recovery of the same Loss and not to prevent recovery of additional Losses arising from
the same or similar or overlapping facts, events, circumstances or conditions)<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 85; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
Notwithstanding anything in this <U>Section 8</U> to the contrary, the limitations set forth in this <U>Section 8.2(d)</U> will not apply
to: (i) any Buyer Parties&rsquo; Fraud (in the case of claims brought by the Company Indemnified Parties); <U>provided</U>, <U>however</U>,
that, notwithstanding any provision of this Agreement to the contrary, in no event shall the maximum aggregate Liability of such Buyer
Party with respect to any Buyer Parties&rsquo; Fraud exceed the aggregate amount of consideration actually paid to the Company Securityholders
pursuant to the terms of this Agreement; (ii) any Company Fraud or Securityholders&rsquo; Representative Fraud, <U>provided</U>, however,
that, notwithstanding any provision of this Agreement to the contrary, a Company Securityholder shall not have any Liability to the Buyer
Indemnified Parties for any Company Fraud or Securityholders&rsquo; Representative Fraud unless such Company Securityholder had actual
knowledge of such Company Fraud or Securityholders&rsquo; Representative Fraud (as applicable), in which case the Liability of such Company
Securityholder to the Buyer Indemnified Parties in respect of such Company Fraud or Securityholders&rsquo; Representative Fraud (as applicable)
shall be several but not joint; and (iii) any Securityholder Fraud, <U>provided</U>, however, that, notwithstanding any provision of
this Agreement to the contrary, an Indemnifying Securityholder shall not have any Liability to the Buyer Indemnified Parties for any
Securityholder Fraud unless such Securityholder Fraud was committed by such Indemnifying Securityholder. Notwithstanding any provision
of this Agreement to the contrary, in no event shall the maximum aggregate Liability of any Indemnifying Securityholder with respect
to any Company Fraud, Securityholders&rsquo; Representative Fraud, and/or Securityholder Fraud exceed, in total, the aggregate amount
of consideration actually paid to such Indemnifying Securityholder pursuant to the terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(x)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Company Indemnified Party in its capacity as an Indemnifying
Party or otherwise shall have, and no such Person shall exercise or assert (or attempt to exercise or assert), any right of contribution,
right of indemnity or other right or remedy against the First Merger Surviving Entity, the Second Merger Surviving Entity or their respective
directors, managers, officers, employees, Affiliates, agents, attorneys, shareholders, members, representatives, assigns or successors
(a) for any third-party claims asserted by any Buyer Indemnified Party, it being acknowledged and agreed that any representations, warranties
and covenants of the Company are solely for the benefit of the Buyer Indemnified Parties, or (b) in connection with any other indemnification
obligation or any other liability to which such Person may become subject or which may be payable in connection with this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(xi)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount of any Losses for which indemnification would
otherwise be payable pursuant to this <U>Section 8</U> shall be reduced by (i) the amount of any insurance proceeds actually paid to
the Indemnified Party in connection with such Loss under applicable insurance policies (net of any increase in premiums, retroactive
premiums, premium adjustments or any deductible or retention amounts, in each case, incurred in recovering the applicable insurance proceeds)
(it being acknowledged and agreed that the Buyer Indemnified Parties shall first use commercially reasonable efforts to satisfy any claims
for Losses arising pursuant to <U>Section 8.2(a)(vi)</U> by recourse to the D&amp;O Tail Insurance prior to bringing any claims against
the Company Securityholders in respect thereof, but, for the avoidance of doubt, the Buyer Indemnified Parties shall not be required
to exhaust their remedies or expend such efforts prior to, or as a condition to, asserting claims for Losses or recovering Losses from
the Company Securityholders), and (ii) any amounts actually received by the Indemnified Party from a third party under any indemnification
rights (other than pursuant to this <U>Section 8</U>) (net of any costs and expenses incurred in recovering from same), in each case
of the foregoing clauses (i) and (ii), to the extent in effect for the benefit of the Company immediately prior to the Closing. If an
Indemnified Party receives any amounts under applicable insurance policies or applicable indemnification arrangements as contemplated
by this <U>Section 8.2(d)(xi)</U> subsequent to its receipt of an indemnification payment by an Indemnifying Party, then such Indemnified
Party will, without duplication, promptly reimburse the Indemnifying Party for any payment made by such Indemnifying Party up to the
amount received by the Indemnified Party (net of the total cost of any recovery of such insurance proceeds or indemnity payments); <U>provided</U>,
that the aggregate amount of reimbursement payments to the Indemnifying Party in respect of any such Losses will not in any event exceed
the aggregate indemnification payment received by the Indemnified Party from the Indemnifying Party with respect to such Losses; <U>provided</U>,
<U>further</U> that, no Indemnified Party shall be required to notify the provider(s) or payor(s) of, or seek recovery for such Losses
under, any such insurance policies or indemnification arrangements prior to seeking and obtaining recovery for such Losses from an Indemnifying
Party pursuant to, and subject to, the limitations of <U>Section 8.2(d)</U>. Without limiting the foregoing, each Indemnified Party agrees
to use commercially reasonable efforts to mitigate any Losses for which indemnification may be sought pursuant to this <U>Section 8</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 86; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(xii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to any claim for Losses with respect to
Taxes pursuant to <U>Section 8.2(a)</U> or <U>Section 8.2(c)(i)</U>, Losses shall not include Taxes of Parent and its Affiliates (including
the Company and its Subsidiaries) to the extent such Taxes are actually reduced by deductions, losses and credits (including, without
limitation, net operating loss carryforwards) generated in the Pre-Closing Tax Periods, but only to the extent not been taken into account
as a reduction in the calculation of the Aggregate Consideration (including the determination of Pre-Closing Tax Amount).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Purchase Price Adjustments</U>. For all U.S. federal and applicable state and local income Tax purposes, (i) amounts paid, and shares
of Parent Common Stock issued, under this Agreement to (or to another on behalf of) any holder of Company Capital Stock by reason of
holding such Company Capital Stock, including such amounts paid as indemnification, shall be treated as adjustments to the purchase price,
and (ii) cash amounts paid under this Agreement by any holder of Company Capital Stock to a Buyer Party, including such amounts paid
as indemnification, shall be treated as contributions by such holder of Company Capital Stock to Parent treated as tax-deferred transactions,
in each case, unless otherwise required by applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>[Reserved]</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(g)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Buyer Parties and First Merger Surviving Entity and
Second Merger Surviving Entity</U>. In the event that the First Merger Surviving Entity and/or the Second Merger Surviving Entity suffers,
incurs or otherwise becomes subject to any Losses as a result of or in connection with any breach of <U>Section 8.2(a)</U>, then (without
<FONT STYLE="color: windowtext"><U>limiting</U></FONT> any of the rights of the First Merger Surviving Entity and/or the Second Merger
Surviving Entity as a Buyer Indemnified Party), Buyer Parties shall also be deemed, by virtue of its ownership of the stock of the First
Merger Surviving Entity and/or the Second Merger Surviving Entity, to have incurred Losses as a result of and in connection with such
breach of <U>Section 8.2(a)</U>, but in either case the total amount both Buyer Parties, the First Merger Surviving Entity and/or the
Second Merger Surviving Entity may recover shall not exceed the amount of such Losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Use of Offset Reserve; Exclusive Source of Recovery</U>. Other than in the case of Company Fraud, Securityholder Fraud or Securityholders&rsquo;
Representative Fraud (in which case the limitations set forth in <U>Section 8.2(d)(ix)</U> shall apply but the limitations set forth
in this <U>Section 8.2(h)</U> will not apply), the sole and exclusive source for recovery of the Buyer Indemnified Parties for any: (i)
Offset Claims shall be the Offset Reserve (for sake of clarity, this means that the sole and exclusive source of recovery of the Buyer
Indemnified Parties for any Offset Claims shall be for the Parent to retain all or some portion (as the case may be) of the Offset Reserve
in accordance with <U>Section 2.9(b)</U>); (ii) Non-Offset Claims shall be for the Parent to retain, in accordance with <U>Section 2.9(b)
</U>and <U>Section 2.9(c)</U>, all or some portion (as the case may be) of the Contingent Payment amounts (if any) or Accelerated Amount
due and payable to the Company Securityholders pursuant to <U>Section 2.9(a)</U>, including, at Parent&rsquo;s sole discretion, the Offset
Reserve; and (iii) Company Securityholder Claims shall be for the Parent to retain, in accordance with <U>Section 2.9(d)</U>, all or
some portion (as the case may be) of the Contingent Payment amounts (if any) or Accelerated Amount due and payable to the relevant Company
Securityholder pursuant to <U>Section 2.9(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 87; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
<U>Method of Recovery</U>. Any amounts due to the Buyer Indemnified Parties pursuant to <U>Section 8.2(a)</U> shall be satisfied, subject
to the limitations set forth in this <U>Section 8</U> (A) in respect of Offset Claims and Non-Offset Claims, by recourse to the Offset
Reserve, subject to the limitations set forth in <U>Section 2.9(b)</U>, and (B) in respect of any Non-Offset Claims, by recourse to any
Contingent Payments or Accelerated Amount, subject to the limitations set forth in <U>Section 2.9(c)</U>. Any amounts due to the Buyer
Indemnified Parties pursuant to <U>Section 8.2(c)</U> shall be satisfied, subject to the limitations set forth in this <U>Section 8</U>,
by recourse to any Contingent Payments or the Accelerated Amount to the relevant Company Securityholder, subject to the limitations set
forth in <U>Section 2.9(d)</U>. Without limiting any other rights or remedies available to the Buyer Parties, the Buyer Parties shall
be entitled to offset any claim for Losses by a Buyer Indemnified Party pursuant to this <U>Section 8</U> or any payments due and payable
by any Indemnifying Securityholder to Buyer Parties pursuant to this Agreement against payments due and payable by any Buyer Indemnified
Party to any Company Indemnified Party under this Agreement</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(j)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Defense of Third-Party Claims</U>. <FONT STYLE="color: windowtext">In
the event that an Indemnified Party becomes aware of a third-party claim (any such claim, a &ldquo;<U>Third Party Claim</U>&rdquo;) pursuant
to which such Indemnified Party believes it may be entitled to indemnification pursuant to this <U>Section 8</U>, the Indemnified Party
will promptly notify the Indemnifying Party of such Third Party Claim. Notwithstanding the foregoing, no delay in providing such notice
will affect an Indemnified Party&rsquo;s rights hereunder, unless (and then only to the extent that) the Indemnifying Party is actually
and materially prejudiced thereby. Such notice must contain a reasonably detailed description of the facts and circumstances giving rise
to the claim to the extent then known and the nature and amount, if then reasonably ascertainable, of such Losses that may be indemnifiable.
The obligations of the Indemnifying Party under this <U>Section 8</U> with respect to Losses arising from any Third Party Claim will
be governed by the following additional terms and conditions:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Indemnifying Party, at its option and at the expense
of the Indemnifying Party, will be entitled to assume control of the defense of any Third Party Claim (except as described in clauses
(A) through (C) below, an &ldquo;<U>Assumable Claim</U>&rdquo;), at any time within 10 Business Days of receiving written notice of the
Third Party Claim from the Indemnified Party (or sooner, if the nature of the Third Party Claim so requires) and may appoint as lead
counsel of such defense any legal counsel selected by the Indemnifying Party and reasonably acceptable to the Indemnified Party; <U>provided</U>,
that the Indemnifying Party shall have acknowledged in writing to the Indemnified Party that, subject to the terms and conditions of
this <U>Section 8</U>, it would be liable for the Losses alleged in such Third Party Claim to the extent provided under this <U>Section
8</U> if the material facts alleged in such Third Party Claim are ultimately determined to be accurate; <U>provided</U>, <U>further</U>,
that the Indemnifying Party must conduct its defense of the Third Party Claim actively and diligently thereafter in order to preserve
its rights in this regard; <U>provided</U>, <U>further</U>, that the Indemnifying Party will not be entitled to assume control of the
defense of any Third Party Claim without the Indemnified Party&rsquo;s express written consent in the event (A) the named parties to
any such Third Party Claim (including any impleaded parties) include both the Indemnifying Party and one or more Indemnified Parties
and, in the opinion of counsel to the Indemnified Party, there is an actual conflict of interest between the Indemnifying Party and the
Indemnified Parties, (B) such Third Party Claim seeks material non-monetary relief against the Indemnified Party, or (C) the claim relates
to or arises in connection with any potential criminal liability or regulatory violation. In the event that the Indemnifying Party assumes
control of the defense of any Third Party Claim, the Indemnifying Party will keep the Indemnified Party informed of all material events
and developments, including promptly providing copies of any correspondence and court filings, with respect to such Third Party Claim.
Notwithstanding the foregoing, the Indemnified Party will be entitled, at its own expense, to participate in the defense of such claim
and to employ counsel of its choice for such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 88; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Indemnifying Party elects to not defend against,
negotiate, settle or otherwise deal with the Third Party Claim, fails to timely notify the Indemnified Party of its election to do so
as herein provided, or is not permitted hereunder to assume such defense, the Indemnified Party shall have the exclusive right (subject
to paragraph (iv) of this <U>Section 8.2(j)</U>) to contest, settle, or pay the amount claimed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with a Third Party Claim, the Indemnified
Parties shall reasonably cooperate with the Indemnifying Party and make available to the Indemnifying Party all pertinent information
under its control, except to the extent not permitted by applicable Law or required to preserve attorney-client privilege.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iv)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither the Indemnifying Party nor any Indemnified Party
may enter into any settlement or compromise with respect to any Third Party Claim without the prior written consent of the other, such
consent not to be unreasonably withheld, conditioned or delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Exclusive Remedy</U>. From and after the Closing, the indemnification provided pursuant to this <U>Section 8</U> shall be the sole
and exclusive remedy for any Losses resulting from or arising out of any breach or claim in connection with this Agreement, the Disclosure
Schedules, the Ancillary Agreements, or any certificate delivered in connection with this Agreement (and, with respect to any particular
Company Securityholder, under such Company Securityholder&rsquo;s Securityholder Joinder Agreement or Letter of Transmittal). For clarity,
this means (a) that the survival periods and liability limits set forth in this <U>Section 8</U> shall control notwithstanding any statutory
or common law provisions or principles to the contrary, (b) all applicable statutes of limitations or other claims periods with respect
to claims shall be shortened or lengthened to the applicable claims periods and survival periods set forth herein, unless provided otherwise,
and (c) the Buyer Indemnified Parties irrevocably waive any and all rights they may have to make claims against any Company Securityholder
under statutory and common law as a result of any Losses and any and all other damages incurred by them with respect to this Agreement
(and with respect to any particular Company Securityholder, under such Company Securityholder&rsquo;s Securityholder Joinder Agreement
or Letter of Transmittal) whether or not in excess of the maximum amounts permitted to be recovered pursuant to this <U>Section 8</U>;
<U>provided</U>, <U>however</U>, that neither the foregoing nor anything else contained in this Agreement shall limit any Indemnified
Party&rsquo;s right to seek and obtain specific performance or injunctive relief to which any Party may be entitled, or in respect of
any rights to enforce any New Hire Documents in accordance with their respective terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
9. TERMINATION OF AGREEMENT</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1
<U>Termination by Mutual Consent</U>. This Agreement may be terminated at any time prior to the Closing, whether before or after receipt
of the Stockholder Approval, by the mutual written consent of Parent and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2
<U>Unilateral Termination</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
Either Parent or the Company, by giving written notice to the other, may terminate this Agreement if (i) a court of competent jurisdiction
or other Governmental Authority shall have issued a final judgment or taken any action (and the final appeal of such judgment or action
has been denied) having the effect of permanently restraining, preventing or enjoining or otherwise prohibiting any of the Mergers or
any other material Contemplated Transaction, or (ii) there has been adopted an applicable Law that makes the consummation of any of the
Mergers on the terms and conditions contemplated by this Agreement illegal; </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>provided</U>,
<U>however</U>, that the Party seeking to terminate this Agreement pursuant to this <U>Section 9.2(a)</U> must have used all reasonable
efforts to remove any such final judgment or action in order to terminate this Agreement under this <U>Section 9.2(a)</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 89; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Either Parent or the Company, by giving written notice to the other, may terminate this Agreement if the Closing has not taken place
on or before the date that is ninety (90) days following the date of this Agreement, if the conditions to the terminating party&rsquo;s
obligations to Closing under <U>Section 7</U> (other than conditions pertaining to covenants to be performed as part of effectuating
the Closing) have not been satisfied and the terminating party has not waived such unsatisfied conditions by such time; <U>provided</U>,
<U>however</U>, that the right to terminate this Agreement pursuant to this <U>Section 9.2(b)</U> shall not be available to any Party
who is at that time in material breach of this Agreement or whose breach of a representation or warranty or covenant made under this
Agreement by such Party results in the failure of any condition set forth in <U>Section 7</U> to be fulfilled or satisfied as of such
date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company, by giving written notice to Parent, may terminate this Agreement at any time prior to the First Merger Effective Time if
any Buyer Party has committed a breach of (i) any of their representations or warranties under <U>Section 4</U>, or (ii) any of their
covenants under this Agreement, and (A) has not cured such breach within ten (10) Business Days after the Company has given Parent written
notice of such breach and its intention to terminate this Agreement pursuant to this <U>Section 9.2(c)</U> (<U>provided</U>, however,
that no such cure period shall be available or applicable to any such breach which by its nature cannot be cured) and (B) if not cured
on or prior to the Closing Date, or if not curable, such breach would result in the failure of any of the conditions set forth in <U>Section
7</U> to be fulfilled or satisfied; <U>provided</U>, however, that the right to terminate this Agreement under this <U>Section 9.2(c)
</U>shall not be available to the Company if the Company is at that time in material breach of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Parent, by giving written notice to the Company, may terminate this Agreement at any time prior to the First Merger Effective Time if
the Company has committed a breach of (i) any of its representations or warranties under <U>Section 3</U> (as modified by the Disclosure
Schedule), or (ii) any of its covenants under this Agreement, and (A) has not cured such breach within ten (10) Business Days after Parent
has given the Company written notice of such breach and its intention to terminate this Agreement pursuant to this <U>Section 9.2(d)
</U>(<U>provided</U>, however, that no such cure period shall be available or applicable to any such breach which by its nature cannot
be cured) and (B) if not cured on or prior to the Closing Date, or if not curable, such breach would result in the failure of any of
the conditions set forth in <U>Section 7</U> to be fulfilled or satisfied; <U>provided</U>, however, that the right to terminate this
Agreement under this <U>Section 9.2(d)</U> shall not be available to Parent if any Buyer Party are at that time in material breach of
this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Parent, by giving written notice to the Company, may terminate this Agreement at any time prior to the First Merger Effective Time if
executed Written Consents evidencing the Stockholder Approval are not delivered to Parent within twenty-four (24) hours after the execution
and delivery of this Agreement by any of the Buyer Parties, the Company and the Securityholders&rsquo; Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3
<U>Effect of Termination</U>. In the event of the termination of this Agreement pursuant to <U>Section 9.1</U> or <U>Section 9.2</U>,
this Agreement shall forthwith become void and there shall be no Liability or obligation on the part of any Buyer Party, the Company,
any Company Securityholder or their respective officers, directors, stockholders or Affiliates; <U>provided</U>, <U>however</U>, that
(a) the provisions of this <U>Section 9.3</U> (Effect of Termination), <U>Section 5.8</U> (Confidentiality) and <U>Section 10</U> (Miscellaneous)
shall remain in full force and effect and survive any termination of this Agreement, and (b) nothing herein shall relieve any Party from
Liability in connection with any fraud, willful breach, or intentional misrepresentation prior to such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 90; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
10. MISCELLANEOUS.</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1
<U>Amendment</U>. This Agreement may not be amended or modified except (a) by an instrument in writing signed by or on behalf of Parent,
the Securityholders Representative, and the Company or (b) by a waiver in accordance with <U>Section 10.3</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2
<U>Securityholders&rsquo; Representative</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective upon and by virtue of the Stockholder Approval
approving and adopting this Agreement and the Mergers, and without any further act of any of the Company Securityholders, the Securityholders&rsquo;
Representative will be hereby irrevocably appointed as the representative of the Company Securityholders and as the attorney-in-fact
and agent for and on behalf of each such Company Securityholder for purposes of this Agreement and will be empowered to take such actions
contemplated to be taken by the Securityholders&rsquo; Representative under this Agreement, the Ancillary Agreements and such other actions
on behalf of such Company Securityholders as it may deem necessary or appropriate in connection with or to consummate the transactions
contemplated hereby or thereby, including, without limiting the generality of the foregoing, (i) taking all actions and making all filings
on behalf of such Company Securityholders with any Governmental Authority or other Person necessary to effect the consummation of the
Contemplated Transactions, (ii) agreeing to, negotiating, entering into settlements and compromises of, complying with orders of courts
with respect to, and otherwise administering and handling any claims under this Agreement and the Ancillary Agreements on behalf of such
Company Securityholders, including indemnifications claims, (iii) negotiating and executing any waivers or amendments of this Agreement
and the Ancillary Agreements, and (iv) taking all other actions that are either necessary or appropriate in its judgment for the accomplishment
of the foregoing or contemplated by the terms of this Agreement and the Ancillary Agreements. The Securityholders&rsquo; Representative
hereby accepts such appointment<FONT STYLE="color: windowtext">. </FONT><FONT STYLE="color: black">No bond shall be required of the Securityholders&rsquo;
Representative.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
Buyer Parties</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall be entitled to deal exclusively with
the Person(s) serving as the Securityholders&rsquo; Representative on all such matters relating to this Agreement (including <U>Section
8</U>) or any of the other Ancillary Agreements to which Buyer Parties and the Securityholders&rsquo; Representative are parties. A decision,
act, consent or instruction of the Securityholders&rsquo; Representative hereunder will constitute a decision, act, consent or instruction
of all Company Securityholders and will be final, binding and conclusive upon each of such Company Securityholders and Buyer Parties
may rely conclusively (without further evidence of any kind whatsoever) upon any such decision, act, consent or instruction of the Securityholders&rsquo;
Representative as being the decision, act, consent or instruction of each and every such Company Securityholder. No Company Securityholder
will have the right to object to, dissent from, protest or otherwise contest the same. Buyer Parties will be relieved from any liability
to any Person for any acts done by them in accordance with such decision, act, consent or instruction of the Securityholders&rsquo; Representative<FONT STYLE="color: windowtext">.
</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Securityholders&rsquo; Representative will incur
no liability with respect to any action taken or suffered by any party in reliance upon any notice, direction, instruction, consent,
statement or other document believed by such Securityholders&rsquo; Representative to be genuine and to have been signed by the proper
person (and the Securityholders&rsquo; Representative will have no responsibility to determine the authenticity thereof), nor for any
other action or inaction, except its own gross negligence, bad faith or willful misconduct. In all questions arising under this Agreement,
the Securityholders&rsquo; Representative may rely on the advice of outside counsel, and the Securityholders&rsquo; Representative will
not be liable to any Company Securityholder for anything done, omitted or suffered in good faith by the Securityholders&rsquo; Representative
based on such advice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company Securityholders will severally (each based
on and limited to its Pro Rata Share) but not jointly indemnify the Securityholders&rsquo; Representative and hold the Securityholders&rsquo;
Representative harmless against any loss, Liability or expense incurred without gross negligence, bad faith or willful misconduct, on
the part of the Securityholders&rsquo; Representative and arising out of or in connection with the acceptance or administration of the
Securityholders&rsquo; Representative&rsquo;s duties hereunder, including the reasonable fees and expenses of any legal counsel or other
agents retained by the Securityholders&rsquo; Representative (collectively, &ldquo;<U>Representative Expenses</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 91; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(e)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At any time after the Closing Date, a majority-in-interest
of Company Securityholders may, by written consent, appoint a new representative as the Securityholders&rsquo; Representative. Notice
together with a copy of the written consent appointing such new representative and bearing the signatures of Company Securityholders
of a majority-in-interest of those Company Securityholders must be delivered to Buyer not less than ten (10) days prior to such appointment.
Such appointment will be effective upon the later of the date indicated in the consent or the date such consent is received by <FONT STYLE="color: windowtext">Parent</FONT>.
For the purposes of this <U>Section 10.2</U>, a &ldquo;majority-in-interest of the Company Securityholders&rdquo; shall mean Company
Securityholders having the right to receive, in the aggregate, a majority of Aggregate Consideration payable to the Company Securityholders
pursuant to the terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(f)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event that the Securityholders&rsquo; Representative
becomes unable or unwilling to continue in its capacity as Securityholders&rsquo; Representative, or if the Securityholders&rsquo; Representative
resigns as a Securityholders&rsquo; Representative, a majority-in-interest of the Company Securityholders may, by written consent, appoint
a new representative as the Securityholders&rsquo; Representative. Notice and a copy of the written consent appointing such new representative
and bearing the signatures of a majority-in-interest of the Company Securityholders must be delivered to <FONT STYLE="color: windowtext">Parent</FONT>.
Such appointment will be effective upon the later of the date indicated in the consent or the date such consent is received by <FONT STYLE="color: windowtext">Parent</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(g)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Expense Fund</U>. At the Closing, Parent shall wire
to the Securityholders&rsquo; Representative the Expense Fund Amount. The Expense Fund Amount shall be held by the Securityholders&rsquo;
Representative in a segregated account (the &ldquo;<U>Expense Fund</U>&rdquo;) and shall be used solely for (i) the purposes of paying
directly or reimbursing the Securityholders&rsquo; Representative for any Representative Expenses incurred pursuant to this Agreement
or (ii) paying directly, or reimbursing the Securityholders&rsquo; Representative for, any third party expenses pursuant to this Agreement
and the Ancillary Agreements. The Securityholders&rsquo; Representative is not providing any investment supervision, recommendations
or advice to any Company Securityholder and shall have no responsibility or liability to any Company Securityholder for any loss of principal
of the Expense Fund other than as a result of the Securityholders&rsquo; Representative&rsquo;s gross negligence or willful misconduct.
The Securityholders&rsquo; Representative will hold these funds separate from its person funds, will not use these funds for any personal
purposes, and will not voluntarily make these funds available to its creditors in the event of bankruptcy. The Securityholders&rsquo;
Representative is not acting as a withholding agent or in any similar capacity in connection with the Expense Fund and has no tax reporting
or income distribution obligations. The Company Securityholders will not receive any interest or earnings on the Expense Fund and irrevocably
transfer and assign to the Securityholders&rsquo; Representative any such interest or earnings. As soon as reasonably determined by the
Securityholders&rsquo; Representative that the Expense Fund is no longer required to be withheld, the Securityholders&rsquo; Representative
shall distribute any amount remaining in the Expense Fund (the &ldquo;<U>Expense Fund Proceeds</U>&rdquo;) to Parent and, promptly following
Parent&rsquo;s receipt of the Expense Fund Proceeds, Parent shall, in its sole discretion, cause the Exchange Agent to pay to (i) each
Participating Holder an amount in cash or in Parent Shares, or a combination thereof, equal to their respective Expense Fund Payment
Amount, and (ii) each Non-Participating Holder, an amount in cash equal to such Non-Participating Holder&rsquo;s Expense Fund Payment
Amount (<U>provided</U>, that Parent must grant Parent Common Stock if necessary to preserve the tax-free nature of the Mergers under
Section 368(a)(1)(A)), and <U>provided</U>, <U>further</U>, that Parent may only make payments in Parent Common Stock if, at the time
the payment is made, (i) the Parent Common Stock is registered under Section 12(b) or 12(g) of the Exchange Act and (ii) Parent has made
all filings it is required to make under the Exchange Act during the prior twelve months). For tax purposes, the Expense Fund will be
treated as having been received and voluntarily set aside by the Company Securityholders at the time of Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 92; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3
<U>Waiver</U>. Any Party to this Agreement may waive compliance or performance of any provision of this Agreement that is intended for
the benefit of such waiving Party. Any such extension or waiver shall be valid only if set forth in a writing executed by the Party to
be bound thereby. Any waiver of any term or condition shall not be construed as a waiver of any subsequent breach or waiver of the same
term or condition or as a waiver of any other term or condition of this Agreement. The failure of any Party to assert any of its rights
under this Agreement shall not constitute a waiver of any of such rights. No course of dealing between or among any persons having any
interest in this Agreement shall be deemed effective to modify, amend or discharge any part of this Agreement or any rights or obligations
of any Party under or by reason of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4
<U>Specific Performance</U>. Each Party agrees that the other Parties shall have the right, in addition to any other rights and remedies
existing in its favor, to seek to enforce its rights and the other Party&rsquo;s obligations hereunder not only by an action or actions
for damages but also by an action or actions for equitable relief, including injunction and specific performance. If any such action
is brought by a Party to enforce this Agreement, the other Party hereby waives the defense that there is an adequate remedy at law or
the requirement for the posting of any bond or similar security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5
<U>Expenses</U>. Except as otherwise expressly provided herein, each of the Parties hereto shall pay all of its own fees, costs and expenses
(including fees, costs and expenses of legal counsel, investment bankers, brokers or other representatives and consultants and appraisal
fees, costs and expenses) incurred in connection with the negotiation of this Agreement and the Ancillary Agreements, and the consummation
of the transactions contemplated hereby and thereby; <U>provided</U>, that, Buyer Parties shall pay all of the Closing Transaction Expenses
in an amount of up to $100,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">10.6
<U>Notices</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any notices or other communications
required or permitted hereunder will be deemed to have been properly given and delivered if in writing by such party or its legal representative
and delivered personally or sent by e-mail transmission of a signed document or by nationally recognized overnight courier service guaranteeing
overnight delivery, addressed as follows<FONT STYLE="color: windowtext">:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
                                            prior to the Effective Time, to the Company:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Precision
    Healing Inc.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">275
    Washington Street, Suite 200</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newton,
    MA 02458</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    dlee@dxwound.com</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    W. David Lee</FONT></P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            a copy (which will not constitute notice) to:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwin
    Procter LLP</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
    Northern Avenue</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boston,
    MA 02210</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    mbison@goodwinlaw.com</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Michael H. Bison</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            to Buyer Parties or, after the First Merger Effective Time, the First Merger Surviving Entity
                                            or, after the Second Merger Effective Time, the Second Merger Surviving Entity:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
    MedTech, Inc.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1200
    Summit Avenue, Suite 414</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fort
    Worth, Texas 76102</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone:
    817-529-2300</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    mmcneil@sanaramedtech.com</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Michael D. McNeil</FONT></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            a copy (which will not constitute notice) to:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Haynes
    and Boone, LLP</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2323
    Victory Avenue, Suite 700</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dallas,
    Texas 75219</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Matthew Fry</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    matt.fry@haynesboone.com</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            to the Securityholders&rsquo; Representative:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furneaux
    Capital Holdco, LLC (d/b/a BlueIO)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c/o
    Goodwin Partners</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200
    Summit Street, Suite 201</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Burlington,
    MA 01803</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    Dave@blueio.co</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Dave Furneaux</FONT></P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            a copy (which will not constitute notice) to:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwin
    Procter LLP</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
    Northern Avenue</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boston,
    MA 02210</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    mbison@goodwinlaw.com</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Michael H. Bison</FONT></P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 93; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise specified herein, such notices or other communications will be deemed given (a) on the date delivered, if delivered personally,
(b) one (1) Business Day after being sent by a nationally recognized overnight courier guaranteeing overnight delivery, and (c) on the
date delivered, if delivered by e-mail (with confirmation of transmission) during business hours (or one (1) Business Day after the date
of delivery if delivered after 5:00 pm in the place of receipt). Notwithstanding the foregoing, if such notices or other communications
would otherwise be deemed given on a day which is not a Business Day, the delivery shall be deemed given the first Business Day following
such day. Each of the Parties will be entitled to specify a different address by delivering notice as aforesaid to each of the other
Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7
<U>Binding Agreement; Assignment</U>. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit
of the Parties and their respective successors and permitted assigns; provided that neither this Agreement nor any of the rights, interests
or obligations hereunder may be assigned by operation of law or otherwise without the prior written consent of Parent and Securityholders&rsquo;
Representative; <U>provided</U>, <U>however</U>, that notwithstanding the foregoing, Parent may at any time in its sole discretion and
without the consent of any other Party assign, in whole or in part, (a) its rights under this Agreement and the Ancillary Agreements
for collateral security purposes to any lender providing financing to any Buyer Party, such permitted assign or any of their Affiliates,
and any such lender may exercise all of the rights and remedies of such assignee hereunder and thereunder; and (b) its rights under this
Agreement and the Ancillary Agreements to any subsequent purchaser of any Buyer Party, their respective Affiliates, or any of their divisions
or any material portion of their assets (whether such sale is structured as a sale of equity, sale of assets, merger, recapitalization
or otherwise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8
<U>Severability</U>. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid
under applicable Law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable Law or public policy,
such provision shall be ineffective only to the extent of such prohibition or invalidity, and all other terms of this Agreement shall
remain in full force and effect for so long as the economic or legal substance of the transactions contemplated hereby is not affected
in any manner materially adverse to any Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">10.9
<U>Construction</U>. The Parties have participated jointly in the negotiation and drafting of this Agreement and the other agreements,
documents and instruments executed and delivered in connection herewith. In the event an ambiguity or question of intent or interpretation
arises, this Agreement and the agreements, documents and instruments executed and delivered in connection herewith shall be construed
as if drafted jointly by the Parties and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of
the authorship of any provisions of this Agreement and the agreements, documents and instruments executed and delivered in connection
herewith. The Parties intend that each representation, warranty and covenant contained herein shall have independent significance. If
any Party has breached any representation, warranty or covenant contained herein in any respect, the fact that there exists another representation,
warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) that the Party has not breached
shall not detract from or mitigate the fact that the Party is in breach of the first representation, warranty or covenant. The word &ldquo;including&rdquo;
shall mean &ldquo;including without limitation&rdquo; regardless of whether such words are included in some contexts but not others.
The use in this Agreement of the masculine pronoun in reference to a Party shall be deemed to include the feminine or neuter, as the
context may require.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The headings, if any, of the individual
sections of each of the Schedules are inserted for convenience only and will not be deemed to constitute a part thereof or a part of
the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 94; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10
<U>Captions</U>. The captions used in this Agreement are for convenience of reference only and do not constitute a part of this Agreement
and shall not be deemed to limit, characterize or in any way affect any provision of this Agreement, and all provisions of this Agreement
shall be enforced and construed as if no caption had been used in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">10.11
<U>Entire Agreement</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Except as otherwise provided
in this Agreement, this Agreement, the Ancillary Agreements and the Confidentiality Agreement constitute the entire agreement between
the parties with respect to the subject matter of this Agreement and supersede all prior agreements and understandings, both oral and
written, between the parties with respect to the subject matter of this Agreement<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">10.12
<U>Counterparts</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement may be executed
in two (2) or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same
instrument. Counterparts may be delivered via electronic mail (including pdf or any electronic signature complying with the U.S. federal
ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been
duly and validly delivered and be valid and effective for all purposes<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13
<U>Choice of Law; Consent to Jurisdiction</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The law of the State of Delaware shall govern this Agreement, the interpretation and enforcement of its terms and any claim or cause
of action (in law or equity), controversy or dispute arising out of or related to it or its negotiation, execution or performance, whether
based on contract, tort, statutory or other law, in each case without giving effect to any conflicts-of-law or other principle requiring
the application of the law of any other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each of the Parties hereto hereby irrevocably and unconditionally consents to submit to the sole and exclusive jurisdiction of the courts
of the State of Delaware and of the United States District Court for the District of Delaware, in each case, located in the State of
Delaware (the &ldquo;<U>Chosen Courts</U>&rdquo;) for any litigation arising out of or relating to the this Agreement and the Ancillary
Agreements, or the negotiation, validity or performance of the this Agreement and the Ancillary Agreements, or the transactions contemplated
hereby and thereby (and agrees not to commence any litigation relating thereto except in such courts), waives any objection to the laying
of venue of any such litigation in the Chosen Courts and agrees not to plead or claim in any Chosen Court that such litigation brought
therein has been brought in any inconvenient forum. Each of the Parties hereto agrees that service of process may also be made on such
party by prepaid certified mail with a proof of mailing receipt validated by the United States Postal Service constituting evidence of
valid service. Service made pursuant to the preceding sentence above shall have the same legal force and effect as if served upon such
party personally within the Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14
<U>WAIVER OF JURY TRIAL</U>. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY AND ANY ACTION, PROCEEDING
OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT, OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF ANY PARTY
IN NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 95; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">10.15
<U>Parties in Interest</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No provision of this Agreement
is intended to confer upon any Person other than the Parties any rights or remedies hereunder; <U>provided however</U>, that the following
Persons are expressly intended as third party beneficiaries with respect to the following specified sections of this Agreement and will
have the right to enforce such specified sections against the parties to this Agreement: with respect to <U>Section 2</U>, the Company
Securityholders and, with respect to Additional Per Share Consideration only, the holders of the Promised Options; with respect to <U>Section
5.11</U>, the D&amp;O Indemnified Persons; and with respect to <U>Section 8</U>, the Persons who are the beneficiaries of rights and
limitations under such Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">10.16
<U>Press Releases and Announcements; Confidentiality</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Parties shall agree upon a mutually acceptable press release or other public announcement (including in any trade journal or other publication)
of or related to the Contemplated Transactions. No Party shall make any other press release or public announcement of this Agreement,
the Ancillary Agreements, or the Contemplated Transactions without the prior written consent of the Securityholders&rsquo; Representative
(in case of disclosure by the Buyer Parties at any time or by the Company on or after the Closing) or by Parent (in case of disclosure
by any Company Securityholder at any time or by the Company on or prior to the Closing), except for any SEC filings or other filings
required by applicable Law (<U>provided</U>, that the Party required to make any such filing will have afforded the other parties, for
a reasonable period prior to the making of such filing, a reasonable opportunity to review and comment upon the intended form and substance
of such filing). No public disclosure of the identities of the Company Securityholders will be made by the Company or any Buyer Party
or any of their respective Subsidiaries prior to, at or after the Closing, without the consent of the Securityholders&rsquo; Representative,
except to the extent required by applicable Law (<U>provided</U>, the party required to make any such disclosure will have afforded the
Securityholders&rsquo; Representative, for a reasonable period prior to the making of such disclosure, a reasonable opportunity to review
and comment upon the intended form and substance of such disclosure)<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">10.17
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Consent to Representation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Effective as of the Closing, Parent and Buyer hereby waive and agree not to assert, and Parent and Buyer agree to cause the First Merger
Surviving Entity, the Second Merger Surviving Entity, and each their respective Subsidiaries to waive and not to assert, any conflict
of interest arising out of or relating to any representation after the Closing of the Securityholders&rsquo; Representative, any Company
Securityholder, any of their respective Affiliates, any officer, employee or director of the Securityholders&rsquo; Representative, the
Company, or any of its subsidiaries, or any Company Securityholder (any such Person, a &ldquo;<U>Designated Person</U>&rdquo;) in any
matter involving this Agreement or any agreement, certificate, instrument or other document executed or delivered pursuant to this Agreement,
the Ancillary Agreements, or any transaction contemplated hereby or thereby (including any litigation, arbitration, mediation or other
proceeding and including any matter regarding the negotiation, execution, performance or enforceability hereof or thereof) (each such
matter, an &ldquo;<U>Applicable Matter</U>&rdquo;) by Goodwin Procter LLP and any other legal counsel currently representing any Designated
Person in connection with this Agreement, any Ancillary Agreement, any agreement, certificate, instrument or other document executed
or delivered pursuant thereto, or any transaction contemplated hereby or thereby (including the negotiation, execution or performance
hereof or thereof) (the &ldquo;<U>Current Representation</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 96; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Effective as of the Closing, Parent and Buyer hereby agree not to control or assert, and Parent and Buyer agree to cause the First Merger
Surviving Entity, the Second Merger Surviving Entity, and each their respective Subsidiaries not to control or assert, any attorney-client
privilege, work product protection or other similar privilege or protection applicable to any communication between any legal counsel
and any Designated Person during the Current Representation in connection with any Applicable Matter (&ldquo;<U>Privileged Deal Communications</U>&rdquo;),
and agrees not to use or rely on, and to cause the First Merger Surviving Entity, the Second Merger Surviving Entity, and each their
respective Subsidiaries not to use or rely on, any such communications, in each case in connection with any Applicable Matter, including
in connection with a dispute with Parent, the First Merger Surviving Entity, the Second Merger Surviving Entity, or any of their respective
Affiliates (including, after the Closing, the Company and each of its Subsidiaries), it being the intention of the parties hereto that,
notwithstanding anything to the contrary in this Agreement or Section 259 of the DGCL, all rights of any Person under or with respect
to such attorney-client privilege, work product protection or other similar privilege or protection applicable to such Privileged Deal
Communications, including the right to waive, assert and otherwise control such attorney-client privilege, work product protection or
other similar privilege or protection, shall be (and are hereby) transferred to or retained by (as applicable), and vested solely in,
such Designated Person; <U>provided</U>, <U>however</U>, that any such privilege or protection applicable to such Privileged Deal Communications
that would be transferred to or retained by (as applicable), or vested solely in, the Company and its Subsidiaries in accordance with
the foregoing shall, upon the Closing, be transferred to or retained by (as applicable) and vested solely in the Securityholders&rsquo;
Representative. Parent agrees to the take the steps necessary, and to cause Buyer, the First Merger Surviving Entity, the Second Merger
Surviving Entity, and each their respective Subsidiaries to the take the steps necessary, to ensure that any such attorney-client privilege,
work product protection or similar privilege or protection applicable to such Privileged Deal Communications shall survive the Closing,
remain in effect and be afforded the treatment described in the immediately preceding sentence. Further, Parent and Buyer agree that
they will not, and that they will cause the First Merger Surviving Entity, the Second Merger Surviving Entity, and each their respective
Subsidiaries not to, knowingly and purposefully, (i) access or use the Privileged Deal Communications, including by way of review of
any electronic data, communications or other information, or by seeking to have the Securityholders&rsquo; Representative or any Seller
waive the attorney-client or other privilege applicable to such Privileged Deal Communications, or by otherwise asserting that Parent
or any Surviving Entity has the right to waive the attorney-client or other privilege or (ii) seek to obtain the Privileged Deal Communications
from Goodwin Procter LLP. In furtherance of the foregoing, it shall not be a breach of any provision of this Agreement if prior to the
Closing the Company, the Securityholders&rsquo; Representative and/or any Company Securityholder, or any of their respective directors,
officers employees or other representatives, takes any action to protect from access or remove from the premises of the Company (or any
offsite back-up or other facilities) any Privileged Deal Communications, including by segregating, encrypting, copying, deleting, erasing,
exporting or otherwise taking possession of any Privileged Deal Communications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">10.18
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Further Assurances</U><FONT STYLE="color: windowtext">.
</FONT>Upon the request of Parent or the Securityholders&rsquo; Representative, each of the parties hereto will do, execute, acknowledge
and deliver all such further acts, assurances, deeds, assignments, transfers, conveyances, and other instruments and papers as may be
reasonably required or appropriate to carry out the Contemplated Transactions<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">10.19
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Release</U><FONT STYLE="color: windowtext">. </FONT>Effective
as of the First Merger Effective Time, provided that the applicable Company Securityholder has been paid the applicable amounts contemplated
by <U>Section 2.6</U>, if any, payable to such Company Securityholder, each such Company Securityholder, on behalf of himself, herself
or itself and his, her or its Affiliates:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Forever waives, releases, remises and discharges the First Merger Surviving Entity, the Second Merger Surviving Entity and their predecessors,
successors, Affiliates, stockholders, directors, officers, employees, consultants, attorneys, agents, assigns and employee benefit plans
(the &ldquo;<U>Released Buyer Parties</U>&rdquo;) from any claim or Liability with respect to any event occurring at or prior to the
First Merger Effective Time, except for any Liability, rights, or claims (i) arising under this Agreement, any of the Ancillary Agreements,
or any New Hire Documents, or (ii) unrelated to the Company, the business of the Company or any Contemplated Transaction (collectively,
the &ldquo;<U>Released Holder Claims</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 97; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Acknowledges that it may hereafter discover facts other than or different from those that it knows or believes to be true with respect
to the subject matter of the Released Holder Claims, but it hereby expressly agrees that, on and as of the First Merger Effective Time,
such Company Securityholder shall have waived and fully, finally and forever settled and released any known or unknown, suspected or
unsuspected, asserted or unasserted, contingent or noncontingent claims with respect to the Released Holder Claims, without regard to
the subsequent discovery or existence of such different or additional facts;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Acknowledges and agrees that if it should hereafter make any claim or demand or commence or threaten to commence any Legal Proceeding
against any Released Buyer Party with respect to any Released Holder Claim, this <U>Section 10.19</U> may be raised as a complete bar
to any such Legal Proceeding, and the applicable Released Buyer Party may recover from such Company Securityholder all costs incurred
in connection with such Legal Proceeding, including attorneys&rsquo; fees; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Waives any rights such Company Securityholder may have as a holder of Company Capital Stock, Company Options or Company Warrants or other
direct or indirect ownership interests in the Company or any of its Subsidiaries or arising from or relating to the transfers or transactions
contemplated hereby (including any voting rights, preemptive rights, rights to repurchase, registration rights, rights of first refusal
or similar rights or restrictions on transfer and any rights to receive notices, opinions or similar documentation in advance of or in
connection with such transfers or transactions, except as expressly contemplated in this Agreement or in any Ancillary Agreement), whether
such rights arise under or pursuant to the Charter Documents of the Company, any Contracts or applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">10.20
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Lock-Up</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
In connection with, and as an inducement to, the Buyer Parties entering into this Agreement and for other good and valuable consideration
the receipt and sufficiency of which is hereby acknowledged, each Company Securityholder agrees with the Buyer Parties that, without
the prior written consent of Parent, during the period commencing at the First Merger Effective Time and continuing until the end of
the Lock-Up Period (as hereinafter defined), such Company Securityholder will not: (1) offer, pledge, sell, contract to sell, sell any
option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, make any short
sale or otherwise transfer or dispose of or lend, directly or indirectly, any shares of Parent Common Stock or any securities convertible
into, exercisable or exchangeable for or that represent the right to receive Parent Common Stock by such Company Securityholder (including
without limitation, Parent Common Stock which may be deemed to be beneficially owned by such Company Securityholder in accordance with
the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon exercise of a stock option
or warrant) (the &ldquo;<U>Securities</U>&rdquo;); (2) enter into any swap or other agreement that transfers, in whole or in part, any
of the economic consequences of ownership of the Securities, whether any such transaction described in clause (1) or (2) above is to
be settled by delivery of Parent Common Stock or such other securities, in cash or otherwise; (3) make any demand for or exercise any
right with respect to, the registration of any Parent Common Stock or any security convertible into or exercisable or exchangeable for
Parent Common Stock; (4) grant any proxies or powers of attorney with respect to any Securities, deposit any Securities into a voting
trust or enter into a voting agreement or similar arrangement or commitment with respect to any Securities; or (5) publicly disclose
the intention to do any of the foregoing (each of the foregoing restrictions, the &ldquo;<U>Lock-Up Restrictions</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Lock-Up Restrictions shall automatically terminate and cease to be effective on the date that is the one (1) year anniversary of
the First Merger Effective Time. The period during which the Lock-Up Restrictions apply to the Securities shall be deemed the &ldquo;<U>Lock-Up
Period</U>&rdquo; with respect thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 98; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Such Company Securityholder agrees that the Lock-Up Restrictions preclude such Company Securityholder from engaging in any hedging or
other transaction with respect to any then-subject Securities which is designed to, or which reasonably could be expected to lead to
or result in, a sale or disposition of such Securities even if such Securities would be disposed of by someone other than such Company
Securityholder. Such prohibited hedging or other transactions would include without limitation any short sale or any purchase, sale or
grant of any right (including without limitation any put or call option) with respect to such Securities or with respect to any security
that includes, relates to, or derives any significant part of its value from such Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Notwithstanding anything to the contrary in this <U>Section 10.20</U>, to the extent permitted by the terms of the Securities, such Company
Securityholder may transfer any of the Securities (i) as a <I>bona fide</I> gift or gifts or charitable contribution(s), (ii) to any
trust for the direct or indirect benefit of such Company Securityholder or the immediate family of such Company Securityholder, (iii)
if such Company Securityholder is a corporation, partnership, limited liability company, trust or other business entity (1) to another
corporation, partnership, limited liability company, trust or other business entity that is a direct or indirect affiliate (as defined
in Rule 405 promulgated under the Securities Act) of such Company Securityholder or (2) as distributions of shares of Parent Common Stock
or any security convertible into or exercisable for Parent Common Stock to limited partners, limited liability company members or stockholders
of such Company Securityholder or holders of similar equity interests in such Company Securityholder, (iv) if such Company Securityholder
is a trust, to the beneficiary of such trust, (v) by testate succession or intestate succession, (vi) to any immediate family member,
any investment fund, family partnership, family limited liability company or other entity controlled or managed by such Company Securityholder,
(vii) to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through
(vi), (viii) to Parent in a transaction exempt from Section 16(b) of the Exchange Act upon a vesting event of the Securities or upon
the exercise of options or warrants to purchase Parent Common Stock on a &ldquo;cashless&rdquo; or &ldquo;net exercise&rdquo; basis or
to cover tax withholding obligations of such Company Securityholder in connection with such vesting or exercise (but for the avoidance
of doubt, excluding all manners of exercise that would involve a sale in the open market of any securities relating to such options or
warrants, whether to cover the applicable aggregate exercise price, withholding tax obligations or otherwise), (ix) acquired by such
Company Securityholder in open market transactions after the First Merger Effective Time, (x) pursuant to a bona fide third party tender
offer, merger, consolidation or other similar transaction made to all holders of Parent&rsquo;s capital stock involving a change of control
of Parent, provided that in the event that such tender offer, merger, consolidation or other such transaction is not completed, the Securities
shall remain subject to the restrictions contained in this Agreement, or (xi) pursuant to an order of a court or regulatory agency; <U>provided</U><I>,
</I>in the case of clauses (i)-(vii), that (A) such transfer shall not involve a disposition for value and (B) the transferee agrees
in writing with Parent to be bound by the terms of this <U>Section 10.20</U>; and <U>provided</U><I>, </I><U>further</U>, in the case
of clauses (i)-(x), no filing by any party under Section 16(a) of the Exchange Act shall be required or shall be made voluntarily in
connection with such transfer. For purposes of this Agreement, &ldquo;immediate family&rdquo; shall mean any relationship by blood, marriage
or adoption, not more remote than first cousin.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 99; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
In addition, the foregoing restrictions shall not apply to (i) the exercise of stock options granted pursuant to equity incentive plans
existing immediately following the First Merger Effective Time, including the &ldquo;net&rdquo; exercise of such options in accordance
with their terms and the surrender of Parent Common Stock in lieu of payment in cash of the exercise price and any tax withholding obligations
due as a result of such exercise (but for the avoidance of doubt, excluding all manners of exercise that would involve a sale in the
open market of any securities relating to such options, whether to cover the applicable aggregate exercise price, withholding tax obligations
or otherwise); <U>provided</U>, that it shall apply to any of the Securities issued upon such exercise, (ii) conversion or exercise of
warrants into Parent Common Stock or into any other security convertible into or exercisable for Parent Common Stock that are outstanding
as of the First Merger Effective Time (but for the avoidance of doubt, excluding all manners of conversion or exercise that would involve
a sale in the open market of any securities relating to such warrants, whether to cover the applicable aggregate exercise price, withholding
tax obligations or otherwise); <U>provided</U>, that it shall apply to any of the Securities issued upon such conversion or exercise;
(iii) the establishment of any contract, instruction or plan (a &ldquo;<U>Plan</U>&rdquo;) that satisfies all of the requirements of
Rule 10b5-1(c)(1)(i)(B) under the Exchange Act; <U>provided</U>, that no sales of the Securities shall be made pursuant to such a Plan
prior to the expiration of the Lock-Up Period, and such a Plan may only be established if no public announcement of the establishment
or existence thereof and no filing with the Securities and Exchange Commission or other regulatory authority in respect thereof or transactions
thereunder or contemplated thereby, by such Company Securityholder, Parent or any other person, shall be required, and no such announcement
or filing is made voluntarily, by such Company Securityholder or any other person, prior to the expiration of the applicable Lock-Up
Period, or (iv) to a bona fide pledge of Securities that creates a mere security interest in the pledged Securities, <U>provided</U>,
that the pledgee thereof agrees in writing in advance to be bound by and comply with all applicable provisions of this Agreement to the
same extent as if it were the Company Securityholder making such pledge and no filing by any party under Section 16(a) of the Exchange
Act shall be required or shall be made voluntarily in connection with such pledge. In furtherance of the foregoing, Parent and its transfer
agent and registrar are hereby authorized to decline to make any transfer of shares of Parent Common Stock if such transfer would constitute
a violation or breach of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
For the avoidance of doubt, notwithstanding anything herein to the contrary, in the event of any conflict or inconsistency between the
terms and provisions of this <U>Section 10.20</U> and the terms and provisions of any Continuing Employee Agreement, the terms and provisions
of the Continuing Employee Agreement shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * *</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 100; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the Parties has executed this Agreement as of the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRECISION
    HEALING INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    W. David Lee</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">W.
    David Lee</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PARENT</B>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SANARA
    MEDTECH INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael D. McNeil </I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    D. McNeil </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BUYER</B>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNITED
    WOUND AND SKIN SOLUTIONS, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael D. McNeil </I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    D. McNeil </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MERGER SUB I:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PH
    MERGER SUB I, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael D. McNeil</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    D. McNeil </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MERGER
    SUB II:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PH
    MERGER SUB II, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael D. McNeil</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    D. McNeil </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITYHOLDERS&rsquo;
    REPRESENTATIVE:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FURNEAUX
    CAPITAL HOLDCO, LLC (DBA BLUEIO)&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dave Furneaux</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dave
    Furneaux</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 101; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 77px; width: 230px"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Sanara
MedTech Inc. Announces Entry into Merger Agreement to Acquire Precision Healing Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>FORT
WORTH, TX / GlobeNewswire / April 4, 2022 / Sanara MedTech Inc</B>. Based in Fort Worth, Texas, Sanara MedTech Inc. (&ldquo;Sanara,&rdquo;
the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; or &ldquo;us&rdquo;) (NASDAQ: SMTI), a provider of products and technologies
for surgical and chronic wound care dedicated to improving patient outcomes, announced today that it has entered into a definitive agreement
and plan of merger with Precision Healing Inc. (&ldquo;Precision Healing&rdquo;), pursuant to which Precision Healing will merge with
and into a wholly owned subsidiary of Sanara. The transaction has been approved by the boards of directors of both companies,
received the requisite approval of Precision Healing stockholders and is expected to close today, subject to satisfaction of customary
closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #26282A"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #26282A; background-color: white">Ron
Nixon, Sanara&rsquo;s Executive Chairman, stated,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;We
have been the exclusive license holder of Precision Healing&rsquo;s technology in the healthcare industry in the U.S. as well as an investor
in the company since 2020. Since that time, the Precision Healing team has continued to develop what we believe will be innovative and
disruptive technologies for the diagnosis of chronic wounds. When completed, we expect that Precision Healing&rsquo;s multispectral imager
and <FONT STYLE="color: #26282A">biomarker assay </FONT>will help patients obtain an early, accurate diagnosis and receive appropriate
treatments more quickly than the current standard of care. We expect that the technologies will also allow physicians and clinicians
to easily assess treatment protocols through proprietary algorithms developed by Precision Healing and put the Company in a position
to partner with value-based care providers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Transaction
Details</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Prior
to this transaction, Sanara owned 25.7% of Precision Healing on a fully diluted basis. The purchase price for this transaction consists
of approximately $5.1 million in stock and cash consideration, the assumption of outstanding options and warrants of Precision Healing
and certain earnout obligations, valuing Precision Healing&rsquo;s equity (excluding shares of Precision Healing held by Sanara and
net of the exercise price of options and warrants assumed  by Sanara) at approximately $7.8 million before the earnout consideration.
The majority of the consideration will be paid by Sanara in stock with a limited number of non-accredited investors receiving cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Concurrent
with the closing of this transaction, Sanara is expected to enter into employment agreements with all key Precision Healing employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Precision
Healing Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
concept for the Precision Healing imager was originally inspired by the team&rsquo;s personal experiences and recognition that wound
care did not utilize diagnostics of the key tissue and biomolecular characteristics in its treatment protocols. With a proven record
of novel diagnostic technology development, as well as significant experience commercializing innovative medical technology, the team
is well positioned to address this problem.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Since
the initial development of the imager and assay, Precision Healing&rsquo;s technology has undergone clinical studies at Brigham and Women&rsquo;s
Hospital (a Harvard teaching hospital) and the University of Miami. The studies have shown compelling patient data that the multispectral
imager and biomarker assay can provide data for key wound characteristics in real-time that can guide clinical treatments for faster
healing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Precision Healing imager 510(k) is being prepared for submission to the FDA and is expected to be filed before the end of Q3 2022, with
the biomarker assay being filed in parallel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Precision
Healing Key Differentiators</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
believe the Precision Healing imager and assay will be differentiated from existing imagers available to clinicians in the following
ways:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
    imager is an advancement beyond existing imaging technology used to determine the underlying causes of stalled healing and provides
    clinically actionable metrics.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
    Precision Healing multispectral imager operates on an advanced wound biology algorithm. The algorithm core is a data-driven, machine
    learning subsystem which was generated from a comprehensive set of advanced clinical measurements of 15 biomarkers, 9 tissue characteristics,
    extensive microbiology and pathology results, along with standard clinical wound metrics. This is expected to help the Company create
    a unique, proprietary, and comprehensive library of wound care data.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Other
    systems rely exclusively on retrospective analysis of traditional clinical observations, which by their nature only yield traditional
    healing results. The Precision Healing approach brings together the science of tissue biology, advanced spectroscopy (optics) and
    bedside molecular assay, with the aim of changing the paradigm of wound assessment.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Strategic
Rationale</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">When
commercially available following receipt of regulatory approval, the Precision Healing imager and assay are expected to be the final
components needed to complete the initial iteration of Sanara&rsquo;s technology platform and comprehensive wound and skin offering.
The imager is intended to be integrated with Sanara&rsquo;s proprietary EMR system and virtual consult capability, giving the Company
the ability to diagnose, treat, track, collect, and further analyze data on the healing progression of wounds across
the continuum of care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
believe that data collected by the Precision Healing platform will help clinicians to rapidly and accurately diagnose the root cause
of a patient&rsquo;s wound and develop tailored treatment protocols that can be adjusted as more information is gathered. Additionally,
the platform is expected to allow the Company to develop evidence-based treatment algorithms to help improve clinical practice guidelines
compared to the current standard of care. Sanara expects that this will allow it to treat wounds more effectively at a lower cost while
improving outcomes and positioning the Company to partner with value-based care providers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">W.
David Lee, Precision Healing&rsquo;s CEO, stated, &ldquo;We started Precision Healing because we identified a need to use technology
to diagnose and treat wounds more efficiently than the current standard of care. By pairing our diagnostic technology with Sanara&rsquo;s
products, EMR, and virtual consult capabilities we believe we are setting the stage to dramatically improve wound healing rates while
lowering costs. Speaking for the entire Precision Healing team, we are excited for this next step in the evolution of our company and
technologies.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Advisors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Haynes
and Boone, LLP served as legal counsel to Sanara and Goodwin Procter LLP served as served as legal counsel to Precision Healing in this
transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>About
Sanara MedTech Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">With
a focus on improving patient outcomes through evidence-based healing solutions, Sanara MedTech Inc. markets, distributes and develops
wound and skincare products for use by physicians and clinicians in hospitals, clinics, and all post-acute care settings and offers wound
care and dermatology virtual consultation services via telemedicine. Sanara&rsquo;s products are primarily sold in the North American
advanced wound care and surgical tissue repair markets. Sanara MedTech markets and distributes CellerateRX&reg; Surgical Activated Collagen&reg;,
FORTIFY TRG&trade; Tissue Repair Graft and FORTIFY FLOWABLE&trade; Extracellular Matrix to the surgical markets as well as the following
products to the wound care market: BIAK&Omacr;S&trade; Antimicrobial Skin and Wound Cleanser, BIAK&Omacr;S&trade; Antimicrobial Wound
Gel, BIAK&Omacr;S&trade; Antimicrobial Skin and Wound Irrigation Solution and HYCOL&trade; Hydrolyzed Collagen. Sanara&rsquo;s pipeline
also contains potentially transformative product candidates for mitigation of opportunistic pathogens and biofilm, wound re-epithelialization
and closure, necrotic tissue debridement, and cell compatible substrates. The Company believes it has acquired the ability to drive its
pipeline from concept to preclinical and clinical development while meeting quality and regulatory requirements. Sanara is constantly
seeking long-term strategic partnerships with a focus on products that improve outcomes at a lower overall cost. In addition, Sanara
is actively seeking to expand within its six focus areas of wound and skincare for the acute, post-acute, and surgical markets. The focus
areas are debridement, biofilm removal, hydrolyzed collagen, advanced biologics, negative pressure wound therapy adjunct products, and
the oxygen delivery system segment of the healthcare industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Information
about Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
statements in this press release that do not constitute historical facts are &ldquo;forward-looking statements,&rdquo; within the meaning
of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements may be identified
by terms such as &ldquo;aim,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believe,&rdquo; contemplate,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predicts,&rdquo;
&ldquo;preliminary,&rdquo; &ldquo;project,&rdquo; &ldquo;seek,&rdquo; &ldquo;target,&rdquo; &ldquo;should,&rdquo; &ldquo;will&rdquo;
or &ldquo;would, or the negatives of these terms, variations of these terms or other similar expressions. These forward-looking statements
include statements regarding the expected timetable for closing the proposed transaction, the potential benefits created by the proposed
transaction, the anticipated impact of the proposed transaction on Sanara&rsquo;s business and future financial and operating results,
the retention of key personnel from Precision Healing, the development of new products, including the Precision Healing imager and assay,
and expansion of the Company&rsquo;s business in telehealth and wound care. These items involve risks, contingencies and uncertainties
such as our ability to satisfy the closing conditions for and consummate the merger on the expected timeline or at all, the ability to
integrate and retain key personnel from Precision Healing, uncertainties associated with the development and process for obtaining regulatory
approval for new products, the extent of product demand, market and customer acceptance, the effect of economic conditions, competition,
pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company&rsquo;s
SEC filings, which could cause the Company&rsquo;s actual operating results, performance or business plans or prospects to differ materially
from those expressed in, or implied by these statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All
forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to revise any of
these statements to reflect the future circumstances or the occurrence of unanticipated events, except as required by applicable securities
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Investor
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Callon
Nichols, Director of Investor Relations</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">713-826-0524</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">CNichols@sanaramedtech.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>SOURCE:
Sanara MedTech Inc</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "P @X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4**** "B
MBB@ HHHH 2EH-9NC:[:Z_;S36C2-'#/);OYD31G>C%6 # 9&1U'![&G9[D.2
M3Y7N:5%%(&!Z'-(L&8+R>!2UF^(3IO\ 8E^NL/!%I3PNETURX2/RR,-N8]!@
MGJ:?HK6']DV?]EM"^FK$HMVMV#1^6 -NTC@C&,8JK:7(YO>Y274-1M-*LYKJ
M^N8;2TB7=)-.X1$'J2> *K>'=(T[0]'@M-)C6*P&Z2-4<N#O8L6W$G.2Q/XU
MC?$SX>Z=\4/"-SX?U.>XM[:9D?S;9PKJRL".H((R.A!_K6IX2\,VO@WPWINB
M6+2-:6,"P1-,VYRJC R?7Z<>F*T]SV6CUOMT.5>T>)=X+E2T?6]]5;L;%%%%
M8G:%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 )7F6A?$?Q-J7QDU?PM<^%Y;30+2'S(=69
M7"R'"8^;&TYW'@'(VGWKTWG/6N8^)'BJ7P/X&UO7H+0WDUC;/,D(S\Q XSCL
M.I/8 UT4;-\G+=RT7DSS\8G&*J^T<5#5V5[I+5'45YQXN^-FD>#?B/H'@Z[L
M[R:^U<(4GAC!CCWN43=SGJIS@<#!-<O^S7\=-6^,D&N)JVF0VDVGM&4N+7<(
MY ^[Y<,3@C;GK_%T'?OOB=XV\,?"WPI?>-/%+1V]AH\1<W7D^9*NXA0D8Z[G
M8JN!ZBMI8=X:LZ-:-WV3ZO8Y:>,6982.)P<^5-[M=$]5;Y'1ZS'=SZ3>II\B
MPWSPNL$CC(60@A21Z XKYZ_9K\#_ !0\,>-M;N?&4MX-*E@9=MU>B<2W!D4A
MU4,<84-DX'4?AZ!\!OVC/!O[1OA^_P!5\(SW12PG$%S;7T/E31$C*D@$@AAG
M!!/0CM7C7CS]O:U\)?$J]T.U\--?Z-I]TUI<WAN-DSLC%7,:8(P"#@$\X[5V
M8.CBJD:N&I4[M[WW1Y^:3P-.KA\;B*SCRMVL]'?NCZ,^)_P]TWXJ>"=1\,ZK
M+<06=Z%W2VS!9$*N&4C((ZJ.HJ;X=>![#X;>#-*\,Z9)-+9:?%Y<<EPP:1OF
M+%F( Y))Z "O./VFK7QEXQ^#<,WPZGNA>330W$HL93%/-:E&)"$8.<F,X!Y
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M_&-_A+_86S0;G7/[4N3;_P"COL\L\<?=.6.>%XS@\\5Z,T:7,)21 T;KAD8
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MO[QMXO\ B?H/PJ\6:E926?AN]TF4+%%DP+?K/(LIYZ;HUB9<]LX)P32^./\
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MQZ.#IX7+U#!8:-HV;6[7W_,]'HHHKB/7"BBB@ K\O_\ @KC#>K\1O 4TA/\
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M)\N3@_(QS\IQN&#7=_"W_@HK\8?AGIL6G3:E:>++&+B--?B::55]/-5E<_\
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M'#6]_P $A?\ D _$W_KYL/\ T">L'_@KQ_R'OAKS_P NU]_Z'#6]_P $A?\
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MDL5?M77XJ?\ !08_\9;^.?\ >M?_ $EBKRLG_COT_P CU<X_@1]3]+/V"?\
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MJ^-_CC^Q'_PG7[0VOV_@+QYX3E;5[^6[DTN^O6AN+261B\D0"HPD"DL<*=P
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M\%?&?Q@U+6K'QKJ\FGA(9-%E+V?EF152*.3^/?*8]SXXVC X.?)OAG_P5/\
M&\WQ$L%\8Z3HK^%;JY2*X33[>1)K2-CM,B,9&W%<AB&'.#C%1_\ !-GP/?\
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M<[A+@@+D;5XP:;^Q+X+D_8_L/$GQ'^,EV? 6GZK#'I>GZ?J"LUQ<$-YC/Y*
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M[-?_ "0_PI_U['_T-JR/C7^TEH_PENDTN"V;6M?D7=]BADVK#G&WS&YP3G@
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M45V6B%HHHJ38**** "O(_P!J[_D@_B/ZV_\ Z/CKURO(_P!J[_D@_B/ZV_\
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; 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>smti-20220330.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaCEKbP9z5Z86ekhvWBybUn6LyovZcsrsCO/IlKmQesA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:SMTI="http://sanaramedtech.com/20220330" elementFormDefault="qualified" targetNamespace="http://sanaramedtech.com/20220330">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://sanaramedtech.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="smti-20220330_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="smti-20220330_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>smti-20220330_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>smti-20220330_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sanaramedtech.com/role/Cover" xlink:href="smti-20220330.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sanaramedtech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140309228185016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  01,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANARA
    MEDTECH INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000714256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">59-2219994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1200
    Summit Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fort
    Worth<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">76102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(817)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">529-2300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SMTI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="smti-20220330.xsd" xlink:type="simple"/>
    <context id="From2022-04-01to2022-04-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000714256</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-04-01to2022-04-01">0000714256</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-04-01to2022-04-01">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-04-01to2022-04-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-04-01to2022-04-01">2022-04-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-04-01to2022-04-01">SANARA     MEDTECH INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-04-01to2022-04-01">TX</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-04-01to2022-04-01">001-39678</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-04-01to2022-04-01">59-2219994</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-04-01to2022-04-01">1200     Summit Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-04-01to2022-04-01">Suite 414</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-04-01to2022-04-01">Fort     Worth</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-04-01to2022-04-01">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-04-01to2022-04-01">76102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-04-01to2022-04-01">(817)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-04-01to2022-04-01">529-2300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-04-01to2022-04-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-04-01to2022-04-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-04-01to2022-04-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-04-01to2022-04-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-04-01to2022-04-01">Common     Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-04-01to2022-04-01">SMTI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-04-01to2022-04-01">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-04-01to2022-04-01">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " !$-(14!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $0TA%3.9"&>
M[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( $0TA%297)PC$ 8  )PG   3              "  <T!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 1#2$5/-?L&9-!   V!
M !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( $0TA%2?H!OPL0(  .(,   -              "  9$,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ 1#2$5)>*NQS     $P(   L
M         ( !;0\  %]R96QS+RYR96QS4$L! A0#%     @ 1#2$5*K$(A8S
M 0  (@(   \              ( !5A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( $0TA%0D'INBK0   /@!   :              "  ;81  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( $0TA%1ED'F2&0$
M ,\#   3              "  9L2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  .43      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sanaramedtech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex2-1.htm</File>
    <File>ex99-1.htm</File>
    <File>smti-20220330.xsd</File>
    <File>smti-20220330_lab.xml</File>
    <File>smti-20220330_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "smti-20220330_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "smti-20220330_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "smti-20220330.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "SMTI",
   "nsuri": "http://sanaramedtech.com/20220330",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-04-01to2022-04-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://sanaramedtech.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-04-01to2022-04-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001493152-22-008931-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-008931-xbrl.zip
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M\F1.\7$!?X#5P[L;'6T9]-DWVQT./@KM"63#77)G[^&6;O83) S1.W&:H*;
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M!5659%9>(;P(PXP!SLP,+' $CGS)>UUZ(:QE+E5$[:J>:J0FQFOW,=Q_1B
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MZG'6<-.I.=?\P\^J -*&PP?GCI>*G9HM,IH+B1EV>:2YI(3H:TM5T"%SUGK
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MR$#6\VEU05)%@3:VU(-HGUM2=1%,+TSG?S2%@HGV*M'()8-I?U@\0DO 55C
M*6X[B_%"!OJ.U5).Q.(<%(/OI[A BM8+S(/8I!BE#!7GLG]_85+[O>^<U9N$
M_@-/JA7I2A0V*GGJ][ ++$ :"X[(&GQ(P32A8CZ(=K<IC_"^4./)4&V :_Q(
M)F7R1'X%S<.EF?Z)-8[@V TD9.T(JH\^7')_)V I@*H9ZRO?8^FFUUV4&=8
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M*#52KHY0[U\QMR13890J]H?4". NS(M0L*LZX@:%3(XU5-[]'M/\X"VANAJ
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M7%(2U[$2>2>22F3$(+S8)BR"'G!)I:/Z*A@J$N[4".NX-BV81N>6UJU\!;K
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M.XV2!<\$GI@)Z[S*2;$,&-C=+M9ZP ZL-@0I'9H,PK9X&":44N)^F9D,2L3
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M4&BJ3)K!Y8+)D@AS X>$,H5\(^(C2S,F$Z.+QH?A\,1GQP"=7T25F69SD^3
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MJ%@55X@!:R@-3)$J*A<#)B?Z'^QOBZQ$7FCZ#LXB&'N)R;=E@DSXW"PE3$[
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M;9O_\Q>]YK_\74^O5_?F'\;NS4?MWGSQ>.S>?*_2+IM:DJ>6Y?"Z:K.)\F6
MO8=W'83Z3!=P_=[7='<,TA5*)7?TNS@-(QS9XS@]JG;X0W7+G4XNSKQ/_WSM
M_?;ZPS]>?RA>>*]__?7URT_>NU_M7WOO?J<?7[[[[?WE[__/>WGY_LVGR[<P
MF'<O_\]__NV/<65M20RC9993E/IG+\W2Z/NV%W<7X5]54<:K;7T5SIX>5\+
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MT#EHTIL CTN>W<0%G5K1/&A<DSA@C0-(ZF=:$M1,).N\1JQP<XR7AO1C+I1
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M5'4\HYDXK8?N3NTJ/7"SII/&;O7BN=BW6;[KB;];K?!^4/)4O^O(=;G.;F&
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MY$/M-R#=T]R -A&BX3*[8B@-PY>]L((%1[0,[(]$JF] R$/N/;VL\)<])N$
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M.EELD;Z 7:0@S#;JF;AR]><-Y^ ,34_$HB?<^\B<62?!K*&\O@V>4;UKJ%F
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MX=O3-6QCY_G_3?9!FG#O>2YB67_P_ES3AN55-0-?JVQ5?[A974\*L;F@)%K
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MB)<52^SB5+!IZL;RNMBTO-"4P0T_);RP?H_>V)Z?%SLR4(\/&:B[S4#]>,A
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MRJ:Q8&D#XRG89[YD[V!="\P A'!<9='UJ&3+D]S*O<6CW+/4^Y*O_,)53X%
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M85AHH7PB?H$[5CV\:1-8%\$Z*73E91V][8Z-*AQ*>[%9[]G9)"C(W[_D*.%
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MD.#O$D$?FZ&C/3E4OB[)_OB09+_;)/N/AR3[GB?9_P13<?)-0@5!A= 7YU$
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M9%>NJ]4PCOB$?[M1,27#?ZPG%WR%>TT8=8YK(F3D6G Z;!$6>,*R[CD\RH1
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MC$9M"2I,$)MND,]RS4+".6=Z"4EUO#O[6[M\4QRI.LI@$%EJ=]807XRQZX3
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MNUR/G-=DAWCR/5;Q'5;:7:^TB5MIJE,BD[,A+A/-4948T!(P8;RU,.)8S"R
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M2[(1>;OE.,Z9&)@=YGC;-Z+,064"+_\&L_FD2H 1+;PBB("2&24\:Q :"Y_
MPK(_O_7I]] 67[*J1>*>NLD<_\*L3Q-[LR<P1TP+YQ/<_ N.0UY)#VM_*%OH
M/%'P'1GM9F8HH_9_SK%P@QA&FQGY@ZZ^^"6,A^J9-&TT8C/$6E)(G3XM7)NZ
M-J4<;+W;IF$1K=88?"T M\*:K!Z*E@&G&?Y[[V?;8SJX'E^7^K?[FNC]UD0/
M]S71':^)_@D>V^@A>G#.K;/CI_:_ 0^12W6+G'F5&A*CRBY#P.,Z8QHF^;U3
MR\#"!0".60=E[Q&HBWM&$B"'$_L8Z8\#:N:VZN4K'<"MVX84/$\#(Z/S+N8#
M\-8[]")7[-MX$Q\9!]_M] 1J5W<#(M3%D>0A(>9)+B0OW$.T[_4?!K&Z-<AH
MBZN*GLEMT.NQ(@C1IO2D\!<TH+*-(M W=UHFDNCZPO>"CJ&\%'Y82;-P383=
M]-"#6\EY?C%<J7>D[]9]*6)WDPK :$5GZ74ZXZYL=/[LTJ"JO+F^&S/4KDRD
MP^9-*U,RJWF@A^T,S0)LR:-^_$GC'>M1>P@]H59JNZ;*<X/E;I&'XSYF^JP'
M*<P20L%G7M3,:ZP;M\YPG. @BLDS[ILVA-O%;2!'FAHKDGY&Y&?)VF)>FM,Q
M)X?/#PZ_?6R9I]U>X']2AO/;A\EP'@E_8XW@@D\@+L'@F6(.NUH2'M,(9MUZ
MM*-UU!<=!2UD/PY^VG5?A#1/_XI!]Y=1Y^E9A$2PMHT@H(7D-'H=G?[K^,VS
MPQ^B#RP\@,(T')>W0MM0KT@[!-*DF&5<]*;V-<-KXN FFM8@@"HA5(XYRC=F
MAGQ>0TPQN1DJ%_GF@MX&?4/D204T70D!,!.5P;Q9@P6&>";M4J1Q$HB]N*:"
M+S'\>)=U^17,8UWF^80RF#0M2-UXE1#^VWR-R'?0C;G*EJ7.COO.X(56Y.&V
M/#-X-_:AS7CQYJPD+!X6MH5HG2\=7RU@/U[>>H\E*,+&<$PV*9:V1P:153A?
M_$^4'4XOLS&S:BSHES"7*?JZYI]T 8$A\*_AYC.C@LF:C]M,CTUF$N9 N6EN
M!1AWU+?-I7[[4>1T'R6LH" ==M2[:<AML%O%"%BB*IIT-V[=JH6$X48P,^:]
M;)HUU;F7U!SU#O(VPB3 94[NG[\IN=\O^H,;D=!67[P3&0@C)WN/C<Z764WD
M%7L@L[E9<<Q:3>+@_G*SN1"4C"R.A3(FT2]MXY'@A7[<F:/^\?LV?U*=[=X=
MFQ*6YPH7]GP$MI%*5@0[8LV@&7912=I"*<.D-  KW6F== I& F<K&,DU3I89
M,M2QUKRMM&4+V[MF:-L2:R&E=<VQC+507T)YPK![R) U[>F[LG[VV^6ADIS)
M)$?GWN3@;!LW]?11M5)0/UQ[))(,\@S3E2AN%2M<X+,,#HF)M*U/LE+YX''?
M:9I24I"P$7D7J2.(M^*$D=>_D:W6MA705B%X]A?LLP8 :\TV8[7LN71U6Z4+
M'GJWP\>93QZV*VMUOS55Z?K>M^:8O"ZS*^DLDM]1K'6KYTU/.PE&M\A01SXI
MIZ_L0N6:\[(JQE=&[2]"OX[8"T0-+F,;8'>3<(:JGRGA$?/2FH8&UEAQ0CPU
M$@5\76[N*-AAD;W,5</--F<$0T1T2C-I:EBI=OWCM!*[L@6^K+#^W;ZP?K^%
M]1?[POJ^L/[0!]OD(0XV0S&=+:[AU&$5G!$7/XILQ"I"A#<G)Q$[</,E[#J,
MC=#>3BEUYAYE)5/$9VE9.YBP?Q=KWKEXM\RF%$VKQ829O(E"F^DY'NFI N/>
MD26XWW$/);C Z@*TSIH<7M-:KMA)RW$RM)G66#S(4M\7-KW''>5@?1[VF=F<
MY@5\J%J"B47DC#\=ZJ\\).NJ2V'\W4$T^/EL./PP/+DXC\Z&[P<7X,-%%Z?1
MQ\$9_"XZ.OWPX?0$[GMZ]'^)CG0_B30TNO8D'4O$]2/*LJ:/WZ+>>U[]NP,F
MM/U89-=H<3XJN1Q7M$VV%FG6F'(1N1884F^2O/*IHWP^!\M&#;M!M)<MW[J,
M I8T@<?0[1B&.V5-,)KI7!!2 76N:!7I94;5PH;Z1H300X=3X=SZ/0/FS[>B
MJM&;EA9F!N=+RU]-U]?UI&;)3<FD<::AW_1;DI8?&';TR_!K;LD1"XIPKKA=
MF O2::'S@]#U/-/4(AV::L'8"PN&.[7T;3M?C^G$V"4_Z %V+5,:G6&J.%/I
MW06[!^#O\^:], !)?[V$2"88,1B^&@H^8GX;*[L-W":<0<S&&)95C/Z99[0E
MG3IVV[C0\5EEJ"A46H4)'E(Z<;::6@5+(FTW=K<S8(U5MYJK#U(0'43)A'\-
MHQ&V$"2!I-:'K (:'4;!4:F+U#C-3#$7X*PD!A^_7AQ B-3-B> W4UA+KFEY
M3Z9ER)U8(6U5:K$3PIK2G]MN1^PQPA3 ";V--"ADT![S)*9&623T8D3O]K;M
M[F9!C?**.6")R\2#%$,$V *SK0.!OQ->)Z,]2J]2BNJ6<X&O@$"3<3IQ (S\
M0,J/:MX,/UZW$W@^4=0D%&UX;N85]LF3T)>H=3F5'\>8$TE-D:K09<O5^%R@
M8 $!"H3=R-WIBVOS1[+P#BY[RSF$G68.D_K28PX.N]]A-',6]PP@TIS7P,<_
M$;' <8UK5G9J"4;SF3ZP[E#NK1>+@LX#'G#Z1I)+AD[3B^%'SJ;F!3&!0&DD
M:1M?X_%P<L09#FSYQ-S/=/Y9>F"]7H&^WZ0T+H['SV'Y<Y'E#"]DEA%?893G
MOY>M^Z5&A.2:'QC!=9;/#)K&8;]9QQ! '.Y(ST5C21,"#L%C\,*FQ19<V-Q_
MR/@<AQ +?L=$,5B/O(VXX@\.7JQ'07CE4A8'3,W<=4N<!R4E8:0)QKY!.VGP
MW'O/XTEX'L$<S'<'+Q\(<2O2$!^K$1R3T3'3$^'..2"7@UJ5DXC8L0BF^#LU
M\"3*BE[7U:N[)JLKI[<6R;R&1]%9!=\[_.:;F/LH'/[[U4T>82P1XK\/P]NZ
M'4::VD85AY"ECJOT'!)+X]*P+7Z <_@"C0*,%/YQ:>*<X6?12ARHWKQTQ\*^
M) 5-["T2)1&C[UBZ&O%2.V2'!+]A1;U<K^6R2!#H2'/49VY^$B$I/9:744K7
M4-88\UQ68= %)+KQ2^-AD <33PSG*AD3,\%O%O4N)JN((L,1HKK -.V%>YZP
MV4(;]0T%3._32SSG',:D,=8GB4&?60'@8'\&8RANC2=AF<955C6T+R7ZMJQ%
MZA0GA>!P38?AC =!#)@*Z-6#E_,,^@D723I#[OY:UC@H,6$OD[C-/8QUU9#%
M,'O6??D,W6OJQ^D_)GSIUZ['?[^OQ]]O/?[EOAZ_:_7X^WRXBW?#;@<<MD]G
MQQ?'0RQ]?#P;G@]/+H9OHG?#L^'K7Z-W@W\-HY/3B^CU<'@"'_CY^/P"_O(F
M^G3R9G@6P14BYP*#HXOH]&UT^,/+EW$T@)\_#.%C;Z(>?LY2Z<#'7+Z<.#H]
MZW:"%WP_^.4<KS@X^16>>' Q/,!/G/LW/8,?/[W^YQ!N?G$*8SR_.#L^NC@^
M/8&OGD079X.3\[?#L\'KX_?'%[_"I=[@9P9@,?"?'P:_RO.93\+C=3NG9_BI
MT_=OHN'_=S3\>(&/\W%X]N'XXL)[>GQDO,[@X\?WQT=DB&B@]:> 8^?3V?FG
MP8D,$B?R;("CA*>'>PP_?*0?+G#BWYZ=?J G[7:.S\\_P:U@#AH/CD,_&_Z_
M3\=G^"C1Z<?C$[K<V^CH]-/)^?!]='P2O3T]^T #A"F"@9T<P27@MN=O8>"G
M9[_B8/ QY#;RT_#M6YK-=P-\N%^[G8]GIQ]/S^'!=8XBGA^<Q>-SO,_1Z0>8
M +K^+\<7[_RY@;>W:7[VP>U?\.&V,""UW?G^&';0H+$Y835<X%*%A7-\PNON
M:'AV,8 ?Y/*_OH.].#P[C_YY>DR;SY1LX^@-K"?<LK25!F>P^&'-+8ML%AW&
MT8OG+U[$L+TO?D$+ALN2-N_Y\<\GN)YQF#"N3R<7Q^_IKV^/S\YQV9X<_PL^
M-8 MPGM/_O!A>/8SW)UW"'PDNCC^ %9I !O@(WX4XE5KPMH'C;MF\*_!\7O:
M$;C?W6WXZ>/I"6UML&4[O3%VI)3NXQ&^/X#%=/+FF'<)+,ZC]Z?GX,4>[+$'
M>^Q!?>%\+]B#(UO*@#CU=(/DFJUM;A1G,XS&]#<1([6-P:0N8-%6*C+1IFV*
M';RU!).A8G>2=C8S:$LT#)PD:AJ4[&/^(0[(I7@O8@G8D=!\#J=0U/-AEUY+
MK-]K2AQ =>77-1WQ.Q7M/Z)M==^T+]0FBM  *X]'JQ=6_2]$S>AOHB+PN1OS
MN7K'M(<$<.J-+RDA;^K JZ(274XP<H4*<\+?#/97$LVEU_/N))W#TC>DA7*5
M5Y>X;Y ==.%\V+)TTL5ZM,=)E40S[&N?E+<C9Z@STW:N%=<BE;LD$0Z<%7<F
MU+Y>DY;&9X_<1T^82,N,+'9HQFEPKDJ?3O3;:C%!&"KVSM9?Y:8;RESK%#N:
MAU?)"B<D+S?.AN$LL/I"HUOS^DC]4(?Z0=_I0$"N;%>H^"C-PM'RJDA*PPF+
M3.F;1HW3INW[+6O$>_NAI9)):73]LW8[-VF1;EQ0NV-"=LUBCOKBADAMSAI'
M7YZ%"MUPXJ(#R0H@ JL0E:.@?3-4,$$9SL32_%O,@5 =FQNQ39J[6K(62<G9
M3V:^:VR"W7F)N[9FQ[QF3Z?3;(QX&RT(V6H6KV+?D736L:#%D%/<*8'%R.^3
M(7[#:**IUM)5EDZC(:MKP/?ESJ:8:IDT"S7.K# "MW1Z4-4=3U8!>;M8&>AL
M36S5]/-KCZ0>">&I')<$H@M#/%K[]:AO((NUO\SX+Q;2PAX^[/#=65N[MI4F
MO)5@&13I*BENVS=3RY$@VC(,=JC)@_OU90-#YSLU:1(G+%G6HOO(U[JE,G2I
M)*;XL6PQ1A6MQ1C<,H1J)<1Q2P=,!>Y>X?!!Y;QO&YZ]U<V!45BQ' P@^2!B
MK(L/#%RMTZRQ=6@CIN,H+5I-'J,^MI"-B"X>'IM*ZL1&8>F&(_ZD'B^<YGFZ
M].O;&=&MZ3BHHXN'0- 6Q%22>^?Q;S7G77CYB=@)QV"FT9,J>YTG!6&$WF3H
MRN;-V:W@R,_F>84T5O)*_E>OSZIV"B62]T"L(#P_0JC&;P$1G&)SMU;TB<U?
M3;+#R5>X:1%:(!R8M$D_10)P95@1_[ [QF+7;&.JR01AV+LUBGCB)0]F,R/@
M,5)!3D61,?$%DC"C!!A[PK 9?@87N%A(<#NP!JI@XT0$>1I^6J]X*JJ=H36\
MS6I51R9HKQQK3L<^LEU1LQ%%A2J1JCN7?9&8&#Y+WF&$S"@]D4YI3^(>'(@T
MZQX8W4CU!&/5"A;U8L9_(V_O>O%'P9USLL6D!-H8"G=GY7X)QN?5'N-SOQB?
M;_88GUW#^#SP>33E\^@"6<.%"O-(;'#312='<%/\^X6&5_M4M#7'LICKF>#D
MRG,.3,=7Z03AY1AH3CG0K"G3GBG>TZB#N4^GH*/=>=^[MKPO>7G_W]0*@@34
M7;T_NVLZ&6.:WVAUU;O3UFO+!:[#7H47WFZZ$G,>^MH54T(THQ2DT!8FO-?@
MVXM\\8S46E9,:TR_F&3E&.(O#6'Q5R)4G3#*(+$1J G0/&56/Q"UX:>52&M]
M '$X'94S_9!#66U8?#$L7*N.$O7L[L:%\ [IZ Q<VY?>0]O5_(R\F+):8G%E
MPE1 7-2UL^S,B:MBZTFQ&?_;73]N]-LL%YN\G%.MXE8[SE]0-UE)'(]3["!;
M26VHVX&75GNOD?L.I<IB.S6GQ&ZTD/J,$[H*;+WNJA?I7*BX=?1F"1.)N+)"
M\P(2EFP"^*?\[Y0;+5?!.=\=D[-K%O9* UI.DTD,J1X#)W)PS4AZN]PVBX[K
M2,N5A;UXN2'MQ@L4?S%/YZ/FWTTN<J0IIHFFF&)5:$A+3T!Q=U[FKJW=C-?N
MQ^065E/T/K7BRFV9:<TN<":"'%UA;[NYRE$3E/(S7BMC6'P@CK ]B#N>C^'Q
M1K#DD'VT7OY!W5EO?.)06U%3ZC0>I\Y1S-W]QM&6)1VH&%D!=G<(!*YP<ZU(
MN<7MR$DV,:D0DPF67,[[+%VXO<M,T<+]CHN$U3!F,"J,$.CD7! SEY[TX"TX
M&F_4Q!U ;L7^W#006.=5<9U1ZG>("2+YR'F*);"VS]C<^E2@*M9[>4R V_W>
MO\^]_QOO_9,<%NY*JJ&\]4]R2< B>7\F/EP^3E-2F3 IP67*"F"4144&@13M
M@J '<#F-\ZJ@;_]/E939L]_ OZ54+/% SK.%="=C6S-2,(QOE;Y@"DYI@;R3
MQ&$2,X_! K\;1[-\S)=05I/?JB(K)]E8R9R< 23%*,-;H&X'IFV)M#FJ%M/D
M.B\(U0ACNF1K-,$2&@HG9XO?JH4\/F7.B#"]PHRS$%(N"VP:9@BH4T0): II
M[^1V.64:Q QSU-5BEMR _6 #L/E[+&AM&4(22Y!!W!/E.&.)Y'3Q6\[)8:+J
M8%-.26E&F8C!$G)!_(F,)8^#F1Y,O1Q576Z8/UI(J'RSS:)N[[')M#'-T;I9
M[L$$HT>]$&%#2R>JVDK6R%)FD;PE0XW8%*H1D[]WPI_JX_9^9V/V<YY/HG.5
M)G1JNNN=&IN/0"&LR&@;.I7V,M)JD8&EJ/:16WQ';B2W+J\_O$EA0R>2?@A^
M4SZK$JKLVWBV#3';%+J2]T];3H*-NFX8MV.[7XYM%L)]!MC"C,9DR=O<7H4X
MD=3$>D3RGLBKBRY(V-/#V-@(/T%XW^U,$=W3^[9O5>[>)+=E,"^P.TMVUW;H
MC'?HV^.SCQ>#:"/*K+E399.RR[OQ*K%@&\%)26:*.X<] YN"Q$,Q:43Q2;+R
M=H1P?^ VQ=.$V9M2Y.#]M* 4#VU3#)-1G$%HL2F4X?X,9Z.L0]XPV*&M1" I
M>X^8I8P.#PZ_^>;;9R]ZXW[O):O('1Z\^N%[^,V5(6JY*$C[Z];AH2Q_PEJ!
M4F<R?(V>FUE/+&^#/K UA^11N'@C27[!K/N*<W74G4>!Q=!3Z2I!W@A4/\/6
M++SI1?(Y;4)58:#56%$]JI;F$;D8OAJ8$YOBF.PZ0'5#0?J'?4'Z?@O2W^X+
MTON"]+T>E',3EV]HA^&#\CS#];8NST:0.H>-D/-XJ,=)[*4."6?]1MW.< _R
M><J/VUOP8GN3E263D9X3 R,O+</GA'142G&GK@[UG%+Y[MM_KV-3CT2BT24'
M-BMODL+(A,-;>U 1X)9D93)C4!XLX!AS&P3^@]@F?-V 3*PZ!2^^>Z%C>O/S
MT?O=>:&[MGYS@[1W&<<:#-$.XJ&%I&R64<TK@*O)^TXG*J_@RNUF\0 -Y+]R
M>BRIWZ(QJMUY3[NV+)>R+*WA-"AG&]Z&_MJ*YG70" )4H+8JYCANP>8J$S&7
MA'E5\B4R./JO\S%5Q[#O0'1&,8G,\5?)=+X3!J-978:P):;@3,#0#9X!2K9+
M,2O88+"&'\'C5:#'+/!'FVUOF<5V2@.8"U\_VXY"GJQ.@+BO@#W1Q^W]C^S2
M)<1?D_(J35=:_UI!^%B6[-[<(7LI356K35GF>E,7EU><<?@4 -8:2"J&TTK8
M[QY'J@0<6W8 -@EUW\C??3_AQW;F5>_4R@[+FA6"<T9;Z,"48$'A86(;5[:%
M)]T[/;=B*@61&6Y+4;2'8DO&N+YG,XL 7/G/A^.&@XQB# <"R+J'6'$DN*'W
M-U/EG"*NHMLITFE5)C-ISG\&_TR]S_MZ]$84L8:>5-H*Y]><D24N:1Z%X#Y:
MR,5W9?GNV&Z%K5E*:<3%\=3Z4?FWZXN8[5%)$R84O+P-7G9G\G=JK85/AM5#
M"%ZB7X51 ]:AK K!4'6//"TX2^'3Z([)%-JQR)V,TP_/3<HIN02#B@)KX= D
MCDZ7>N=BC%$$)[A<\JKZW[J=FPRCJ22;<3041UHDU/*6!CPP%@'C@[<%&PTK
MA%:I1LX8<-4FZ92".#AI20[BV^>'GC8<5_H\Z3A%_]7THS1<07)X#8/\$"U(
M);]HF@">=27G4!C M"Y0A6 %@?^X;Y(:R(N<NG*KTC:6N[((+2)Y^@CX2;@]
MK8"5H_LSFE7IL_+W6YU(U*K:NZM/]G'#1JE25#TA9O]C/DG*JY\^PEK,4%&*
M-_6VH)YZN/4E#7IT-IH&/6WE440OKO3Q+,GFI8.+AM_=NUD]RT=P<G<[KXL,
M;-N'=!9]&*.H328<<!\@:DS@MV_2]]4XX<#/*+!PK%J?1(/^%2^4A%PL/0X\
MH4(EB.5BGPYY+(_[ .RI+P+LJ:'>$8=1-42>6J\'W8TU54$I;5G!K'QPTE1;
MFC(*0_HL>[K4I[:/OB)=ZL#X2.'B_9<2ESH?[G;HTSTE[/16[Q9<EL29(G=
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MMY]46*#F]XM X+7S*8N6EG32!C(@5@VG$NR2Z?D>KN?4XFTU8ZR1:O@."B:
MI?MPP;,M_5N/6K:I'K+.\PB6+0#KV-3UYW>A[HQ]WA])]DAZD#,)\U?OLV0$
M%HW,G&.T'2MC<#DH&58A[P]:ETF^!#N'4LU8 ^34S@3ID;(18BF3B+@%P7B
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MRJ;\06=023F&( _&BL=(7,NO\]:0]6;6&'[R@!G<;5^F*=R$$/UK^!_K^/(
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M<KVT2%@)"('3<EQXZ][A.JR)T6S]FDP6M9XR;JF',1/:7>I\DOLND=9C07I
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MAN-G=74:^X,[Q''S63T$(RBH@.GKB12,%V@R'H.+X":B\-48PT!W=Q+];0D
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M3M\'@66H(:D?X5\AEW?=:+E48C^1A';?* 7;S<'*/K^C<X<E _5]A3T0.8>
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MH:*<5VYS#AU)O&:(2B=-&MO-YV#&NN0*N-2WL7Q(3?%C6U"HR'OQ9M- Z*:
M@\Z.:#D>+;+IJ-X^0.P(/' ,+;R2FY&'%HE'4_B0:E%(_%A9RO53U9^+-+$B
MF))$,6 .Z5X:+?<VR9F ;H*:>@KH/ WX)&)(>@72^2'*-L'_39FT5I.LG(C@
MH%K-C.' _#?(/ZT@9X.:R@/?\A+["H:=(X.D*2I-F8=^+QC#43BU!6Q2!X\*
MJ0J5\EYA:N?IZ&"KDEL^Y_MX8@*@3:FUR3<\I\9O#OR'4+MT!L=VCS'R61V=
MTG8)(CK$>#'G [A8.AY#"I!) 0$"I4.GPMG5SRFEP%IUT-&P@V4]U6BF$Y9A
M3 L&X7GEAJ(.-T3F DYG4LR9ME*012GHU'6ETLMZOC23Q. F$-]%B"EEJ^<+
M3NZ66:7:/(TD*@"2NUA@6D4Y5.!PD2HEP4RZQV+6W$UR\U*1M]23P;;>M+EZ
M<!<YIG37U[GV^>:A<\SJQY2)9#&]@;N_?7D/[CL+#4U2_D$$F+I3C ZIQ.3X
MK"5K5%N1#X>!4+ZL7N@"+%$E,<4\CG0O(MW;-9JKV:*NX^-?,/KL4E YB=56
M<[\6^R1ZC-6T1R0>F[ Z)2YVD[#SK/:2U3ULS>B1X7(0G"EN-GOZ]#$KP& Z
M\( 4"R[E-LGN?H\FAX& $J[AO4%)QEUI.UN]60[&!=[FG SEZJMH*IO'Y!K0
MN7.,71V:;CRZ_+PN\O;JN_C4@ *S-;-('6GUJ92L5Y]BUZN/Z.:X2\^2%W/I
M!=VUD+7D;(##"[J?H:1^N$O?N$]K "0SN/JL@GR8RR.G77PTU_W9HFB@:*_W
M.^>Q*AK(9)O2R6"N8H#$= ,'W9+$=V LOZ)/'1?0 S9$KC(0'&OE(3'2U8Q.
M5V+1C1U+S :?!:-3B:$M4D)^J]ACX9O[$+BFZ1V,.A<F.Y<B\)M$&G!O:<;D
M,ZP(1_IV*9T8+S=IV#8GCT9GC8U=MR!Y02MN[Z@.5.T,L=& V\RH;Z.DKA$)
MZ+A'M=-:%JNTWC#<XN72R4TY_%V:0AS$2UE1@7CEE&P)Y=?Z$8+IA+,_[CP9
MB'O,7E=J?>B40B_ODA05M*$X(')72A/M)%:PW-)GRS-7P ?R-IQ2$,R2#=\F
MLS'>IAL>^4*8BF^03"J&ZC<=_UGN%5PLW8_17B3(;")=+ B%9Z0,HB+E2Q]=
M>9F]V .GKZBR'5MTVO6(66,K2_2M^<J:+R//THX(P2ZS;4_,*O%B+WQ&:*5M
MR,UFPB?)H0=YTFV--&29V+*U*C)""J;@OF+F0?1T!3E\%R/1/:.0@_S5^#77
MSNEK P0Z!(D=W [DN'(ECCN%N91.F*QBK(OZ>.%EPE\F5T[*9"P*K$6^C"/H
M>(%.!TG7\&2_=WRP1T=-*7.2&C[93DA/QEH^AAA3XN2R2!)UV6GC]DW?,CP9
M ]: \]B,&J3MB+(TBC;M.;3M]Y@I$)P&D]0C@\Z*%YJEL(T^6C*[-\]OOVV^
MWVY1\/VU5Y@O:MC5I](ZK)O[-"A;0>I%V Y/I(EOIO,8<78;2OAH3*5/ 6_I
M.M=><:.1.;/<,4"M\6P8EKTR'C(NY.)!DRQ,9GU6SP*+<DBFW6723" -R'79
MM6W0.^1S4C&=D@XZI%0!,R643 '_E?,=C0/9[Q7Z_.OSY]UUTU\60J;[1/<H
MD995.]_[U=]_H!9N'!'VJ.V,+\'-IH[2^/OQLF42KD0>1%:%^,RW9^-/'OVP
M^=/VCYM;C[?_?GMVM1?I^-^!_?>9R:DO: @7YTZHKE6S';__U]'>P<ZZ4BW?
MCW_CR/'YAHT?GJGW<K/DCCK4H;KKW_BC_HT;T6&Q7C ?TG\82?Y+2?0?5/H_
M4$L#!!0    ( $0TA%0_G2Y_T"(  %WP   +    9F]R;3@M:RYH=&WM7>E7
M&[FR_\XY_ ]ZO'O?@?>PL8U9D^$>8I9X6(/))#-?<N1NV6YH=W>D;L#YZU]5
M2;W9;;:8Q"&>>V> ;BVE4NE7BTKJM_^YZ[OL1DCE^-X?"]5R98$)S_)MQ^O^
ML1"%G=+FPG]VYN?>]D(H!V4]]<="+PR#[965V]O;\NUJV9?=E>K6UM;*'999
MT(6V[PK+U2J5ZLKGD^.6U1-]7G(\%7+/$DDEU_&NQ[>/;Y.B;>DZN:+X).YD
M=66D:7AKIQ6RA==7],M<T;"PZ)HN&L9%'>77:]6-^^C0)9(*=^/*5I%F&*'X
M_.[B."T>%I=/BZZ$DGNJX\L^#V$.L:6U4J56JJUG&BDI8>4:@K_+7?_FP78V
M2ZO5N)V1R<F/%%^WN4HX;HLA=L=]P@NH4:M^K<=%I>B,;7A]!=[&!2-5ZG(>
M)(4[7+6IH'E![98JU0S5\$;ZKE"%=>A-027+C[Q0#HKI-R^I6EQ!R7"T WA8
MT';KY+*9E%7<XY+WA1T*JU>V_#Y6J%565RL+M.H$M^$GPW_>AD[HBIVW*_HG
MO.V+D#-LJ"2^1L[-'PL-WPN%%Y8N!P%,@Z7_^F,A%'?ABEZ<*UAOQ33[]K]*
M)7;@"-?>9BT1OF&G0,DVN[/OWK#F'OWRI5+;_?*Q]>_:WN'N[CG\P/&P4NFQ
MM5>WON!XOXR,\TL\SB<T5M_2M>J5:O++$ZJO5;X(D#T8!/Q_WP,V#AK '\G=
MIF>+NR,Q^%*!?S:J]=K:^E/:W<JTN]L7G@W_A@<N[W[I<%>))S2U_@Z8O?>E
M^L7 AFX3'CVEC=J75H]+H;[4OA!*ZD84/7M*.WM(R[EI:W6$I+&-MWU[P%0X
M<,4?"QV0P6U6K00ANW3Z4.14W+(+O\^]9?U@&0B03H>DW79NXGJVHP*7#[:9
MYWN"7CIWVRBV0N)ZH+\<VQ8>K0[\$PJ>1GUHR]*"?Q=>(*H<2+^/LE*JU&$9
MAG[Z^P+S8-30E7"V"Z5A82<5A[<KN2Z^IU<-L7\L "QOMWT (.Z1F&3IR4G1
MP@Z]+R1A)<<(I C04DA0X4+I$@C+VXKT+9#&2(EN]PAQ53]T2O$Z+-\I>\&\
M#@$_X+73#URA,<-TE6]<=Z?\2,:]03&2BFW##.;8]S(CQK:XFJ!Y2)XFSQT;
MWW0<(1D-110JLT;S*#]GPY73[E8*^S.]!<!?WQZE BP*&>[Q4.RD0XA;2M^-
M5(.I'%,I?C-,5HZ ^*%A:9[/D>=H)L."'.%F7W 52;%C5NXVE(D;BU_EN\#6
MQK2O86!L%X8)5.C9?:1P,](/0 -,XRAOL2XM"![Z,O/ZZ3P8IK&HU4RG>\+S
M^X[W4+</\V6XWZ*&X_<Y+HPPU*S0S'K4\!"CYML5J \_\7]O@SQ"MWW7?@1,
MOV%]+KN.M\TJ;QA*8XF[3A?^M& E";FP\S__75VOO'F[$NR\9"])^QD]=A&Y
MHG3.NZ1NLZKDUK'#'NJ@RK\7<B_:O@3&E$(_V&;O7&Y=LSI0IGS7L=\P\[+M
MAZ'?C]]7RVMI"1Q223G?0'%6@S =.C+9_#=#WDJ.OE<P!2K@WI"6WWQ8R[]M
M[WP\;5[N[\W/M2YW+_=;;U?:P"UL;&=Z26[M-SY>-"^;^ZWYN=W3/;;_N?%^
M]_1PGS7.3DZ:K5;S[/01XWBA(=0>-81/7/7 IP]];WE^;J_<*+-:9:V^=2_9
MCUL#3QP8%*V5UQSO.<+[&ZR.@[.+$Z"+ZJ-.1%-\J[)''D:IM.=;$9J%Z.!]
ML1)G*'6+OEGOKHZ#WE6M_L&"]K[7+L[VM["S63H:-D(3V?E9TO\(SR*>\BDE
M#R8=T.5B__1R?NYB__SLXG+&S>_BYGDD5<2]<'XN].&QA>$L5EUEOF35M45[
MB?D=%O;$5',9E8ZP(NF$CE#S<_MW5H][8#OL6B&27]U:K4\U_5,N)>AUS<\!
M(R]$X,N0+>(#9*S@8%(+%3)Q STP2:^%O;3-AB%Y=PB2S\EGV]<>73$V][>N
MK8M/5\?7M^UG8W,V>F!#3WVHU[/Y8 "4"Z\(NW.$+>SL!M)Q67698:MCX7Q*
MYZU8K$+>=@4T[;KPW**=B\H"_1UPVX[_?O(0,HY#X@]8ONOR0('-'_^F7=6W
MH7QZ!S="AH[%W9@YX(G$CN_;T'X)*RPWI,D:+N/6APZM78BNHW"'(<108_'R
M\-8..YZU%Y[=/']Y#(?T\OTN[+1V3W<O=C6/3_;W+O<;[UGSM%%^C%T3VO@?
M^=+S_?CV)KBP%O?ON!5J6I"'B(4RX1WCBJE 6!A$LYD#TQPJ!AH)H%$N%?-G
MA1;ES@P\7AUXK-:>@!V/,W6&L:.2PXZF9_D2]##M2[9"T&(-O0/7\.TQ4'+Y
M^; NO>8_^]6):%K</L4(;R@"Z=_@^LBKVD?0N;!S*>ZX>B3.? <H&*E-IIPF
M.YF\"<_=T)(JHOS7E,!J3@(/'%? C+6%+!:WVL;)>D5] GML8HHK[1*W-*JE
MU:WUC<V9]/P:TM/(2<\EOVN:+2B+L.$^4=H]/+R2)S>UYJ4[,5D:0\#"SMI6
MJ5;#W)KZ;V__$%YK6GS)_+ G)+L"_UO9#@40WK8E;83Z'5W(R8+]TH16WX]=
M6S^'T0V_WW<4IIL9@@QC$?"8%LP9.Q_/SN9%2U.RWP]<?R!DS,_\BM=E3OWR
MKV.N Z[&7!\-=/V:5ON$T:X049-!U+=PO_/9TZGW12O)G[$*GO@D#RO/K9SR
MW+5M*90R/XX=3U3'V&"?;@^O5QM1Q:M.3'$6=+ZP4ZU5*GH:6Q% 6<AV;X07
MC:3G&(E='@D<;CXPOMH8EZ9?;9R)]U^MQNH+CJ^VL-.*G%"P>O51-D$02_2O
M)V>K1?/0@%_/Y*5_ZQ7/PMGQX.,@N*[O7W0G/0MIUPL[![XTP9A/\%OOT;)5
M*1H3F39G\AQ<5[!:QGC,M0VO=;1YY$1[S[<[G^PQ%Q/X!%<Y^&Y=7(B@15";
MN$#384,,TZV731;\7WK]O"N2M7,?)MW]QPG&QV;^_+#[^6YC[^JKZ$QZ">5Z
M7]C96*]6QF]Q_"Z>C>&-\6TZ+)"PR)R NTS<"2L*G1N,]H*A*-3,\'X\6T'*
M-"4H:[^.53WE&[/I?LW__/=FK;KQ!N0V%*X(>KXGF$?NX3(ZWVZ$5C[C4G!
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M&GBQNF2R ,>/Z,7F*_&7[QN?_GH]2=ABK6C>9LKO%0]X-]1^VG/TW2V7I%#
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M7(BB'3H??IJD?";1$[>_>!B"XA@5&IQ\$!PM(&!R:;/>7..225JEPQH&A9-
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MDX@;ADHI4EI?*V4U#%N*9*2[@L!J2U=_(S&(BK<Y:C4"C?KVV/Q?[J)'88P
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MD;P><\-RM&3H:T90_DC09?E:O?K*]2H?GV])B2(YX4*-UFF,N0VC+K'S-Z:
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M2P$"% ,4    " !$-(14\ZM)W1OX 0#I00\ "0              @ $
M97@R+3$N:'1M4$L! A0#%     @ 1#2$5#*(F^"&%0  5VD   H
M     ( !0O@! &5X.3DM,2YH=&U02P$"% ,4    " !$-(14/YTN?] B  !=
M\   "P              @ 'P#0( 9F]R;3@M:RYH=&U02P$"% ,4    " !$
M-(14$\LG<#P#   $#   $0              @ 'I, ( <VUT:2TR,#(R,#,S
M,"YX<V102P$"% ,4    " !$-(14/&)X[O\*  !LAP  %0
M@ %4- ( <VUT:2TR,#(R,#,S,%]L86(N>&UL4$L! A0#%     @ 1#2$5,FL
M=3=7!P  RU@  !4              ( !AC\" '-M=&DM,C R,C S,S!?<')E
:+GAM;%!+!08     !@ & &T!   01P(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
